[go: up one dir, main page]

WO2022038500A1 - Novel heterocyclic compounds for combating phytopathogenic fungi - Google Patents

Novel heterocyclic compounds for combating phytopathogenic fungi Download PDF

Info

Publication number
WO2022038500A1
WO2022038500A1 PCT/IB2021/057545 IB2021057545W WO2022038500A1 WO 2022038500 A1 WO2022038500 A1 WO 2022038500A1 IB 2021057545 W IB2021057545 W IB 2021057545W WO 2022038500 A1 WO2022038500 A1 WO 2022038500A1
Authority
WO
WIPO (PCT)
Prior art keywords
oxadiazol
chlorodifluoromethyl
ethyl
methyl
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2021/057545
Other languages
French (fr)
Inventor
Paras Raybhan BHUJADE
Maruti N Naik
Santosh Shridhar AUTKAR
Ruchi GARG
Alexander G.M. KLAUSENER
Parsaram Dadasaheb ASWALE
Visannagari RAMAKRISHNA
Rohit Arvind DENGALE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PI Industries Ltd
Original Assignee
PI Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PI Industries Ltd filed Critical PI Industries Ltd
Publication of WO2022038500A1 publication Critical patent/WO2022038500A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • C07F9/65306—Five-membered rings containing two nitrogen atoms
    • C07F9/65318—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups A01N57/10, A01N57/18, A01N57/26, A01N57/34
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing acyclic or cycloaliphatic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/26—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-nitrogen bonds
    • A01N57/28—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-nitrogen bonds containing acyclic or cycloaliphatic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/26—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-nitrogen bonds
    • A01N57/30—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-nitrogen bonds containing aromatic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Definitions

  • the present invention relates to novel heterocyclic compounds which are useful in combating phytopathogenic fungi, a process for preparing the heterocyclic compounds, a combination and a composition comprising the novel heterocyclic compounds.
  • the present invention also relates to a method for combating phytopathogenic fungi.
  • Oxadiazole compounds are known to be useful in the pharmaceutical field. For instance, WO2013066835 discloses oxadiazole compounds as pharmaceutically active agents.
  • Oxadiazole compounds are also known to be useful as crop protection agents to combat or prevent microorganism’s infestations.
  • EP0276432, WO2015185485, EP3165093, EP3167716, EP3165093, WO2017110861, WO2017110862, WO2017110864, WO2017211652, WO2017220485, WO2017072247, WO2017076742, WO2018065414, WO2018118781 and WO2018202491 disclose the oxadiazole compounds which are used as fungicides.
  • oxadiazole compounds reported in the above cited literature have disadvantages in certain aspects, such as that they exhibit a narrow spectrum of efficacy or that they do not have satisfactory fungicidal activity, particularly at low application rates. Therefore, the need remains for the development of new fungicidal compounds, so as to provide compounds being effective against a broader spectrum of fungi, having lower toxicity, higher selectivity, and being used at lower dosage rates to reduce or avoid unfavorable environmental or toxicological effects whilst still allowing effective and long-lasting pest control. Therefore, it is an object of the present invention to provide compounds having an improved/enhanced activity and/or a broader efficacy spectrum against phytopathogenic fungi.
  • the present invention relates to a compound of formula (I), wherein, Het, A, L 1 , R 6 and R 7 are as defined in the detailed description.
  • the present invention also relates to a process for preparing the compound of formula (I).
  • the compounds of formula (I) have been found to be advantageous over the compounds reported in the literature in either of improved fungicidal activity, broader spectrum of biological efficacy, lower application rates, more favourable biological or environmental properties, or enhanced plant compatibility.
  • the present invention further relates to a combination comprising the compound of formula (I) of the present invention and at least one further pesticidally active substance for effectively controlling or preventing phytopathogenic fungi which are difficult to combat.
  • the present invention still further relates to a composition comprising the compound of formula (I) as such or the compound of formula (I) in combination with a pesticidally active substance.
  • the present invention still further relates to a method and use of the compound of formula (I) as such or the combination or the composition thereof for combating plant diseases, particularly phytopathogenic fungi.
  • transitional phrase “consisting of” excludes any element, step or ingredient not specified. If in the claim, such would close the claim to the inclusion of materials other than those recited except for impurities ordinarily associated therewith.
  • the phrase “consisting of” appears in a clause of the body of a claim, rather than immediately following the preamble, it limits only the element set forth in that clause; other elements are not excluded from the claim as a whole.
  • the transitional phrase “consisting essentially of” is used to define a composition or method that includes materials, steps, features, components or elements, in addition to those literally disclosed, provided that these additional materials, steps, features, components or elements do not materially affect the basic and novel characteristic(s) of the claimed invention.
  • invertebrate pests includes but is not limited to fungi, stramenopiles (oomycetes), bacteria, nematodes, mites, ticks, insects and nematodes of economic importance.
  • pest control means inhibition of invertebrate pest development (including necrosis, retarded growth and/or death), and related expressions are defined analogously.
  • agronomic refers to the production of field crops such as for food, feed and fiber and includes the growth of corn, soybeans and other legumes, rice, cereal (e.g., wheat, oats, barley, rye, rice, maize), leafy vegetables (e.g., lettuce, cabbage, and other cole crops), fruiting vegetables (e.g., tomatoes, pepper, eggplant, crucifers and cucurbits), potatoes, sweet potatoes, grapes, cotton, tree fruits (e.g., pome, stone and citrus), small fruit (berries, cherries) and other specialty crops (e.g., canola, sunflower, olives).
  • wheat e.g., wheat, oats, barley, rye, rice, maize
  • leafy vegetables e.g., lettuce, cabbage, and other cole crops
  • fruiting vegetables e.g., tomatoes, pepper, eggplant, crucifers and cucurbits
  • potatoes e.g., sweet potatoes, grapes, cotton, tree fruits (e.
  • nonagronomic refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
  • horticultural crops e.g., greenhouse, nursery or ornamental plants not grown in a field
  • turf e.g., sod farm, pasture, golf course, lawn, sports field, etc.
  • wood products stored product
  • agro-forestry and vegetation management e.g., public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
  • Nonagronomic applications include protecting an
  • fungicidal and “fungicidally” refers to observable effects on a fungal pathogen to provide protection of an animal from the disease. Fungicidal effects typically relate to diminishing the occurrence or activity of the target pathogen. Such effects on the pathogens include necrosis, death, retarded growth, or lessened ability to grow on or in the host animal. These effects on pathogens provide control (including prevention, reduction or elimination) of infestation or infection of the animal.
  • alkyl used either alone or in compound words such as “alkylthio” or “haloalkyl” or - N(alkyl) or alkylcarbonylalkyl or alkylsuphonylamino includes straight-chain or branched C 1 to C 24 alkyl, preferably C 1 to C 15 alkyl, more preferably C 1 to C 10 alkyl, most preferably C 1 to C 6 alkyl.
  • Non- limiting examples of alkyl include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2- methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2- dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3- dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylprop
  • the alkyl is at the end of a composite substituent, as, for example, in alkylcycloalkyl
  • the part of the composite substituent at the start for example the cycloalkyl
  • other radicals for example alkenyl, alkynyl, hydroxy, halogen, carbonyl, carbonyloxy and the like, are at the end.
  • alkenyl used either alone or in compound words includes straight-chain or branched C 2 to C 24 alkenes, preferably C 2 to C 15 alkenes, more preferably C 2 to C 10 alkenes, most preferably C 2 to C 6 alkenes.
  • Non-limiting examples of alkenes include ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2 -propenyl, 2- methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1- butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3- butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2 -propenyl, 1-ethyl-1-propenyl,1-ethyl
  • Alkenyl also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl. This definition also applies to alkenyl as a part of a composite substituent, for example haloalkenyl and the like, unless defined specifically elsewhere.
  • Non-limiting examples of alkynes include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3- butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1- methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl -2- propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3- pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-penty
  • alkynyl as a part of a composite substituent, for example haloalkynyl etc., unless specifically defined elsewhere.
  • alkynyl can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl.
  • cycloalkyl means alkyl closed to form a ring. Non-limiting examples include cyclopropyl, cyclopentyl and cyclohexyl. This definition also applies to cycloalkyl as a part of a composite substituent, for example cycloalkylalkyl etc., unless specifically defined elsewhere.
  • cycloalkenyl means alkenyl closed to form a ring including monocyclic, partially unsaturated hydrocarbyl groups. Non-limiting examples include cyclopropenyl, cyclopentenyl and cyclohexenyl. This definition also applies to cycloalkenyl as a part of a composite substituent, for example cycloalkenylalkyl etc., unless specifically defined elsewhere.
  • cycloalkynyl means alkynyl closed to form a ring including monocyclic, partially unsaturated groups. Non-limiting examples include cyclopropynyl, cyclopentynyl and cyclohexynyl.
  • cycloalkynyl as a part of a composite substituent, for example cycloalkynylalkyl etc., unless specifically defined elsewhere.
  • cycloalkoxy “cycloalkenyloxy” and the like are defined analogously. Non limiting examples of cycloalkoxy include cyclopropyloxy, cyclopentyloxy and cyclohexyloxy. This definition also applies to cycloalkoxy as a part of a composite substituent, for example cycloalkoxy alkyl etc., unless specifically defined elsewhere.
  • halogen either alone or in compound words such as “haloalkyl”, includes fluorine, chlorine, bromine or iodine.
  • haloalkyl when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different.
  • haloalkyl include chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 1,1-dichloro
  • haloalkyl as a part of a composite substituent, for example haloalkylaminoalkyl etc., unless specifically defined elsewhere.
  • haloalkenyl “haloalkynyl” are defined analogously except that, instead of alkyl groups, alkenyl and alkynyl groups are present as a part of the substituent.
  • haloalkoxy means straight-chain or branched alkoxy groups where some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as specified above.
  • Non-limiting examples of haloalkoxy include chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2- dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy.
  • haloalkylthio means straight-chain or branched alkylthio groups where some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as specified above.
  • Non-limiting examples of haloalkylthio include chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 1-chloroethylthio, 1- bromoethylthio, 1- fluoroethylthio, 2-fluoroethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2- chloro-2- fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2- trichloroethylthio, pentafluoroethylthio and 1,1,1-triflu
  • haloalkylthio as a part of a composite substituent, for example haloalkylthioalkyl etc., unless specifically defined elsewhere.
  • haloalkylsulfinyl include CF 3 S(O), CCl 3 S(O), CF 3 CH 2 S(O) and CF 3 CF 2 S(O).
  • haloalkylsulfonyl include CF 3 S(O) 2 , CCl 3 S(O) 2 , CF 3 CH 2 S(O) 2 and CF 3 CF 2 S(O) 2 .
  • hydroxy means —OH
  • Amino means —NRR, wherein R can be H or any possible substituent such as alkyl.
  • sulfinyl means SO
  • sulfonyl means S(O) 2 .
  • alkoxy used either alone or in compound words included C 1 to C 24 alkoxy, preferably C 1 to C 15 alkoxy, more preferably C 1 to C 10 alkoxy, most preferably C 1 to C 6 alkoxy.
  • alkoxy examples include methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1- dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1- ethylpropoxy, hexoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 1-methylpentoxy, 2- methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3- dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2- ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2- methylpropoxy and the different isomers.
  • alkoxyalkyl denotes alkoxy substitution on alkyl.
  • alkoxyalkyl include CH 3 OCH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • alkoxyalkoxy denotes alkoxy substitution on alkoxy.
  • alkylthio includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio, 1,1- dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2- dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 1- methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio,
  • Halocycloalkyl, halocycloalkenyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkoxyalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, haloalkylcarbonyl, cycloalkylcarbonyl, haloalkoxylalkyl, and the like, are defined analogously to the above examples.
  • alkylthioalkyl denotes alkylthio substitution on alkyl.
  • alkylthioalkyl include -CH 2 SCH 2 , -CH 2 SCH 2 CH 2 , CH 3 CH 2 SCH 2 , CH 3 CH 2 CH 2 CH 2 SCH 2 and CH 3 CH 2 SCH 2 CH 2 .
  • Alkylthioalkoxy denotes alkylthio substitution on alkoxy.
  • cycloalkylalkylamino denotes cycloalkyl substitution on alkyl amino.
  • alkoxyalkoxyalkyl is an alkoxy group bonded to a skeleton via a carbonyl group (-CO-). This definition also applies to alkoxycarbonyl as a part of a composite substituent, for example cycloalkylalkoxycarbonyl and the like, unless specifically defined elsewhere.
  • alkoxycarbonylalkylamino denotes alkoxy carbonyl substitution on alkyl amino.
  • Alkylcarbonylalkylamino denotes alkyl carbonyl substitution on alkyl amino.
  • alkylthioalkoxycarbonyl, cycloalkylalkylaminoalkyl and the like are defined analogously.
  • alkylsulfinyl include methylsulphinyl, ethylsulphinyl, propylsulphinyl, 1- methylethylsulphinyl, butylsulphinyl, 1-methylpropylsulphinyl, 2-methylpropylsulphinyl, 1,1- dimethylethylsulphinyl, pentylsulphinyl, 1-methylbutylsulphinyl, 2-methylbutylsulphinyl, 3- methylbutylsulphinyl, 2,2-dimethylpropylsulphinyl, 1-ethylpropylsulphinyl, hexylsulphinyl, 1,1- dimethylpropylsulphinyl, 1,2-dimethylpropylsulphinyl, 1-methylpentylsulphinyl, 2- methylpentylsulphinyl, 3-methylpentylsulphinyl, 4-methylp
  • arylsulfinyl includes Ar-S(O), wherein Ar can be any carbocyle or heterocylcle. This definition also applies to alkylsulphinyl as a part of a composite substituent, for example haloalkylsulphinyl etc., unless specifically defined elsewhere.
  • alkylsulfonyl include methylsulphonyl, ethylsulphonyl, propylsulphonyl, 1-methylethylsulphonyl, butylsulphonyl, 1-methylpropylsulphonyl, 2-methylpropylsulphonyl, 1,1- dimethylethylsulphonyl, pentylsulphonyl, 1-methylbutylsulphonyl, 2-methylbutylsulphonyl, 3- methylbutylsulphonyl, 2,2-dimethylpropylsulphonyl, 1-ethylpropylsulphonyl, hexylsulphonyl, 1,1- dimethylpropylsulphonyl, 1,2-dimethylpropylsulphonyl, 1-methylpentylsulphonyl, 2- methylpentylsulphonyl, 3-methylpentylsulphonyl, 4-methylpentylsulphony
  • arylsulfonyl includes Ar-S(O) 2 , wherein Ar can be any carbocyle or heterocylcle. This definition also applies to alkylsulphonyl as a part of a composite substituent, for example alkylsulphonylalkyl etc., unless defined elsewhere. “Alkylamino”, “dialkylamino”, and the like, are defined analogously to the above examples.
  • carrier or carbocyclic includes “aromatic carbocyclic ring system” and “non-aromatic carbocylic ring system” or polycyclic or bicyclic (spiro, fused, bridged, nonfused) ring compounds in which ring may be aromatic or non-aromatic (where aromatic indicates that the Huckel rule is satisfied and non-aromatic indicates that the Huckel rule is not statisfied).
  • non-aromatic heterocycle or “non-aromatic heterocyclic” means three- to fifteen- membered, preferably three- to twelve- membered, saturated or partially unsaturated heterocycle containing one to four heteroatoms from the group of oxygen, nitrogen and sulphur: mono, bi- or tricyclic heterocycles which contain, in addition to carbon ring members, one to three nitrogen atoms and/or one oxygen or sulphur atom or one or two oxygen and/or sulphur atoms; if the ring contains more than one oxygen atom, they are not directly adjacent; non-limiting examples oxiranyl, aziridinyl, thietanyl, oxetanyl, azetidinyl, 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3- tetrahydrothienyl, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-pyr
  • heterocyclyl as a part of a composite substituent, for example heterocyclylalkyl etc., unless specifically defined elsewhere.
  • heteroaryl or “aromatic heterocyclic” means 5 or 6-membered, fully unsaturated monocyclic ring system containing one to four heteroatoms from the group of oxygen, nitrogen and sulphur; if the ring contains more than one oxygen atom, they are not directly adjacent; 5-membered heteroaryl containing one to four nitrogen atoms or one to three nitrogen atoms and one sulphur or oxygen atom; 5-membered heteroaryl groups which, in addition to carbon atoms, may contain one to four nitrogen atoms or one to three nitrogen atoms and one sulphur or oxygen atom as ring members, non-limiting examples furyl, thienyl, pyrrolyl, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, thiazolyl, imidazoly
  • 6-membered heteroaryl which contains one to four nitrogen atoms: 6-membered heteroaryl groups which, in addition to carbon atoms, may contain, respectively, one to three and one to four nitrogen atoms as ring members, non-limiting examples 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4- pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl, 1,2,4-triazin- 3-yl and 1,2,4,5-tetrazin-3-yl; benzofused 5-membered heteroaryl containing one to three nitrogen atoms or one nitrogen atom and one oxygen or sulphur atom: non-limiting examples indol-1-yl, indol- 2-yl, indol-3-yl, indol-4-yl, indol-5-yl, indol
  • trialkylsilyl includes 3 branched and/or straight-chain alkyl radicals attached to and linked through a silicon atom such as trimethylsilyl, triethylsilyl and t-butyl-dimethylsilyl.
  • “Halotrialkylsilyl” denotes at least one of the three alkyl radicals is partially or fully substituted with halogen atoms which may be the same or different.
  • alkoxytrialkylsilyl denotes at least one of the three alkyl radicals is substituted with one or more alkoxy radicals which may be the same or different.
  • trialkylsilyloxy denotes a trialkylsilyl moiety attached through oxygen.
  • the total number of carbon atoms in a substituent group is indicated by the “C i -C j ” prefix where i and j are numbers from 1 to 21.
  • C 1 -C 3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl
  • C 2 alkoxyalkyl designates CH 3 OCH 2
  • C 3 alkoxyalkyl designates, for example, CH 3 CH(OCH 3 ), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2
  • C 4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • inventive compound of the present invention may, if appropriate, be present as mixtures of different possible isomeric forms, especially of stereoisomers, for example E and Z, threo and erythro, and also optical isomers, but if appropriate also of tautomers. Both the E and the Z isomers, and also the threo and erythro isomers, and the optical isomers, any desired mixtures of these isomers and the possible tautomeric forms are disclosed and claimed.
  • pest for the purpose of the present disclosure includes but is not limited to fungi, stramenopiles (oomycetes), bacteria, nematodes, mites, ticks, insects and rodents.
  • Plant is understood here to mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants).
  • Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant cultivars which are protectable and non-protectable by plant breeders’ rights.
  • plant includes a living organism of the kind exemplified by trees, shrubs, herbs, grasses, ferns, and mosses, typically growing in a site, absorbing water and required substances through its roots, and synthesizing nutrients in its leaves by photosynthesis.
  • plants for the purpose of the present invention include but are not limited to agricultural crops such as wheat, rye, barley, triticale, oats or rice; beet, e.g. sugar beet or fodder beet; fruits and fruit trees, such as pomes, stone fruits or soft fruits, e.g.
  • leguminous plants such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit and citrus trees, such as oranges, lemons, grapefruits or mandarins; any horticultural plants, vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; cucurbitaceae; oleaginous plants; energy and raw material plants, such as cereals, corn, soybean, other leguminous plants, rape, sugar cane or oil palm; tobacco; nuts; coffee; tea;
  • the plant for the purpose of the present invention includes but is not limited to cereals, corn, rice, soybean and other leguminous plants, fruits and fruit trees, grapes, nuts and nut trees, citrus and citrus trees, any horticultural plants, cucurbitaceae, oleaginous plants, tobacco, coffee, tea, cacao, sugar beet, sugar cane, cotton, potato, tomato, onions, peppers and vegetables, ornamentals, any floricultural plants and other plants for use of human and animals.
  • plant parts is understood to mean all parts and organs of plants above and below the ground.
  • plant parts include but is not limited to cuttings, leaves, twigs, tubers, flowers, seeds, branches, roots including taproots, lateral roots, root hairs, root apex, root cap, rhizomes, slips, shoots, fruits, fruit bodies, bark, stem, buds, auxillary buds, meristems, nodes and internodes.
  • locus thereof includes soil, surroundings of plant or plant parts and equipment or tools used before, during or after sowing/planting a plant or a plant part.
  • compositions optionally comprising other compatible compounds to a plant or a plant material or locus thereof include application by a technique known to a person skilled in the art which include but is not limited to spraying, coating, dipping, fumigating, impregnating, injecting and dusting.
  • applied means adhered to a plant or plant part either physically or chemically including impregnation.
  • Het is selected from the group consisting of Het-1 to Het-6; wherein, # indicates the point of attachment to A.
  • the present invention provides a compound of formula (IA), wherein, R 1 , A, L 1 , R 6 and R 7 are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A),
  • the present invention provides a compound of formula (IA-A1), wherein, m is an integer selected from 0 to 4, and R 1 , R A , R 6 , R 7 are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A2), wherein, m is an integer selected from 0 to 4; and R 1 , R A , R 4 , R 5 , R 6 , R 7 are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A3), wherein, m is an integer selected from 0 to 4; and R 1 , R A , R 6 , R 7 are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A4), wherein, m is an integer selected from 0 to 4; and R 1 , R A , R 4 , R 5 , R 6 , R 7 are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A5), wherein, m is an integer selected from 0 to 4; and R 1 , R A , R 4 , R 5 , R 6 , R ’ , R 7 are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A6), ( ) wherein, R 1 , R A , R 4 , R 5 , R 6 , R 7 and m are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-A7), wherein, R 1 , R A , R 4 , R 5 , R 6 , R 7 and m are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-B), wherein, R 1 , R A , R 6 , R 7 and m are as defined in the above detailed description.
  • the present invention provides a compound of formula (IA-B1), Formula (IA-B1) wherein, R 1 , R A , R 6 , R 7 and m are as defined in the above detailed description.
  • the present invention provides the compound of formula (I), wherein R 1 is selected from the group consisting of CF 3 , CF 2 H and CF 2 Cl.
  • R 1 is selected from the group consisting of CF 3 , CF 2 H and CF 2 Cl.
  • the present invention provides the compound of formula (I), wherein A is phenyl, napthalenyl, furyl, thienyl, pyrrolyl, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, imidazolyl, oxadiazolyl, triazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, quin
  • the present invention provides the compound of formula (I), wherein R A is selected from the group consisting of halogen, cyano, nitro, thiol, amino, hydroxy, C 1 - C 6 -alkyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkylalkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 6 - hydroxyalkyl, C 3 -C 8 -halocycloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy and C 1 -C 6 -haloalkoxycarbonyl.
  • R A is selected from the group consisting of halogen, cyano, nitro, thiol, amino, hydroxy, C 1 - C 6 -alkyl, C 3 -C 8 -cycloal
  • the present invention provides the compound of formula (I), wherein R 4 and R 5 are selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C 1 - C 6 -alkyl, C 2 -C 6 -alkenyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy and C 1 -C 6 -haloalkoxy.
  • the present invention provides the compound of formula (I), wherein R 6 and R 7 are selected from the group consisting of C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 - alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl, C 1 -C 6 -haloalkyl, –OR 8 , -NR 9 R 10 , C 6 -C 10 -aryl, C 7 -C 14 - aralkyl, C 3 -C 10 -heterocyclyl and C 3 -C 10 -heterocyclyl-C 1 -C 6 -alkyl; wherein the ring member atoms of the heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from N, O and S; and wherein the aliphatic or cyclic groups of R 6 and R 7 are unsubstit
  • the present invention provides the compound of formula (I), wherein R 7a is selected from the group consisting of C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 - C 6 -haloalkoxy, C 6 -C 10 -aryl, C 7 -C 14 -aralkyl, C 3 -C 10 -heterocyclyl and C 3 -C 10 -heterocyclyl-C 1 -C 6 -alkyl; wherein the aliphatic or cyclic moieties of R 7a may optionally be substituted with one or more groups of R 7aa selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C 1 -C 6 - alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6
  • the present invention provides the compound of formula (I), wherein R 8 is selected from the group consisting of C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl and C 1 -C 6 -haloalkyl.
  • the present invention provides the compound of formula (I), wherein R 9 and R 10 are selected from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C 6 -C 10 -aryl, C 7 -C 14 -aralkyl, C 3 -C 10 -heterocyclyl, C 3 -C 10 - heterocyclyl-C 1 -C 6 -alkyl; wherein the aliphatic or cyclic groups of R 9 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R 9a .
  • the present invention provides the compound of formula (I), wherein R 9 and R 10 together with the N atom to which they are attached may form a saturated or partially unsaturated monocyclic 5 to 6 membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms 1, 2 or 3 heteroatoms independently selected from N and O as ring member atoms.
  • the present invention provides the compound of formula (I), wherein R 9a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, C 1 -C 6 -alkyl, C 1 - C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy and C 3 -C 8 -cycloalkyl.
  • the present invention provides the compound of formula (I), wherein R’ is selected from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 1 -C 6 - haloalkyl, C 1 -C 6 -alkoxy and C 1 -C 6 -haloalkoxy.
  • the compound of formula (I) of the present invention is selected from ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate, ethyl bis(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate, diethyl (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonate, methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphine oxide, methyl(piperidin-1-yl)(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphine oxide, ethyl methyl(4-
  • the compounds of the present disclosure may be present either in pure form or as mixtures of different possible isomeric forms such as stereoisomers or constitutional isomers.
  • the various stereoisomers include enantiomers, diastereomers, chiral isomers, atropisomers, conformers, rotamers, tautomers, optical isomers, polymorphs, and geometric isomers. Any desired mixtures of these isomers fall within the scope of the claims of the present disclosure.
  • one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other isomer(s) or when separated from the other isomer(s).
  • An anion part of the salt in case the compound of Formula (I) is a cationic or capable of forming a cation can be inorganic or organic.
  • a cation part of the salt in case the compound of formula (I) is an anionic or capable of forming anion can be inorganic or organic.
  • examples of inorganic anion part of the salt include but are not limited to chloride, bromide, iodide, fluoride, sulfate, phosphate, nitrate, nitrite, hydrogen carbonates, hydrogen sulfate.
  • organic anion part of the salt examples include but are not limited to formate, alkanoates, carbonates, acetates, trifluoroacetate, trichloroacetate, propionate, glycolate, thiocyanate, lactate, succinate, malate, citrates, benzoates, cinnamates, oxalates, alkylsulphates, alkylsulphonates, arylsulphonates aryldisulphonates, alkylphosphonates, arylphosphonates, aryldiphosphonates, p-toluenesulphonate, and salicylate.
  • inorganic cation part of the salt examples include but are not limited to alkali and alkaline earth metals.
  • organic cation part of the salt examples include but are not limited to pyridine, methyl amine, imidazole, benzimidazole, hitidine, phosphazene, tetramethyl ammonium, tetrabutylammonium, choline and trimethylamine.
  • Metal ions in metal complexes of the compound of formula (I) are especially the ions of the elements of the second main group, especially calcium and magnesium, of the third and fourth main group, especially aluminium, tin and lead, and also of the first to eighth transition groups, especially chromium, manganese, iron, cobalt, nickel, copper, zinc and others. Particular preference is given to the metal ions of the elements of the fourth period and the first to eighth transition groups.
  • the metals can be present in the various valencies that they can assume.
  • Formula (I) thus includes all crystalline and non- crystalline forms of the compound that formula (I) represents.
  • Non-crystalline forms include embodiments which are solids such as waxes and gums as well as embodiments which are liquids such as solutions and melts.
  • Crystalline forms include embodiments which represent essentially a single crystal type and embodiments which represent a mixture of polymorphs (i.e. different crystalline types).
  • polymorph refers to a particular crystalline form of a chemical compound that can crystallize in different crystalline forms, these forms having different arrangements and/or conformations of the molecules in the crystal lattice. Although polymorphs can have the same chemical composition, they can also differ in composition due to the presence or absence of co- crystallized water or other molecules, which can be weakly or strongly bound in the lattice. Polymorphs can differ in such chemical, physical and biological properties as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspensibility, dissolution rate and biological availability.
  • a polymorph of a compound represented by formula (I) can exhibit beneficial effects (e.g., suitability for preparation of useful formulations, improved biological performance) relative to another polymorph or a mixture of polymorphs of the same compound represented by formula (I).
  • Preparation and isolation of a particular polymorph of a compound represented by formula (I) can be achieved by methods known to those skilled in the art including, for example, crystallization using selected solvents and temperatures.
  • the present invention provides a process for the synthesis of a compound of formula (I), wherein the definitions of Het, A, L 1 , R 6 , R 7 , R 9 and R 10 in the compounds of formula (I) and in the compounds of formula 1 to 16 are as defined in the above detailed description of the invention unless otherwise specifically stated.
  • the present invention provides a process for preparing the compound of formula (I) comprising the steps of: a) reacting a compound of formula 3 with a compound of formula R 6 -X wherein X is Cl, Br or I; to affford a compound of formula 4; b) reacting a compound of formula 4 with hydroxyl amine to afford a compound of formula 5; c) reacting a compound of formula 5 with a suitable carboxylic acid anhydride of formula (a) or a suitable acid chloride of formula (b) to afford a compound of formula 6, wherein Het is Het- 1; d) reacting a compound of formula 6 with a suitable chlorinating reagent to afford a compound of formula 7; wherein, R 6 is selected from the group consisting of C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 - alkynyl, C 3 -C 6 -cycloalkyl and C 3 -C
  • the process for the synthesis of compound of formula (I) further comprising the steps of: f) reacting a compound of formula 15 with a suitable chlorinating reagent to afford a compound of formula (I); wherein, R 6 is -OEt; Het, A, L 1 , R 6 , R 9 and R 10 are as defined in claim 1; g) reacting a compound of formula 14 with a compound of formula HNR 9 R 10 to afford a compound of formula (I); wherein, R 6 is -OEt; R 7 is -NR 9 R 10 .
  • the present invention provides a process for preparing the compound of formula (I) comprising the steps of: a) reacting a compound of formula 9 with hydroxyl amine to afford a compound of formula 10; b) reacting a compound of formula 10 with a suitable carboxylic acid anhydride of formula (a) or acid chloride of formula (b) to obtain a compound of formula 11, wherein Het is Het-1; c) reacting a compound of formula 11 with suitable halogenating reagent to afford a compound of formula 12; d) reacting the compound of formula 12 with a suitable reagent to afford a compound of formula 13; e) reacting the compound of formula 13 with suitable chlorinating reagent to afford a compound of formula 14; f) reacting a compound of formula 14 with a compound of formula HNR 9 R 10 to afford a compound of formula (I);
  • the following schemes illustrate approaches to generate compounds of formula (I).
  • the compounds of the present invention as defined by formula (I) and/or in the tables 1 to 8 may be prepared, in known manner, in a variety of ways as described in the schemes 1-6; General scheme: 1 wherein, L 1 is CH 2 ; X is Cl, Br or I; and Het is ; R 6 is selected from the group consisting of C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl and C 3 -C 6 -cycloalkenyl; A, R 1 , R 7 , R 9 and R 10 are as defined in the detailed description above.
  • the compound of formula 2 can be obtained by reacting the compound of formula 1 with a preformed complex of anilinium hypophosphite and hexamethyldisilazane. This reaction is typically carried out in a suitable aprotic solvent such as dichloromethane, toluene, acetonitrile, tetrahydrofuran, and the like at a suitable temperature ranging from 0 to 35 °C.
  • a suitable aprotic solvent such as dichloromethane, toluene, acetonitrile, tetrahydrofuran, and the like at a suitable temperature ranging from 0 to 35 °C.
  • the complex of anilinium hypophosphite and hexamethyldisilazane can be prepared by reacting an equimolar mixture of anilinium hypophosphite and hexamethyldisilazane at a suitable temperature ranging from 100 to 110 °C.
  • the compound of formula 3 can be obtained by esterification of the compound of formula 2 with ethanol in the presence of a suitable esterification reagent such as pivaloyl chloride and a suitable solvent such as pyridine. This reaction can be carried out at a temperature ranging from 0 to 35 °C.
  • the compound of formula 3 can also be obtained by reacting the compound of formula 2 with ethanol in the presence of a suitable coupling reagent such as N,N′-dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP), and the like at an ambient temperature (Tetrahedron Letters, 2005, vol.46, issue: 19, p.3359 – 3362).
  • Step: 3 The compound of formula 4 can be obtained by alkylating the compound of formula 3 with a compound of formula R 6 -X wherein X is Cl, Br or I, in the presence of a suitable base such as lithium bis(trimethylsilyl)amide and in a suitable aprotic solvent such as tetrahydrofuran, at a temperature ranging from -78 °C to 25 °C.
  • a suitable base such as lithium bis(trimethylsilyl)amide
  • a suitable aprotic solvent such as tetrahydrofuran
  • Step: 5 The compound of formula 6 wherein Het is ; can be obtained by reacting the compound of formula 5 with carboxylic acid anhydride of formula (a) or acid chloride of formula (b).
  • Step: 6 The compound of formula 7 can be obtained by reacting the compound of formula 6 with a suitable reagent such as oxalyl chloride or thionyl chloride. This reaction can be carried out in a suitable solvent such as dichloromethane at a temperature ranging from 0 to 40 °C.
  • Step: 7 The compound of formula (I) wherein L 1 is CH 2 ; Het is and R 6 is methyl can be obtained by reacting the compound of formula 7 with the compound of formula HNR 9 R 10 in the presence of a suitable base such as triethylamine, N,N-diisopropylethylamine, and the like at a temperature ranging from 0 to 50 °C. This reaction is carried out in a suitable solvent such as dichloromethane, tetrahydrofuran, ethyl acetate, and the like.
  • a suitable base such as triethylamine, N,N-diisopropylethylamine, and the like at a temperature ranging from 0 to 50 °C.
  • a suitable solvent such as dichloromethane, tetrahydrofuran, ethyl acetate, and the like.
  • Step 1 The compound of formula 4 wherein L 1 is CH 2 can be directly obtained by reacting the compound of formula 1 wherein L 1 is CH 2 and X is Cl, Br or I, with compound of formula (iii) (Arbuzov reaction) optionally in the presence of a suitable base such as sodium hydroxide. This reaction may optionally be carried out in a suitable solvent such as toulene, acetonitrile, N,N-dimethylformamide, and the like at a temperature ranging from 90 to 120 °C. [Tetrahedron, 1984, 40, p. 2731; Australian Journal of Chemistry, 1983, 36, 12, p.2517 – 2536].
  • Step: 1 The compound of formula 10 can be obtained by reacting the compound of formula 9 with hydroxyl amine in a suitable polar protic solvent such as ethanol, methanol, and the like. Alternatively, this reaction can also be carried out by using hydroxylamine hydrochloride in the presence of suitable organic and/or inorganic bases such as triethylamine, N,N-diisopropylethylamine, sodium bicarbonate, and the like.
  • Step: 2 The compound of formula 11 wherein Het is ; can be obtained by reacting the compound of formula 10 with carboxylic acid anhydride of formula (a) or acid chloride of formula (b). These reactions are typically performed in a suitable aprotic solvent such as tetrahydrofuran, 1,4-dioxane, dichloromethane, and the like optionally in the presence of a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like at temperature ranging from 0 to 50 °C.
  • a suitable aprotic solvent such as tetrahydrofuran, 1,4-dioxane, dichloromethane, and the like
  • a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like at temperature ranging from 0 to 50 °C.
  • Step: 3 The compound of formula 12 wherein Het is or in which R 1 is CF 3 ; can be obtained by radical halogenation of compound of formula 11 with a suitable halogenating reagent such as N-bromosuccinimide or N-chlorosuccinimide in the presence of a suitable radical initiator such as azobisisobutyronitrile or benzoyl peroxide.
  • a suitable radical initiator such as azobisisobutyronitrile or benzoyl peroxide.
  • This reaction can be carried out in a suitable solvent such as chloroform, carbon tetrachloride and the like at refluxing temperatures.
  • Step: 4 The compound of formula 13 wherein L 1 is CH 2 ; Het is or in which R 1 is CF 3 can be obtained by reacting the compound of formula 12 wherein L 1 is CH 2 ; Het is o wherein R 1 is CF 3 , with triethyl phosphite at a temperature ranging from 30 to 110 °C.
  • the compound of formula 13 wherein L 1 is a direct bond; Het is or wherein R 1 is CF 3 can be obtained by reacting the compound of formula 12 wherein L 1 is a direct bond; Het is wherein R 1 is CF 3 , with diethyl phosphonate in the presence of Pd (0) catalyst such as tetrakis(triphenylphosphine)palladium. This reaction is typically carried out in presence of a suitable base such as triethylamine, diisopropyl ethyl amine, and the like at temperature ranging from 50 °C to 90 °C.
  • Pd (0) catalyst such as tetrakis(triphenylphosphine)palladium.
  • Step: 5 The compound of formula 14 wherein L 1 is CH 2 or a direct bond; Het is or wherein R 1 is CF 3 ; can be obtained by reacting the compound of formula 13 with a suitable chlorinating reagent such as phosphorous oxychloride at temperature ranging from 0 to 80 °C.
  • a suitable chlorinating reagent such as phosphorous oxychloride at temperature ranging from 0 to 80 °C.
  • Step: 6 The compound of formula (I) wherein L 1 is CH 2 or a direct bond; Het is or wherein R 1 is CF 3 ; R 6 is -OEt; R 7 is -NR 9 R 10 ; can be obtained by reacting the compound of formula 14 with the compound of formula HNR 9 R 10 in the presence of a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like at a temperature ranging from 0 to 50 °C. This reaction is carried out in a suitable solvent such as dichloromethane, tetrahydrofuran, ethyl acetate, and the like.
  • a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like
  • the compound of formula 15 can be obtained by reacting the compound of formula 6 with a suitable chlorinating reagent such as oxalyl chloride to obtain the chloride derivative of compound of formula 15 which was hydrolysed with water at 0-5 °C to obtain compound of formula 15.
  • a suitable chlorinating reagent such as oxalyl chloride
  • This reaction is typically carried out in a suitable solvent such as dichloromethane.
  • this reaction can also be carried out by reacting the compound of formula 6 with trimethylsilyl bromide as reported in the Journal of Medicinal Chemistry, 1998, vol. 41, # 5, p. 752 – 759.
  • Step: 2 The compound of formula (I) wherein R 7 is -NR 9 R 10 is obtained by reacting compound of formula 15 with a suitable amine of formula HNR 9 R 10 in the presence of a suitable coupling reagent such as 1-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 4-dimethylaminopyridine. This reaction is carried out in a suitable solvent such as tetrahydrofuran at refluxing temperature.
  • Step: 1 The compound of formula 15 can be obtained by reacting the compound of formula 6 with lithium bromide. This reaction is typically carried out in a suitable solvent such as 2-pentanone at refluxing temperature.
  • Step: 2 The compound of formula 14 can be obtained by reacting the compound of formula 15 with a suitable chlorinating reagent such as oxalyl chloride or thionyl chloride. This reaction can be carried out in a suitable solvent such as dichloromethane at a temperature ranging from 0 to 40 °C optionally in the presence of a suitable catalyst such as dimethylformamide.
  • a suitable chlorinating reagent such as oxalyl chloride or thionyl chloride.
  • the present invention relates to an agrochemical composition
  • an agrochemical composition comprising the compound of formula (I), agriculturally acceptable salts, metal complexes, constitutional isomers, stereo-isomers, diastereoisomers, enantiomers, chiral isomers, atropisomers, conformers, rotamers, tautomers, optical isomers, polymorphs, geometric isomers, or N-oxides thereof optionally with one or more additional active ingredient with the auxiliary such as inert carrier or any other essential ingredient such as surfactants, additives, solid diluents and liquid diluents.
  • the compound of formula (I) and the composition according to the invention, respectively, are suitable as fungicides.
  • Plasmodiophoromycetes Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti).
  • Plasmodiophoromycetes Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti).
  • Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides.
  • they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.
  • the compound of formula (I) and the composition according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e.g.
  • the present invention provides a composition comprising at least one compound of formula (I) and seed.
  • the amount of the compound of formula (I) in the composition ranges from 0.1 g ai (gram per active ingredient) to 10 kg ai (kilogram per active ingredient) per 100 kg of seeds.
  • the compound of formula (I) and composition thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
  • plant propagation material is to be understood to denote all the generative or reproductive parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant.
  • treatment of plant propagation materials with the compound of formula (I), the combination and or the composition thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.
  • cultiva plants is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein).
  • Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination.
  • one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant.
  • Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo-or polypeptides e. g.
  • auxin herbicides such as dicamba or 2,4-D
  • bleacher herbicides such as hydroxylphenylpyruvate dioxygena
  • herbicides e. bromoxynil or ioxynil herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or ACCase inhibitors.
  • These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61, 2005, 246; 61, 2005, 258; 61, 2005, 277; 61, 2005, 269; 61, 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci.
  • mutagenesis e.g. Clearfield ® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun ® sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron.
  • the Bacillus are particularly from Bacillus thuringiensis, such as ⁇ - endotoxins, e. g. Cry1A(b), Cry1A(c), Cry1F, Cry1F(a2), Cry11A(b), Cry111A, Cry111B(b1) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1, VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp.
  • VIP1A(b), Cry1A(c), Cry1F, Cry1F(a2), Cry11A(b), Cry111A, Cry111B(b1) or Cry9c vegetative insecticidal proteins (VIP), e. g. VIP1, VIP2, VIP3 or VIP3A
  • insecticidal proteins of bacteria colonizing nematodes e. g. Photorhabdus spp.
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins
  • toxins produced by fungi such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins
  • proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors
  • ribosome-inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA- reductase
  • ion channel blockers such as blockers of sodium or calcium channels
  • these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins.
  • Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO02/015701).
  • Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP374753, WO93/007278, WO95/34656, EP427529, EP451878, WO03/18810 und WO03/52073.
  • the methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.
  • insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of arthropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda).
  • Genetically modified plants capable to synthesize one or more insecticidal proteins are, e.
  • WO 03/018810 MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the Cry1Ac toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1 F toxin and PAT enzyme).
  • plants capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens by the use of recombinant DNA techniques are also within the scope of the present invention. Examples of such proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, e.
  • PR proteins pathogenesis-related proteins
  • plant disease resistance genes e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the Mexican wild potato Solanum bulbocastanum
  • T4-lysozym e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora
  • the methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.
  • plants capable to synthesize one or more proteins, by the use of recombinant DNA techniques, to increase the productivity e. g.
  • plants that contain a modified amount of substances of content or new substances of content, by the use of recombinant DNA techniques, to improve human or animal nutrition e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera ® rape, DOW Agro Sciences, Canada) are also within the scope of the present invention.
  • plants that contain a modified amount of substances of content or new substances of content by the use of recombinant DNA techniques, to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora ® potato, BASF SE, Germany) are also within the scope of the present invention.
  • the present invention also relates to a method for combating infestation of plants by phytopathogenic micro-organisms in agricultural crops and or horticultural crops wherein an effective amount of at least one compound of formula (I) or the combination of the present invention or the composition of the present invention, is applied to the seeds of plants.
  • the compound, the combination and the composition of the present invention can be used for combating plant diseases.
  • the compound of formula (I), the combination and or the composition thereof, respectively, are particularly suitable for controlling the following plant diseases: Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis); Altemaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp.
  • Albugo spp. white rust
  • vegetables e. g. A. Candida
  • sunflowers e. g. A. tragopogonis
  • Altemaria spp. Alternaria leaf spot
  • rape A. brass
  • Botrytis cinerea (teleomorph: Botryotinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn (e. g.
  • Gray leaf spot C. zeae-maydis
  • rice sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice
  • Cladosporium spp. on tomatoes e. g. C. fulvum: leaf mold
  • cereals e. g. C. herbarum (black ear) on wheat
  • Cochliobolus anamorph: Helminthosporium of Bipolaris
  • spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C.
  • sativus anamorph: B. sorokiniana
  • rice e. g. C. miyabeanus, anamorph: H. oryzae
  • Colletotrichum teleomorph: Glomerella
  • spp. anthracnose on cotton (e. g. C. gossypii), corn (e. g. C. graminicola: Anthracnose stalk rot), soft fruits, potatoes (e. g. C. coccodes: black dot), beans (e. g. C. lindemuthianum) and soybeans (e. g. C. truncatum or C. gloeosporioides); Corticium spp., e. g. C. C.
  • sasakii sheath blight
  • Corynespora cassiicola leaf spots
  • Cycloconium spp. e. g. C. oleaginum on olive trees
  • Cylindrocarpon spp. e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.
  • liriodendri Neonectria liriodendri: Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D. phaseolorum (damping off) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. D.
  • tritici-repentis tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (£. pyri), soft fruits (£. veneta: anthracnose) and vines (£.
  • ampelina anthracnose
  • Entyloma oryzae leaf smut
  • Epicoccum spp. black mold
  • Erysiphe spp. potowdery mildew
  • sugar beets £. betae
  • vegetables e. g. E. pisi
  • cucurbits e. g. E. cichoracearum
  • cabbages e. g. E. cruciferarum
  • Eutypa lata Eutypa canker or dieback, anamorph: Cytosporina lata, syn.
  • G. sabinae rust on pears
  • Helminthosporium spp. syn. Drechslera, teleomorph: Cochliobolus
  • Hemileia spp. e. g. H. vastatrix (coffee leaf rust) on coffee
  • Isariopsis clavispora syn. Cladosporium vitis
  • Macrophomina phaseolina syn. phaseoli
  • root and stem rot on soybeans and cotton
  • Microdochium syn. Fusarium
  • nivale pink snow mold
  • Microsphaera diffusa (powdery mildew) on soybeans
  • Monilinia spp. e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants
  • Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas
  • Peronospora spp. downy mildew) on cabbage (e. g. P.
  • brassicae brassicae
  • rape e. g. P. parasitica
  • onions e. g. P. destructor
  • tobacco P. tabacina
  • soybeans e. g. P. manshurica
  • Phakopsora pachyrhizi and P. meibomiae staybean rust
  • Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P.
  • betae root rot, leaf spot and damping-off
  • Phomopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), soybeans, potatoes and tomatoes (e. g. P.
  • Plasmodiophora brassicae club root
  • Plasmopara spp. e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers
  • Plasmopara spp. e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers
  • Podosphaera spp. powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples
  • Polymyxa spp. e. g. on cereals, such as barley and wheat (P.
  • Pseudocercosporella herpotrichoides eyespot, teleomorph: Tapesia yallundae
  • Pseudoperonospora downy mildew
  • Pseudopezicula tracheiphila red fire disease or .rotbrenner', anamorph: Phialophora) on vines
  • Puccinia spp. rusts
  • oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ramularia leaf spots, Physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp.
  • R. solani root and stem rot
  • S. solani silk and stem rot
  • S. solani silk and stem rot
  • S. solani silk blight
  • R. cerealis Rhizoctonia spring blight
  • Rhizopus stolonifer black mold, soft rot
  • Rhynchosporium secalis scald
  • Sarocladium oryzae and S. attenuatum sheath rot) on rice
  • Sclerotinia spp e. g.
  • R. solani root and stem rot
  • S. solani silk blight
  • R. cerealis Rhizoctonia spring blight
  • Rhizopus stolonifer black mold, soft rot
  • Rhynchosporium secalis scald
  • Sarocladium oryzae and S. attenuatum sheath rot
  • Sclerotinia spp Sclerotinia spp.
  • seed rot or white mold on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn.
  • Erysiphe) necator prowdery mildew, anamorph: Oidium tuckeri
  • Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf; Sphacelotheca spp. (smut) on corn, (e. g. S. reiliana: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp.
  • S. nodorum Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum
  • wheat Synchytrium endobioticum on potatoes (potato wart disease)
  • Taphrina spp. e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums
  • Thielaviopsis spp. black root rot
  • tobacco, pome fruits, vegetables, soybeans and cotton e. g. T. basicola (syn. Chalara elegans); Tilletia spp.
  • Non-limiting examples of pathogens of fungal diseases which can be treated in accordance with the invention include: Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts for example those caused by Pucciniales such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp.
  • Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae
  • rusts for example those caused by Pucciniales such as
  • Puccinia striiformis f.sp. Secalis Pucciniastrum coryli, or Uredinales such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and other rots and diseases such as those caused by Cryptococcus spp., Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, ltersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani
  • Blastocladiomycetes such as Physoderma maydis.
  • Mucoromycetes such as Choanephora cucurbitarum; Mucor spp.; and Rhizopus arrhizus
  • diseases caused by rust disease pathogens for example Gymnosporangium species, for example Gymnosporangium sabinae; Hemileia species, for example Hemileia vastatrix; Phakopsora species, for example Phakopsora pachyrhizi or Phakopsora meibomiae; Puccinia species, for example Puccinia recondita, Puccinia graminis oder Puccinia striiformis; Uromyces species, for example Uromyces appendiculatus; In particular, Cronartium ribicola (White pine blister rust); Gymnosporangium juniperi-virginianae (Cedar-apple rust); Hemileia vast
  • Puccinia persistens subsp.
  • Puccinia sorghi rust in corn
  • Puccinia striiformis 'Yellow rust' in cereals
  • Uromyces appendiculatus rust of beans
  • Uromyces phaseoli Bean rust
  • Puccinia melanocephala 'Brown rust' in sugarcane
  • Puccinia kuehnii 'Orange rust' in sugarcane
  • Plants which can be treated in accordance with the invention include the following: cotton, flax, grapevine, fruits, vegetables, such as Rosaceae sp (for example pome fruits such as apples, pears, apricots, cherries, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example banana trees and plantations), Rubiaceae sp.
  • Rosaceae sp for example pome fruits such as apples, pears, apricots, cherries, almonds and peaches
  • Ribesioidae sp. Juglandaceae sp.
  • Betulaceae sp. Ana
  • Theaceae sp. for example coffee
  • Theaceae sp. Sterculiceae sp.
  • Rutaceae sp. for example lemons, oranges and grapefruit
  • Vitaceae sp. for example grapes
  • Solanaceae sp. for example tomatoes, peppers
  • Liliaceae sp. for example lettuce
  • Umbelliferae sp. for example Cruciferae sp., Chenopodiaceae sp.
  • Cucurbitaceae sp. for example cucumber
  • Alliaceae sp. for example leek, onion
  • peas for example peas
  • major crop plants such as Poaceae/Gramineae sp.
  • Poaceae/Gramineae sp. for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale
  • Asteraceae sp. for example sunflower
  • Brassicaceae sp. for example white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes, and oilseed rape, mustard, horseradish and cress
  • Fabacae sp. for example bean, peanuts
  • Papilionaceae sp. for example soya bean
  • phytophthora rot (Phytophthora megasperma), brown stem rot (Phialophora gregata), pythium rot (Pythium aphanidennatum, Pythium irregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum), rhizoctonia root rot, stem decay, and damping-off (Rhizoctonia solani), sclerotinia stem decay (Sclerotinia sclerotiorum), sclerotinia southern blight (Sclerotinia rolfsii), thielaviopsis root rot (Thielaviopsis basicola).
  • the present invention also relates to the use of the compound of formula (I), the combination or the composition thereof for combating the following plant diseases: Puccinia spp. (rusts) on various plants, for example, but not limited to P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye and Phakopsoraceae spp. on various plants, in particular Phakopsora pachyrhizi and P.
  • Puccinia spp. rusts
  • rusts rusts
  • P. triticina brown or leaf rust
  • P. striiformis stripe or yellow rust
  • P. hordei dwarf rust
  • the present invention further relates to the use of the compound of formula (I), the combination or the composition thereof for combating against phytopathogenic fungi such as Phakopsora pachyrhizi, Phakopsora meibomiae, of agricultural crops and or horticultural crops.
  • the compound of formula (I), the combination and the composition thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials.
  • protection of materials is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, cooling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria.
  • Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Pora spp., Serpula spp.
  • Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.
  • Basidiomycetes such as Coniophora spp
  • Candida spp. and Saccharomyces cerevisae are particularly suitable for controlling the following plant diseases: Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans.
  • the present invention further relates to a method for combating phytopathogenic fungi.
  • the method comprises treating the fungi or the materials, plants, plant parts, locus thereof, soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula (I) or the combination or the composition comprising at least one compound of formula (I).
  • the method of treatment according to the invention can also be used in the field of protecting stored products or harvest against attack of fungi and microorganisms.
  • the term "stored products” is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired.
  • Stored products of crop plant origin such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains
  • timber whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as furniture or objects made from wood.
  • Stored products of animal origin are hides, leather, furs, hairs and the like.
  • the combination according to the present invention can prevent disadvantageous effects such as decay, discoloration or mold.
  • stored products is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms.
  • the compound of formula (I), the combination and the composition thereof, respectively, may be used for improving the health of a plant.
  • the invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compound I and the composition thereof, respectively.
  • plant health is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e. g.
  • the above identified indicators for the health condition of a plant may be interdependent or may result from each other.
  • the compound of formula (I) can be present in different crystal modifications or polymorphs whose biological activity may differ. They are likewise subject matter of the present invention.
  • the compounds of formula (I) are employed as such or in the form of a composition for treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active ingredients.
  • the application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi.
  • Plant propagation materials may be treated with a compound of formula (I), the combination and the composition thereof protectively either at or before planting or transplanting.
  • the invention also relates to agrochemical compositions comprising an auxiliary and at least one compound of formula (I).
  • An agrochemical composition comprises a fungicidally effective amount of a compound of formula (I).
  • effective amount denotes an amount of the composition or of the compound of formula (I), which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants.
  • Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound of formula (I) used.
  • the compound of formula (I), their -oxides, metal complexes, isomers, polymorphs or the agriculturally acceptable salts thereof can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof.
  • agrochemical compositions e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof.
  • composition types are suspensions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e.
  • compositions types are defined in the "Catalogue of pesticide Formulation types and international coding system", Technical Monograph No.2, 6 th Ed.
  • compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product Formulation, Agrow Reports DS243, T&F Informa, London, 2005.
  • Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.
  • Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g.
  • Suitable solid carriers or fillers are mineral earths, e. g.
  • silicates silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
  • Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
  • Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof.
  • sulfonates are alkylaryl sulfonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl-and tridecylbenzenes, sulfonates of naphthalenes and alkyl naphthalenes, sulfosuccinates or sulfosuccinamates.
  • sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters.
  • phosphates are phosphate esters.
  • carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.
  • Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof.
  • alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents.
  • Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide.
  • N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides.
  • esters are fatty acid esters, glycerol esters or monoglycerides.
  • sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides.
  • polymeric surfactants are home- or copolymers of vinyl pyrrolidone, vinyl alcohols, or vinyl acetate.
  • Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines.
  • Suitable amphoteric surfactants are alkylbetains and imidazolines.
  • Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide.
  • Suitable polyelectrolytes are polyacids or polybases.
  • polyacids are alkali salts of polyacrylic acid or polyacid comb polymers.
  • polybases are polyvinyl amines or polyethylene amines.
  • Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound of formula (I) on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
  • Suitable thickeners are polysaccharides (e. g.
  • xanthan gum carboxymethyl cellulose
  • inorganic clays organic clays (organically modified or unmodified), polycarboxylates, and silicates.
  • Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.
  • Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
  • Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
  • Suitable colorants e. g. in red, blue, or green
  • examples are inorganic colorants (e. g.
  • Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.
  • Examples for composition types and their preparation are: i) Water-soluble concentrates (SL, LS) 10-60 wt% of a compound of formula (I) and 5-15 wt% wetting agent (e. g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e. g.
  • Dispersible concentrates 5-25 wt% of a compound of formula (I) and 1-10 wt% dispersant (e. g. polyvinyl pyrrolidone) are dissolved in organic solvent (e. g. cyclohexanone) ad 100 wt%. Dilution with water gives a dispersion.
  • Emulsifiable concentrates EC 15-70 wt% of a compound of formula (I) and 5-10 wt% emulsifiers (e. g.
  • binder e. g. polyvinyl alcohol
  • binder e. g. polyvinyl alcohol
  • dispersants and wetting agents e. g. sodium lignosulfonate and alcohol ethoxylate
  • Water-dispersible powders and water-soluble powders (WP, SP, WS) 50-80 wt% of a compound of formula (I) are ground in a rotor-stator mill with addition of 1-5 wt% dispersants (e. g. sodium lignosulfonate), 1-3 wt% wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance.
  • dispersants e. g. sodium lignosulfonate
  • wetting agents e. g. alcohol ethoxylate
  • solid carrier e. g. silica gel
  • Microcapsules An oil phase comprising 5-50 wt% of a compound of formula (I), 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.
  • a protective colloid e.
  • an oil phase comprising 5-50 wt% of a compound of formula (I) according to the invention, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocyanate monomer (e. g. diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol).
  • a polyamine e. g. hexamethylenediamine
  • the monomers amount to 1-10 wt%.
  • the wt% relate to the total CS composition.
  • Dustable powders (DP, DS) 1-10 wt% of a compound of formula (I) are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt%.
  • Granules (GR, FG) 0.5-30 wt% of a compound of formula (I) are ground finely and associated with solid carrier (e. g. silicate) ad 100 wt%. Granulation is achieved by extrusion, spray-drying or fluidized bed.
  • Ultra-low volume liquids (UL) 1-50 wt% of a compound of formula (I) are dissolved in organic solvent (e.
  • compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1-1 wt% anti-foaming agents, and 0.1-1 wt% colorants.
  • the agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active ingredient (ai).
  • the active ingredients (ai) are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
  • compositions in question give, after two-to-tenfold dilution, active substance concentrations from 0.01 to 60% by weight, preferably from 0.1 to 40%, in the ready-to-use preparations. Application can be carried out before or during sowing.
  • Methods for applying the compound of formula (I), the combination and the composition thereof, respectively, are application onto plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, and soaking as well as in-furrow application methods.
  • the compound of formula (I), the combination and the composition thereof, respectively are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.
  • the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 1.0 kg per ha, and in particular from 0.1 to 1.0 kg per ha.
  • amounts of active substance from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kg of plant propagation material (preferably seeds) are generally required.
  • the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.
  • oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides may be added to the active substances or the compositions comprising them as premix or, if appropriate, not until immediately prior to use (tank mix).
  • pesticides e. g. herbicides, insecticides, fungicides, growth regulators, safeners, biopesticides
  • a pesticide is generally a chemical or biological agent (such as pesticidally active ingredient, compound, composition, virus, bacterium, antimicrobial or disinfectant) that through its effect deters, incapacitates, kills or otherwise discourages pests.
  • Target pests can include insects, plant pathogens, weeds, mollusks, birds, mammals, fish, nematodes (roundworms), and microbes that destroy property, cause nuisance, spread disease or are vectors for disease.
  • pesticide includes also plant growth regulators that alter the expected growth, flowering, or reproduction rate of plants; defoliants that cause leaves or other foliage to drop from a plant, usually to facilitate harvest; desiccants that promote drying of living tissues, such as unwanted plant tops; plant activators that activate plant physiology for defense against certain pests; safeners that reduce unwanted herbicidal action of pesticides on crop plants; and plant growth promoters that affect plant physiology e.g.
  • the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system.
  • the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained.
  • 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.
  • composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e. g. seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate.
  • a spray tank or any other kind of vessel used for applications (e. g. seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate.
  • one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit comprising a) a composition comprising component 1) as defined herein and at least one auxiliary; and b) a composition comprising component 2) as defined herein and at least one auxiliary; and optionally c) a composition comprising at least one auxiliary and optionally a further active component 3) as defined herein.
  • the present invention provides a combination comprising the compound of formula (I) and at least one further pesticidally active substance selected from the group consisting of fungicides, insecticides, nematicides, acaricides, biopesticides, herbicides, safeners, plant growth regulators, antibiotics, fertilizers and nutrients.
  • the compound of formula (I), the combination and the composition thereof comprising them in the use as fungicides with other fungicides may result in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, extraordinary and unexpected effects are obtained.
  • the present invention also relates to the combination comprising at least one compound of formula (I) and at least one further pesticidally active substance selected from the group of fungicides, insecticides, nematicides, acaricides, biopesticides, herbicides, safeners, plant growth regulators, antibiotics, fertiliers and nutrients.
  • the pesticidally active substances reported in WO2015185485 pages 36-43 and WO2017093019 pages 42-56 can be used in conjunction with the compound of formula (I).
  • the active substances referred to as component 2 their preparation and their activity e. g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available.
  • the compounds described by IUPAC nomenclature, their preparation and their pesticidal activity are also known (cf. Can. J.
  • the present invention furthermore relates to agrochemical mixtures comprising at least one compound of formula (I) (component 1) and at least one further active substance useful for plant protection.
  • agrochemical mixtures comprising at least one compound of formula (I) (component 1) and at least one further active substance useful for plant protection.
  • an additional effect can be obtained.
  • This can be obtained by applying the compound of formula (I) and at least one further pesticidally active substance simultaneously, either jointly (e. g. as tank-mix) or separately, or in succession, wherein the time interval between the individual applications is selected to ensure that the active substance applied first still occurs at the site of action in a sufficient amount at the time of application of the further pesticidally active substance(s).
  • the order of application is not essential for working of the present invention.
  • the time between both applications may vary e. g. between 2 hours to 7 days. Also, a broader range is possible ranging from 0.25 hour to 30 days, preferably from 0.5 hour to 14 days, particularly from 1 hour to 7 days or from 1.5 hours to 5 days, even more preferred from 2 hours to 1 day.
  • the weight ratio of the component 1) and the component 2) generally depends on the properties of the active components used, usually it is in the range of 1:1000 to 1000:1, often in the range of 1:100 to 100:1, regularly in the range of 1:50 to 50:1, preferably in the range of 1:20 to 20:1, more preferably in the range of 1:10 to 10:1, even more preferably in the range of 1:4 to 4:1 and in particular in the range of 1:2 to 2:1.
  • the weight ratio of the component 1) and the component 2) usually is in the range of 1000:1 to 1:1000, often in the range of 100:1 to 1:100, regularly in the range of 50:1 to 1:50, preferably in the range of 20:1 to 1:20, more preferably in the range of 10:1 to 1:10, even more preferably in the range of 4:1 to 1:4 and in particular in the range of 2:1 to 1:2.
  • the ternary mixtures i.e.
  • the weight ratio of component 1) and component 2) depends from the properties of the active substances used, usually it is in the range of 1:100 to 100:1, regularly in the range of 1:50 to 50:1, preferably in the range of 1:20 to 20:1, more preferably in the range of 1:10 to 10:1 and in particular in the range of 1:4 to 4:1, and the weight ratio of component 1) and component 3) usually it is in the range of 1:100 to 100:1, regularly in the range of 1:50 to 50:1, preferably in the range of 1:20 to 20:1, more preferably in the range of 1:10 to 10:1 and in particular in the range of 1:4 to 4:1.
  • any further active components are, if desired, added in a ratio of 20:1 to 1:20 to the component 1). These ratios are also suitable for inventive mixtures applied by seed treatment.
  • the invention disclosed in the present disclosure shall now be elaborated with the help of non-limiting examples.
  • Example 1 Preparation of methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphine oxide (Compound no 4) and methyl(piperidin-1-yl)(1-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphine oxide (Compound no 5) a) Step 1: (4-cyanobenzyl)phosphinic acid A mixture of Anilinium hypophosphite (11.44 g, 72 mmol) and hexamethyldisilazane (15.1 mL, 72 mmol) were taken together and was heated at 110 °C under nitrogen for 3 h till the reaction mixture became clear.
  • reaction mixture was then cooled to 0 °C, and dichloromethane (50 mL) was added followed by the addition of 4-(bromomethyl) benzonitrile (9.9 g, 50.3 mmol).
  • the resulting reaction mixture was stirred at 25 °C for 16 h.
  • 10 % aqueous sodium hydroxide solution 50 mL was added drop wise to the reaction mixture at 0-5 °C to adjust it to pH 10, and stirring was continued for 10 min.
  • the aqueous layer was separated and acidified to pH 3 by adding of a 4 M aqueous hydrochloric acid solution. This aqueous layer was concentrated to dryness.
  • Step 2 ethyl (4-cyanobenzyl)phosphinate (4-Cyanobenzyl) phosphinic acid (8.5g, 47 mmol) was dissolved in ethanol (80 mL) and cooled to 0 °C. Pyridine (8.73 mL, 108 mmol) was added and the reaction mixture was stirred for 10 minutes.
  • Step 3 ethyl (4-cyanobenzyl)(methyl)phosphinate and ethyl (1-(4- cyanophenyl)ethyl)(methyl)phosphinate
  • Ethyl (4-cyanobenzyl)phosphinate (3 g, 14.3 mmol) was dissolved in anhydrous tetrahydrofuran (10 mL) under nitrogen atmosphere. The solution was cooled to -78 °C and purged with nitrogen for 5 min. Lithium bis(trimethylsilyl)amide (14.3 mL, 14.3 mmol) was added at -78 °C, and the reaction mixture was stirred for 10 min.
  • Methyl iodide (0.9 mL, 14.3 mmol) was added and the resulting reaction mixture was slowly allowed to warm to 25 °C within 3 h. After completion of the reaction, the reaction mixture was quenched with aqueous saturated ammonium chloride solution (20 mL). The product was extracted twice with ethyl acetate (60 mL). The combined ethyl acetate layers were dried over anhydrous sodium sulphate and concentrated under reduced pressure.
  • the resulting crude product was purified by column chromatography to obtain a 2:1 mixture of ethyl (4- cyanobenzyl)(methyl)phosphinate and ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate (2 g).
  • Step 4 ethyl (4-(N'-hydroxycarbamimidoyl)benzyl)(methyl)phosphinate and ethyl (1-(4-(N'- hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate
  • a solution of a 2:1 mixture of ethyl (4-cyanobenzyl)(methyl)phosphinate and ethyl (1-(4- cyanophenyl)ethyl)(methyl)phosphinate 1.7 g
  • 50 % aqueous hydroxylamine solution 0.06 mL, 14.8 mmol
  • Step 5 ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate (Compound no.
  • the reaction mixture was diluted with 50 mL of ethyl acetate and washed with a saturated aqueous solution of sodium bicarbonate (25 mL).
  • the ethyl acetate layer was dried over anhydrous sodium sulphate and concentrated to obtain 2.3 g of a crude product containing a mixture of ethyl methyl(1- (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinate and ethyl methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate.
  • 0.4 g of the crude product was purified by prep-HPLC to isolate two pure compounds.
  • Ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate (compound no. 1): 1 H- NMR (400 MHz, DMSO-d6) ⁇ 8.00 (d, 2H), 7.51 (dd, 2H), 3.87-4.00 (m, 2H), 3.35 (s, 1H), 1.32-1.37 (m, 3H), 1.18 (t, , 3H); LCMS (M+H): 334.95. Ethyl methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinate (compound no.
  • Step 6 methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic chloride and methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinic chloride
  • a solution of a 2:1 mixture of ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinate and ethyl methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphinate 1.5 g) in dichloromethane (5 mL), oxalyl chloride (2 M in dichloromethane) (4.3 mL, 8.6 mmol) was added at 0 °C, and the
  • reaction mixture was concentrated under reduced pressure to obtain a crude product containing a 2:1 mixture of methyl(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphinic chloride and methyl(1-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)ethyl)phosphinic chloride (1.4 g). It was used as such in the next step without purification.
  • Step 7 methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide (Compound no 4) and methyl(piperidin-1-yl)(1-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)ethyl)phosphine oxide (Compound no 5)
  • piperidine 0.293 mL, 2.9 mmol
  • triethylamine 1.0 mL, 7.4 mmol
  • dichloromethane 7.4 mmol
  • the resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was diluted with dichloromethane (10 mL) and washed with a saturated aqueous solution of sodium bicarbonate (20 mL). The dichloromethane layer was separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain crude product.
  • the obtained crude product was purified by prep-HPLC to obtain methyl(piperidin-1-yl)(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide (65 mg) and methyl(piperidin-1- yl)(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphine oxide (110 mg).
  • Example 2 Preparation of ethyl bis(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphinate (Compound no.2) a) Step 1: ethyl bis(4-cyanophenyl)phosphinate To a stirred mixture of 1-bromo-4-iodobenzene (0.3 g, 1.1 mmol) and anilinium hypophosphite (0.337 g, 2.1 mmol) in acetonitrile (10 mL), (3-aminopropyl)triethoxysilane (0.494 mL, 2.1 mmol) was added at 25 °C.
  • reaction mixture was degassed by nitrogen gas for 10 min.
  • [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (0.07 g, 0.085 mmol) was added and the mixture was degassed again for 5 min.
  • the reaction mixture was heated at 80 °C for 3 h.
  • the reaction mixture was basified using sodium bicarbonate and extracted with 10 % ethyl acetate in hexane.
  • the aqueous layer was acidified using 10 % aqueous hydrochloric acid to pH 3 and extracted by 10 % methanol in dichloromethane (20 mL).
  • the organic layer was dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product.
  • the obtained crude product was purified by column chromatography on silica gel using 70 % ethyl acetate in hexane as an eluent to obtain ethyl bis(4- cyanophenyl)phosphinate (0.156 g, 50 % yield).
  • Step 2 ethyl bis(4-(N'-hydroxycarbamimidoyl)phenyl)phosphinate
  • a solution of ethyl bis(4-cyanophenyl)phosphinate (0.35 g, 1.2 mmol) in ethanol (10 mL) hydroxylamine (50 % aqueous solution) (0.762 mL, 5.9 mmol) was added at 25 °C and stirred for 16 h. After completion of the reaction, the reaction mixture was concentrated to obtain ethyl bis(4-(N'- hydroxycarbamimidoyl)phenyl)phosphinate (0.42 g, 98 % yield).
  • Step 3 ethyl bis(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate
  • ethyl bis(4-(N'-hydroxycarbamimidoyl)phenyl)phosphinate 0.428 g, 1.2 mmol
  • trifluoroacetic anhydride 0.5 mL, 3.5 mmol
  • the reaction mixture was poured into ice cold saturated solution of sodium bicarbonate in water (20 mL).
  • the product was extracted by ethyl acetate (20 mL). The ethyl acetate layer was dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product.
  • the crude product was purified by column chromatography on silica gel using 50 % ethyl acetate in hexane as an eluent to obtain ethyl bis(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate (0.25 g, 41 % yield).
  • Example 3 Preparation of ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate (Compound no.20) a) Step 1: diethyl (4-cyanobenzyl)phosphonate A solution of 4-(bromomethyl)benzonitrile (5 g, 25.5 mmol) and triethyl phosphite (8.92 mL, 51 mmol) was stirred at 110 °C for 16 h.
  • Step 2 (4-(N'-hydroxycarbamimidoyl)benzyl)phosphonate
  • diethyl (4-cyanobenzyl)phosphonate 5 g, 19.7 mmol
  • hydroxylamine 50% aqueous solution
  • the resulting reaction mixture was stirred at 60 °C for 10 h.
  • the reaction mixture was concentrated under reduced pressure to remove the volatiles and to obtain diethyl (4-(N'- hydroxycarbamimidoyl)benzyl)phosphonate (5 g, 88 % yield).
  • Step 3 diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonate (compound no.3)
  • diethyl (4-(N'-hydroxycarbamimidoyl)benzyl)phosphonate (5 g, 17.47 mmol)
  • trifluoroacetic anhydride (4.44 mL, 31.4 mmol) was added slowly at 0-5 °C under nitrogen atmosphere.
  • the resulting reaction mixture was stirred for 12 h at 25 °C.
  • Step 4 ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate Phosphorous oxychloride (138 ⁇ l, 1.482 mmol) was added to diethyl (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonate (450 mg, 1.235 mmol) at 5-10 °C. To this reaction mixture, N,N- dimethylformamide (0.053 mL, 0.686 mmol) was added and the resulting reaction mixture was stirred at 80 °C for 6 h under nitrogen atmosphere.
  • N,N- dimethylformamide 0.053 mL, 0.686 mmol
  • Step 5 ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate
  • ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate 150 mg, 0.423 mmol
  • dichloromethane 5 mL
  • 2-methylpropan-1-amine 0.63 mL, 0.6 mmol
  • triethylamine 0.088 mL, 0.6 mmol
  • the resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was diluted with ethyl acetate (10 mL) and washed twice with water (10 mL). The ethyl acetate layer was separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product.
  • the obtained crude product was purified by flash column chromatography on silica gel using eluent 60 % ethyl acetate/hexane to obtain ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)phosphonamidate (60 mg, 36 % yield).
  • Example 4 Preparation of N-(4-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide (Compound no.46) a) Step 1 : methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic acid To a solution of ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate (8.2 g, 24.5 mmol) in dichloromethane (60 mL), oxalyl chloride (5.37 mL, 61.3 mmol) was added at 0 °C.
  • reaction mixture was stirred at 25 °C for 16 h. After completion of reaction, the reaction mixture was cooled to 0 °C, water (6 mL) was added dropwise until all the effervescences ceases. Volatiles were removed under reduced pressure and the crude was co-distilled with toluene to remove traces of water to obtain methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic acid (7 g, 93 % yield).
  • Step 2 N-(4-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinic amide (Compound no.46)
  • 4-fluoroaniline (0.44 g, 3.9 mmol)
  • methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic acid 0.4 g, 1.3 mmol
  • 4- dimethylaminopyridine 0.319 g, 2.6 mmol
  • Example 5 Preparation of N-phenyl-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2- yl)benzyl)phosphonamidate (Compound no.52) a) Step 1: 5-(p-tolyl)-1H-tetrazole To a stirred solution of 4-methylbenzonitrile (40 g, 341 mmol) in N,N-dimethylformamide (150 mL), sodium azide (24.42 g, 376 mmol) was added at 25 °C and cooled to 0 °C. To the obtained mixture, ceric ammonium nitrate (28 g, 51 mmol) was slowly added.
  • 4-methylbenzonitrile 40 g, 341 mmol
  • N,N-dimethylformamide 150 mL
  • sodium azide 24.42 g, 376 mmol
  • ceric ammonium nitrate 28 g, 51 mmol
  • the resulting reaction mixture was stirred at 120 °C for 6 h. After completion of the reaction, the reaction mixture was cooled to 25 °C and crushed ice (300g) was added portion wise into it under stirring. Stirring was continued for 10 minutes to obtain a precipitate. The precipitate was filtered, washed with water and dried under reduced pressure to obtain 5-(p-tolyl)-1H-tetrazole (42 g, 77 % yield).
  • Step 3 2-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)-1,3,4-oxadiazole
  • 2-(p-tolyl)-5-(trifluoromethyl)-1,3,4-oxadiazole 15 g, 66 mmol
  • chloroform 200 mL
  • N-bromosuccinimide (12.87 g, 72.3 mmol) was added and stirred at 70 °C for 10 minutes.
  • 2,2′-azobis(2-methylpropionitrile) 1.295 g, 7.89 mmol
  • Step 4 diethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate
  • a mixture of triethyl phosphate (1 g, 5.5 mmol) and 2-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)- 1,3,4-oxadiazole (1.69 g, 5.49 mmol) was stirred at 70 °C for 2 h. The mixture was concentered under reduced pressure to obtain diethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate (1.6 g, 80 % yield).
  • Step 5 (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonochloridate Phosphorus oxychloride (1.54 mL, 16.47 mmol) was added dropwise at 0 °C to diethyl (4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate (2 g, 5.5 mmol) and stirred for 15 min. Then to this solution, N,N-dimethylformamide (0.043 mL, 0.55 mmol) was added dropwise at 0 °C, and the resulting reaction mixture was stirred at 80 °C for 4 h.
  • N,N-dimethylformamide 0.043 mL, 0.55 mmol
  • the resulting reaction mixture was stirred at 25 °C for 48 h. After completion of the reaction, the reaction mixture was quenched by pouring into 10 % aqueous hydrochloric acid solution (50 mL) at 0-5 °C. The product was extracted by ethyl acetate (150 mL). The ethyl acetate layer was washed with water (50 mL), dried over anhydrous sodium sulphate and concentrated under reduce pressure to obtain a crude product.
  • Example 6 Preparation of ethyl N-(2,4-difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate (Compound no.66) a) Step 1: 2-(Chloromethyl)imidazo[1,2-a]pyridine-7-carbonitrile To a stirred solution of 2-aminoisonicotinonitrile (5 g, 42.0 mmol) in ethanol (30 mL), 1,3- dichloropropan-2-one (10.66 g, 84 mmol) was added, and stirred was continued at 90 °C for 36 h.
  • Step 4 Diethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (Compound no.64) To a stirred solution of diethyl ((7-(N'-hydroxycarbamimidoyl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.4 g, 1.2 mmol) in tetrahydrofuran (10 mL), trifluoroacetic anhydride (0.312 mL, 2.2 mmol) was added slowly at 0-5 °C under nitrogen atmosphere and stirred for 18 h at 25 °C.
  • the reaction mixture was quenched by pouring in saturated aqueous sodium bicarbonate solution (20 mL) at 0-5 °C.
  • the product was extracted with ethyl acetate (20 mL).
  • the ethyl acetate layer was washed with water (20 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product.
  • the crude product was purified by column chromatography on silica gel to obtain diethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.12 g, 24% yield).
  • Step 5 Ethyl hydrogen ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin- 2-yl)methyl)phosphonate
  • diethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.200 g, 0.5 mmol) in 2-pentanone (3 mL)
  • lithium bromide (0.052 g, 0.6 mmol) was added in one portion at 25 °C and stirred for 2 h at 110 °C.
  • Step 7 Ethyl N-(2,4-difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate (Compound no.66) To a stirred solution of ethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonochloridate (0.3 g, 0.7 mmol) in dichloromethane (3 mL), triethylamine (0.212 mL, 1.5 mmol) and 2,4-difluoroaniline (0.118 g, 0.9 mmol) were added at 0 °C.
  • Example 7 Preparation of ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)phosphonamidate (Compound no.78) a) Step 1: N'-hydroxy-4-iodobenzimidamide To a stirred solution of 4-iodobenzonitrile (5 g, 21.8 mmol) in methanol (50 mL), hydroxylamine (7.4 mL, 26.2 mmol) was added slowly at 25 °C under nitrogen atmosphere and stirred for 12 h at 25 °C.
  • Step 3 diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonate (compound no.76)
  • diethyl phosphonate 6.38 mL, 49.4 mmol
  • triethylamine 7.19 mL, 41.2 mmol
  • tetrakis(triphenylphosphine)palladium 1.9 g, 1.6 mmol
  • the reaction mixture was allowed to stir for 3 h at 90 °C.
  • the reaction mixture was diluted with water 50 mL, extracted with ethyl acetate (3 x 35 mL) and washed with saturated aqueous sodium chloride solution.
  • the combined ethyl acetate layer was dried over anhydrous sodium sulphate and evaporated under reduced pressure to obtain a crude product.
  • the crude product was purified by column chromatography to obtain diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate (7 g, 49 % yield).
  • Step 4 ethyl hydrogen (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonate (Compound no.75)
  • diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonate 4.5 g, 12.85 mmol
  • 2-pentanone 30 mL
  • lithium bromide 103 mg, 1.2 mmol
  • Step 5 ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonochloridate
  • ethyl hydrogen (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate
  • oxalyl chloride (0.17 mL, 1.9 mmol) was added at 0 °C.
  • the reaction mixture was stirred for 30 min at 0 °C and stirred for 2 h at 25 °C. Then the volatiles were removed under reduced pressure.
  • Example 8 Preparation of diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.88) a) Step 1: tert-butyl (tert-butoxycarbonyl)(4-cyanobenzyl)carbamate To a stirred solution of di-tert-butyl iminodicarbonate (22.16g, 102 mmol) in N,N-dimethylformamide (200 mL), potassium carbonate (21.15 g, 153 mmol) was added at 0 °C, and the reaction mixture was stirred at same temperature for 15 min.
  • Step 2 tert-butyl-(tert-butoxycarbonyl)(4-(N'-hydroxycarbamimidoyl)benzyl)carbamate
  • hydroxylamine 50% aq solution
  • 12.15 mL, 199 mmol was added at 0 °C and stirred at same temperature for 16 h. Volatiles were evaporated under reduced pressure to dryness.
  • Step 3 tert-butyl (tert-butoxycarbonyl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)carbamate
  • tert-butyl-(tert-butoxycarbonyl)(4-(N'-hydroxycarbamimidoyl)benzyl)carbamate 20 g, 55 mmol
  • trifluoroacetic anhydride 15.46 mL, 109 mmol
  • Step 4 (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride
  • tert-butyl (tert-butoxycarbonyl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)carbamate (20 g, 45.1 mmol) in tetrahydrofuran (200 mL)
  • hydrogen chloride (4M in 1,4- dioxane) (45.1 mL, 180 mmol) was added at 0 °C.
  • the resulting reaction mixture was stirred at 70 °C for 16 h.
  • reaction mixture was then cooled to 20 °C and evaporated to dryness under reduced pressure.
  • residue was co-distilled twice with toluene (20 mL) to obtain (4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (9 g, 71 % yield) as a white solid.
  • reaction mixture was quenched by addition of water (100 mL) and extracted with ethyl acetate (2 x 100 mL). The combined organic layer was dried over anhydrous sodium sulphate and evaporated to dryness under reduced pressure to obtain a crude product.
  • the crude product was purified by prep-HPLC to afford diethyl (4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (0.278 g, 68 % yield).
  • Example 9 Preparation of dimethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.89) To a stirred solution of (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (0.3 g, 1.1 mmol) in tetrahydrofuran (10 mL), triethylamine (0.45 mL, 3.2 mmol) was added, followed by dimethyl phosphorochloridate (0.202 g, 1.4 mmol) at 0 °C. The reaction mixture was stirred at 25 °C for 2 h.
  • Example 10 Preparation of dimethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.90) a) Step 1: N'-hydroxy-4-methylbenzimidamide To a stirred solution of 4-methylbenzonitrile (5 g, 42.7 mmol) in ethanol (50 mL), 50% aqueous solution of hydroxylamine (3.92 mL, 64 mmol) was added. The reaction mixture was heated to 70 °C under nitrogen atmosphere for 16 h. The reaction mixture was evaporated under reduced pressure to dryness to obtain N'-hydroxy-4-methylbenzimidamide (6 g, 94 % yield) as a white solid.
  • Step 2 3-(p-tolyl)-5-(trifluoromethyl)-1,2,4-oxadiazole
  • N'-hydroxy-4-methylbenzimidamide 6 g, 40 mmol
  • trifluoroacetic anhydride 8.46 mL, 59.9 mmol
  • the resulting reaction mixture was stirred at 25 °C for 16 h.
  • the reaction mixture was diluted with water (100 mL) and the product was extracted with ethyl acetate (3 X 50 mL).
  • Step 3 3-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole
  • N-bromosuccinimide (6.67 g, 37.5 mmol) followed by 2,2′-azobis(2- methylpropionitrile) (0.32 g, 1.97 mmol) were added.
  • the reaction mixture was heated to 48 °C for 10 h.
  • the reaction mixture was cooled to 25 °C, diluted with water (100 mL) and extracted with dichloromethane (3 X 50 mL). The combined dichloromethane layer were dried over anhydrous sodium sulphate and evaporated under reduced pressure to obtain a crude product.
  • the obtained crude product was purified by flash column chromatography to obtain 3-(4-(bromomethyl)phenyl)-5- (trifluoromethyl)-1,2,4-oxadiazole (6.57 g, 54.2 % yield) as white solid.
  • Step 4 N-methyl-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine
  • 3-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole (1 g, 3.26 mmol) in tetrahydrofuran (10 mL) 2 M methanamine in tetrahydrofuran solution (8.14 mL, 16.28 mmol) was added at 0 °C .
  • the resulting solution was allowed to stir for 24 h at 25 °C. After completion of the reaction, the volatiles were evaporated.
  • Step 5 dimethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.90)
  • N-methyl-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride 0.3 g, 1.12 mmol
  • triethylamine (0.71 mL, 5.1 mmol
  • dimethyl phosphorochloridate 0.186 mL, 1.5 mmol
  • the resulting reaction mixture was stirred at 25 °C for 2 h.
  • the reaction was quenched with water (100 mL) and extracted twice with ethyl acetate (100 mL).
  • the combined ethyl acetate layer was dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure to obtain a crude product.
  • the crude product was purified by column chromatography to obtain dimethyl methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (0.204 g, 55 % yield).
  • Example 11 Preparation of ethyl N-(2,4-difluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonamidate (Compound no.91)
  • N-methyl-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride 0.4 g, 1.3 mmol
  • triethylamine 0.49 mL, 6.8 mmol
  • diethyl phosphorochloridate 0.296 mL, 2.0 mmol
  • the resulting reaction mixture was stirred at 25 °C for 2 h.
  • the reaction mixture was quenched with water (100 mL) and extracted with ethyl acetate (2 x 100 mL).
  • the combined organic layer was dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure to obtain a crude product.
  • the crude product was purified by column chromatography to obtain diethyl methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (0.16 g, 30 % yield).
  • Example 12 Preparation of ethyl (1-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)(methyl)phosphinate (compound no.87) a) Step 1: ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate To a degassed solution of ethyl (4-cyanobenzyl)phosphinate (0.8 g, 3.4 mmol) in anhydrous tetrahydrofuran (10 mL), lithium bis(trimethylsilyl)amide (4.85 mL, 5.2 mmol) was added at -78 °C under nitrogen atmosphere.
  • Step 2 ethyl-(1-(4-(N'-hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate
  • ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate (0.57 g, 2.403 mmol) in ethanol (60 mL)
  • a 50% aqueous solution of hydroxylamine 0.08 mL, 4.8 mmol
  • reaction mixture was concentrated and three times co-evaporated with ethyl acetate (each 30 mL) under reduced pressure to obtain ethyl-(1-(4-(N'- hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate (0.43 g, 66 % yield).
  • Step 3 ethyl (1-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)(methyl)phosphinate (Compound no.87)
  • ethyl-(1-(4-(N'-hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate (0.350 g, 1.295 mmol)
  • 2-chloro-2,2-difluoroacetic anhydride 0.315 g, 1.3 mmol
  • the resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was poured into a mixture of ethyl acetate (100 mL) and an aqueous saturated solution of sodium bicarbonate (75 mL) and stirred for 10 min. The organic layer was isolated, washed by saturated solution of sodium bicarbonate (100 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product.
  • Example 13 Preparation of ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate (compound no.95) To a stirred solution of ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate (0.25 g, 0.71 mmol) in dichloromethane (3 ml), 4-dimethylaminopyridine (0.09 g, 0.71 mmol) and methanol (0.027 g, 0.85 mmol) were added at 0 °C.
  • the compounds of general formula (I) show fungicidal activities which are exerted with respect to numerous phytopathogenic fungi which attack on important agricultural crops.
  • the compounds of the present invention were assessed for their activity as described in the following tests:
  • Example 1 Pyricularia oryzae (Rice blast):
  • Example 2 Botrytis cinerea (Gray mold): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate.
  • Example 3 Alternaria solani (early blight of tomato/potato): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates.
  • each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 25 °C temperature and 60% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control. Compounds 4 5 27 34 35 38 46 74 91 at 300ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive pathogen growth.
  • Example 4 Colletotrichum capsici (anthracnose): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes.
  • Example 5 Corynespora cassiicola (Leaf spot of tomato): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 25 °C temperature and 70% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control.
  • the sprayed plants were also assessed for plant damage by recording symptoms like necrosis, chlorosis and stunting.
  • Compounds 1 2 3 4 5 6 7 8 12 13 14 15 16 17 18 20 21 22 23 24 25 26 27 28 29 31 32 34 35 36 39 41 42 43 45 48 49 50 58 59 60 61 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 87 88 89 90 91 at 300 ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive disease development.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to a compound of formula (I), wherein, Het, A, L1, R6 and R7 are as defined in the detailed description and a process for preparing the compound of formula (I). The present invention also relates to a method for combating phytopathogenic fungi.

Description

TITLE OF THE INVENTION: NOVEL HETEROCYCLIC COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI FIELD OF THE INVENTION: The present invention relates to novel heterocyclic compounds which are useful in combating phytopathogenic fungi, a process for preparing the heterocyclic compounds, a combination and a composition comprising the novel heterocyclic compounds. The present invention also relates to a method for combating phytopathogenic fungi. BACKGROUND OF THE INVENTION: Oxadiazole compounds are known to be useful in the pharmaceutical field. For instance, WO2013066835 discloses oxadiazole compounds as pharmaceutically active agents. Oxadiazole compounds are also known to be useful as crop protection agents to combat or prevent microorganism’s infestations. For instance in, EP0276432, WO2015185485, EP3165093, EP3167716, EP3165093, WO2017110861, WO2017110862, WO2017110864, WO2017211652, WO2017220485, WO2017072247, WO2017076742, WO2018065414, WO2018118781 and WO2018202491 disclose the oxadiazole compounds which are used as fungicides. The oxadiazole compounds reported in the above cited literature have disadvantages in certain aspects, such as that they exhibit a narrow spectrum of efficacy or that they do not have satisfactory fungicidal activity, particularly at low application rates. Therefore, the need remains for the development of new fungicidal compounds, so as to provide compounds being effective against a broader spectrum of fungi, having lower toxicity, higher selectivity, and being used at lower dosage rates to reduce or avoid unfavorable environmental or toxicological effects whilst still allowing effective and long-lasting pest control. Therefore, it is an object of the present invention to provide compounds having an improved/enhanced activity and/or a broader efficacy spectrum against phytopathogenic fungi. This objective is achieved by the heterocyclic compounds of the formula (I) and/or their agriculturally useful salts for combating phytopathogenic fungi. SUMMARY OF THE INVENTION: The present invention relates to a compound of formula (I),
Figure imgf000002_0001
wherein, Het, A, L1, R6 and R7 are as defined in the detailed description. The present invention also relates to a process for preparing the compound of formula (I). The compounds of formula (I) have been found to be advantageous over the compounds reported in the literature in either of improved fungicidal activity, broader spectrum of biological efficacy, lower application rates, more favourable biological or environmental properties, or enhanced plant compatibility. The present invention further relates to a combination comprising the compound of formula (I) of the present invention and at least one further pesticidally active substance for effectively controlling or preventing phytopathogenic fungi which are difficult to combat. The present invention still further relates to a composition comprising the compound of formula (I) as such or the compound of formula (I) in combination with a pesticidally active substance. The present invention still further relates to a method and use of the compound of formula (I) as such or the combination or the composition thereof for combating plant diseases, particularly phytopathogenic fungi. DETAILED DESCRIPTION OF THE INVENTION: DEFINITIONS: The definitions provided herein for the terminologies used in the present disclosure are for illustrative purpose only and in no manner limit the scope of the present invention disclosed in the present disclosure. As used herein, the terms “comprises”, “comprising”, “includes”, “including”, “has”, “having”, “contains”, “containing”, “characterized by” or any other variation thereof, are intended to cover a non-exclusive inclusion, subject to any limitation explicitly indicated. For example, a composition, mixture, process or method that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process or method. The transitional phrase “consisting of” excludes any element, step or ingredient not specified. If in the claim, such would close the claim to the inclusion of materials other than those recited except for impurities ordinarily associated therewith. When the phrase “consisting of” appears in a clause of the body of a claim, rather than immediately following the preamble, it limits only the element set forth in that clause; other elements are not excluded from the claim as a whole. The transitional phrase “consisting essentially of” is used to define a composition or method that includes materials, steps, features, components or elements, in addition to those literally disclosed, provided that these additional materials, steps, features, components or elements do not materially affect the basic and novel characteristic(s) of the claimed invention. The term “consisting essentially of” occupies a middle ground between “comprising” and “consisting of”. Further, unless expressly stated to the contrary, “or” refers to an inclusive “or” and not to an exclusive “or”. For example, a condition A “or” B is satisfied by any one of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present). Also, the indefinite articles “a” and “an” preceding an element or component of the present invention are intended to be nonrestrictive regarding the number of instances (i.e. occurrences) of the element or component. Therefore “a” or “an” should be read to include one or at least one, and the singular word form of the element or component also includes the plural unless the number is obviously meant to be singular. As referred to in this disclosure, the term “invertebrate pests” includes but is not limited to fungi, stramenopiles (oomycetes), bacteria, nematodes, mites, ticks, insects and nematodes of economic importance. In the context of this disclosure “pest control” means inhibition of invertebrate pest development (including necrosis, retarded growth and/or death), and related expressions are defined analogously. The term “agronomic” refers to the production of field crops such as for food, feed and fiber and includes the growth of corn, soybeans and other legumes, rice, cereal (e.g., wheat, oats, barley, rye, rice, maize), leafy vegetables (e.g., lettuce, cabbage, and other cole crops), fruiting vegetables (e.g., tomatoes, pepper, eggplant, crucifers and cucurbits), potatoes, sweet potatoes, grapes, cotton, tree fruits (e.g., pome, stone and citrus), small fruit (berries, cherries) and other specialty crops (e.g., canola, sunflower, olives). The term “nonagronomic” refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications. Nonagronomic applications include protecting an animal from a fungal disease by administering a fungicidally effective (i.e. biologically effective) amount of a compound of the present invention, typically in the form of a composition formulated for veterinary use, to the animal to be protected. As referred to in the present disclosure and claims, the terms “fungicidal” and “fungicidally” refers to observable effects on a fungal pathogen to provide protection of an animal from the disease. Fungicidal effects typically relate to diminishing the occurrence or activity of the target pathogen. Such effects on the pathogens include necrosis, death, retarded growth, or lessened ability to grow on or in the host animal. These effects on pathogens provide control (including prevention, reduction or elimination) of infestation or infection of the animal. The meaning of various terms used in the description shall now be illustrated. The term “alkyl”, used either alone or in compound words such as “alkylthio” or “haloalkyl” or - N(alkyl) or alkylcarbonylalkyl or alkylsuphonylamino includes straight-chain or branched C1 to C24 alkyl, preferably C1 to C15 alkyl, more preferably C1 to C10 alkyl, most preferably C1 to C6 alkyl. Non- limiting examples of alkyl include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2- methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2- dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3- dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl or the different isomers. If the alkyl is at the end of a composite substituent, as, for example, in alkylcycloalkyl, the part of the composite substituent at the start, for example the cycloalkyl, may be mono- or polysubstituted identically or differently and independently by alkyl. The same also applies to composite substituents in which other radicals, for example alkenyl, alkynyl, hydroxy, halogen, carbonyl, carbonyloxy and the like, are at the end. The term “alkenyl”, used either alone or in compound words includes straight-chain or branched C2 to C24 alkenes, preferably C2 to C15 alkenes, more preferably C2 to C10 alkenes, most preferably C2 to C6 alkenes. Non-limiting examples of alkenes include ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2 -propenyl, 2- methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1- butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3- butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2 -propenyl, 1-ethyl-1-propenyl,1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4- hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1- pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1- methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4- pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3- dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3- dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3- dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl- 1-butenyl, 2- ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2- methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl and the different isomers. “Alkenyl” also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl. This definition also applies to alkenyl as a part of a composite substituent, for example haloalkenyl and the like, unless defined specifically elsewhere. Non-limiting examples of alkynes include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3- butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1- methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl -2- propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3- pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3- methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3- butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1- ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl and the different isomers. This definition also applies to alkynyl as a part of a composite substituent, for example haloalkynyl etc., unless specifically defined elsewhere. The term “alkynyl” can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl. The term “cycloalkyl” means alkyl closed to form a ring. Non-limiting examples include cyclopropyl, cyclopentyl and cyclohexyl. This definition also applies to cycloalkyl as a part of a composite substituent, for example cycloalkylalkyl etc., unless specifically defined elsewhere. The term “cycloalkenyl” means alkenyl closed to form a ring including monocyclic, partially unsaturated hydrocarbyl groups. Non-limiting examples include cyclopropenyl, cyclopentenyl and cyclohexenyl. This definition also applies to cycloalkenyl as a part of a composite substituent, for example cycloalkenylalkyl etc., unless specifically defined elsewhere. The term “cycloalkynyl” means alkynyl closed to form a ring including monocyclic, partially unsaturated groups. Non-limiting examples include cyclopropynyl, cyclopentynyl and cyclohexynyl. This definition also applies to cycloalkynyl as a part of a composite substituent, for example cycloalkynylalkyl etc., unless specifically defined elsewhere. The term “cycloalkoxy”, “cycloalkenyloxy” and the like are defined analogously. Non limiting examples of cycloalkoxy include cyclopropyloxy, cyclopentyloxy and cyclohexyloxy. This definition also applies to cycloalkoxy as a part of a composite substituent, for example cycloalkoxy alkyl etc., unless specifically defined elsewhere. The term “halogen”, either alone or in compound words such as “haloalkyl”, includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Non- limiting examples of “haloalkyl” include chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 1,1-dichloro-2,2,2-trifluoroethyl, and 1,1,1-trifluoroprop-2-yl. This definition also applies to haloalkyl as a part of a composite substituent, for example haloalkylaminoalkyl etc., unless specifically defined elsewhere. The terms “haloalkenyl”, “haloalkynyl” are defined analogously except that, instead of alkyl groups, alkenyl and alkynyl groups are present as a part of the substituent. The term “haloalkoxy” means straight-chain or branched alkoxy groups where some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as specified above. Non-limiting examples of haloalkoxy include chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2- dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy. This definition also applies to haloalkoxy as a part of a composite substituent, for example haloalkoxyalkyl etc., unless specifically defined elsewhere. The term “haloalkylthio” means straight-chain or branched alkylthio groups where some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as specified above. Non-limiting examples of haloalkylthio include chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 1-chloroethylthio, 1- bromoethylthio, 1- fluoroethylthio, 2-fluoroethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2- chloro-2- fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2- trichloroethylthio, pentafluoroethylthio and 1,1,1-trifluoroprop-2-ylthio. This definition also applies to haloalkylthio as a part of a composite substituent, for example haloalkylthioalkyl etc., unless specifically defined elsewhere. Non-limiting examples of “haloalkylsulfinyl” include CF3S(O), CCl3S(O), CF3CH2S(O) and CF3CF2S(O). Non-limiting examples of “haloalkylsulfonyl” include CF3S(O)2, CCl3S(O)2, CF3CH2S(O)2 and CF3CF2S(O)2. The term “hydroxy” means –OH, Amino means –NRR, wherein R can be H or any possible substituent such as alkyl. Carbonyl means -C(=O)- , carbonyloxy means -OC(=O)-, sulfinyl means SO, sulfonyl means S(O)2. The term “alkoxy” used either alone or in compound words included C1 to C24 alkoxy, preferably C1 to C15 alkoxy, more preferably C1 to C10 alkoxy, most preferably C1 to C6 alkoxy. Examples of alkoxy include methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1- dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1- ethylpropoxy, hexoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 1-methylpentoxy, 2- methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3- dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2- ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2- methylpropoxy and the different isomers. This definition also applies to alkoxy as a part of a composite substituent, for example haloalkoxy, alkynylalkoxy, etc., unless specifically defined elsewhere. The term “alkoxyalkyl” denotes alkoxy substitution on alkyl. Non-limiting examples of “alkoxyalkyl” include CH3OCH2, CH3OCH2CH2, CH3CH2OCH2, CH3CH2CH2CH2OCH2 and CH3CH2OCH2CH2. The term “alkoxyalkoxy” denotes alkoxy substitution on alkoxy. The term “alkylthio” includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio, 1,1- dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2- dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 1- methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3- dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2- trimethylpropylthio, 1-ethyl-1-methylpropylthio and 1-ethyl-2-methylpropylthio and the different isomers. Halocycloalkyl, halocycloalkenyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkoxyalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, haloalkylcarbonyl, cycloalkylcarbonyl, haloalkoxylalkyl, and the like, are defined analogously to the above examples. The term “alkylthioalkyl” denotes alkylthio substitution on alkyl. Non-limiting examples of “alkylthioalkyl” include -CH2SCH2, -CH2SCH2CH2, CH3CH2SCH2, CH3CH2CH2CH2SCH2 and CH3CH2SCH2CH2. “Alkylthioalkoxy” denotes alkylthio substitution on alkoxy. The term “cycloalkylalkylamino” denotes cycloalkyl substitution on alkyl amino. The terms “alkoxyalkoxyalkyl”, “alkylaminoalkyl”, “dialkylaminoalkyl”, “cycloalkylaminoalkyl”, “cycloalkylaminocarbonyl” and the like, are defined analogously to “alkylthioalkyl” or “cycloalkylalkylamino”. The term “alkoxycarbonyl” is an alkoxy group bonded to a skeleton via a carbonyl group (-CO-). This definition also applies to alkoxycarbonyl as a part of a composite substituent, for example cycloalkylalkoxycarbonyl and the like, unless specifically defined elsewhere. The term “alkoxycarbonylalkylamino” denotes alkoxy carbonyl substitution on alkyl amino. “Alkylcarbonylalkylamino” denotes alkyl carbonyl substitution on alkyl amino. The terms alkylthioalkoxycarbonyl, cycloalkylalkylaminoalkyl and the like are defined analogously. Non-limiting examples of “alkylsulfinyl” include methylsulphinyl, ethylsulphinyl, propylsulphinyl, 1- methylethylsulphinyl, butylsulphinyl, 1-methylpropylsulphinyl, 2-methylpropylsulphinyl, 1,1- dimethylethylsulphinyl, pentylsulphinyl, 1-methylbutylsulphinyl, 2-methylbutylsulphinyl, 3- methylbutylsulphinyl, 2,2-dimethylpropylsulphinyl, 1-ethylpropylsulphinyl, hexylsulphinyl, 1,1- dimethylpropylsulphinyl, 1,2-dimethylpropylsulphinyl, 1-methylpentylsulphinyl, 2- methylpentylsulphinyl, 3-methylpentylsulphinyl, 4-methylpentylsulphinyl, 1,1- dimethylbutylsulphinyl, 1,2-dimethylbutylsulphinyl, 1,3-dimethylbutylsulphinyl, 2,2- dimethylbutylsulphinyl, 2,3-dimethylbutylsulphinyl, 3,3-dimethylbutylsulphinyl, 1- ethylbutylsulphinyl, 2-ethylbutylsulphinyl, 1,1,2-trimethylpropylsulphinyl, 1,2,2- trimethylpropylsulphinyl, 1-ethyl-1-methylpropylsulphinyl and 1-ethyl-2-methylpropylsulphinyl and the different isomers. The term “arylsulfinyl” includes Ar-S(O), wherein Ar can be any carbocyle or heterocylcle. This definition also applies to alkylsulphinyl as a part of a composite substituent, for example haloalkylsulphinyl etc., unless specifically defined elsewhere. Non-limiting examples of “alkylsulfonyl” include methylsulphonyl, ethylsulphonyl, propylsulphonyl, 1-methylethylsulphonyl, butylsulphonyl, 1-methylpropylsulphonyl, 2-methylpropylsulphonyl, 1,1- dimethylethylsulphonyl, pentylsulphonyl, 1-methylbutylsulphonyl, 2-methylbutylsulphonyl, 3- methylbutylsulphonyl, 2,2-dimethylpropylsulphonyl, 1-ethylpropylsulphonyl, hexylsulphonyl, 1,1- dimethylpropylsulphonyl, 1,2-dimethylpropylsulphonyl, 1-methylpentylsulphonyl, 2- methylpentylsulphonyl, 3-methylpentylsulphonyl, 4-methylpentylsulphonyl, 1,1- dimethylbutylsulphonyl, 1,2-dimethylbutylsulphonyl, 1,3-dimethylbutylsulphonyl, 2,2- dimethylbutylsulphonyl, 2,3-dimethylbutylsulphonyl, 3,3-dimethylbutylsulphonyl, 1- ethylbutylsulphonyl, 2-ethylbutylsulphonyl, 1,1,2-trimethylpropylsulphonyl, 1,2,2- trimethylpropylsulphonyl, 1-ethyl-1-methylpropylsulphonyl and 1-ethyl-2-methylpropylsulphonyl and the different isomers. The term “arylsulfonyl” includes Ar-S(O)2, wherein Ar can be any carbocyle or heterocylcle. This definition also applies to alkylsulphonyl as a part of a composite substituent, for example alkylsulphonylalkyl etc., unless defined elsewhere. “Alkylamino”, “dialkylamino”, and the like, are defined analogously to the above examples. The term “carbocycle or carbocyclic” includes “aromatic carbocyclic ring system” and “non-aromatic carbocylic ring system” or polycyclic or bicyclic (spiro, fused, bridged, nonfused) ring compounds in which ring may be aromatic or non-aromatic (where aromatic indicates that the Huckel rule is satisfied and non-aromatic indicates that the Huckel rule is not statisfied). The term “heterocycle or heterocyclic” includes “aromatic heterocycle or heteroaryl ring system” and “non-aromatic heterocycle ring system” or polycyclic or bicyclic (spiro, fused, bridged, nonfused) ring compounds in which ring may be aromatic or non-aromatic, wherein the heterocycle ring contains at least one heteroatom selected from N, O, S(O)0-2, and or C ring member of the heterocycle may be replaced by C(=O), C(=S), C(=CR*R*) and C=NR*, * indicates integers. The term “non-aromatic heterocycle” or “non-aromatic heterocyclic” means three- to fifteen- membered, preferably three- to twelve- membered, saturated or partially unsaturated heterocycle containing one to four heteroatoms from the group of oxygen, nitrogen and sulphur: mono, bi- or tricyclic heterocycles which contain, in addition to carbon ring members, one to three nitrogen atoms and/or one oxygen or sulphur atom or one or two oxygen and/or sulphur atoms; if the ring contains more than one oxygen atom, they are not directly adjacent; non-limiting examples oxiranyl, aziridinyl, thietanyl, oxetanyl, azetidinyl, 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3- tetrahydrothienyl, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5- isoxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 1-pyrazolidinyl, 3- pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2- thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 1-imidazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,2,4-triazolidin-1-yl, 1,2,4-triazolidin-3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4- triazolidin-1-yl, 1,3,4-triazolidin-2-yl, 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4- dihydrothien-3-yl, pyrrolinyl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2- isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4- isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3- isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2- isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol- 2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol- 1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1- yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2- yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4- dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, pyrazynyl, morpholinyl, thiomorphlinyl, 1,3-dioxan-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2- tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4- hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl, 1,3,5-hexahydrotriazin-2-yl, 1,2,4- hexahydrotriazin-3-yl, cycloserines, 2,3,4,5-tetrahydro[1H]azepin-1- or -2- or -3- or -4- or -5- or -6- or -7- yl, 3,4,5,6-tetra-hydro[2H]azepin-2- or -3- or -4- or -5- or -6- or-7-yl, 2,3,4,7- tetrahydro[1H]azepin-1- or -2- or -3- or -4- or -5- or -6- or-7- yl, 2,3,6,7-tetrahydro[1H]azepin-1- or - 2- or -3- or -4- or -5- or -6- or -7- yl, hexahydroazepin-1- or -2- or -3- or -4- yl, tetra- and hexahydrooxepinyl such as 2,3,4,5-tetrahydro[1 H]oxepin-2- or -3- or -4- or -5- or -6- or -7- yl, 2,3,4,7-tetrahydro[1H]oxepin-2- or -3- or -4- or -5- or -6- or -7- yl, 2,3,6,7-tetrahydro[1H]oxepin-2- or -3- or -4- or -5- or -6- or -7- yl, hexahydroazepin-1- or -2- or -3- or -4- yl, tetra- and hexahydro-1,3- diazepinyl, tetra- and hexahydro-1,4-diazepinyl, tetra- and hexahydro-1,3-oxazepinyl, tetra- and hexahydro-1,4-oxazepinyl, tetra- and hexahydro-1,3-dioxepinyl, tetra- and hexahydro-1,4-dioxepinyl. This definition also applies to heterocyclyl as a part of a composite substituent, for example heterocyclylalkyl etc., unless specifically defined elsewhere. The term “heteroaryl” or “aromatic heterocyclic” means 5 or 6-membered, fully unsaturated monocyclic ring system containing one to four heteroatoms from the group of oxygen, nitrogen and sulphur; if the ring contains more than one oxygen atom, they are not directly adjacent; 5-membered heteroaryl containing one to four nitrogen atoms or one to three nitrogen atoms and one sulphur or oxygen atom; 5-membered heteroaryl groups which, in addition to carbon atoms, may contain one to four nitrogen atoms or one to three nitrogen atoms and one sulphur or oxygen atom as ring members, non-limiting examples furyl, thienyl, pyrrolyl, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, thiazolyl, imidazolyl, 1,2,4-oxadiazolyl, 1,2,4-thiadiazolyl, 1,2,4-triazolyl, 1,3,4-oxadiazolyl, 1,3,4-thiadiazolyl, 1,3,4-triazolyl, tetrazolyl; nitrogen-bonded 5-membered heteroaryl containing one to four nitrogen atoms, or benzofused nitrogen-bonded 5-membered heteroaryl containing one to three nitrogen atoms: 5-membered heteroaryl groups which, in addition to carbon atoms, may contain one to four nitrogen atoms or one to three nitrogen atoms as ring members and in which two adjacent carbon ring members or one nitrogen and one adjacent carbon ring member may be bridged by a buta-1,3-diene-l,4-diyl group in which one or two carbon atoms may be replaced by nitrogen atoms, where these rings are attached to the skeleton via one of the nitrogen ring members, non-limiting examples 1-pyrrolyl, 1- pyrazolyl, 1,2,4-triazol-1- yl, 1-imidazolyl, 1,2,3-triazol-1-yl and 1,3,4-triazol-1-yl. 6-membered heteroaryl which contains one to four nitrogen atoms: 6-membered heteroaryl groups which, in addition to carbon atoms, may contain, respectively, one to three and one to four nitrogen atoms as ring members, non-limiting examples 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4- pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl, 1,2,4-triazin- 3-yl and 1,2,4,5-tetrazin-3-yl; benzofused 5-membered heteroaryl containing one to three nitrogen atoms or one nitrogen atom and one oxygen or sulphur atom: non-limiting examples indol-1-yl, indol- 2-yl, indol-3-yl, indol-4-yl, indol-5-yl, indol-6-yl, indol-7-yl, benzimidazol-1-yl, benzimidazol-2-yl, benzimidazol-4-yl, benzimidazol-5-yl, indazol-1-yl, indazol-3-yl, indazol-4-yl, indazol-5-yl, indazol- 6-yl, indazol-7-yl, indazol-2-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4-yl, 1-benzofuran- 5-yl, 1-benzofuran- 6-yl, 1-benzofuran-7-yl, 1-benzothiophen-2-yl, 1-benzothiophen-3-yl, 1- benzothiophen-4-yl, 1- benzothiophen-5-yl, 1-benzothiophen-6-yl, 1-benzothiophen-7-yl, 1,3- benzothiazol-2-yl, 1,3- benzothiazol-4-yl, 1,3-benzothiazol-5-yl, 1,3-benzothiazol-6-yl, 1,3- benzothiazol-7-yl, 1,3-benzoxazol-2-yl, 1,3-benzoxazol-4-yl, 1,3-benzoxazol-5-yl, 1,3-benzoxazol-6-yl and 1,3-benzoxazol-7-yl; benzofused 6-membered heteroaryl which contains one to three nitrogen atoms: non-limiting examples quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl, isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl and isoquinolin-8-yl. The term “trialkylsilyl” includes 3 branched and/or straight-chain alkyl radicals attached to and linked through a silicon atom such as trimethylsilyl, triethylsilyl and t-butyl-dimethylsilyl. “Halotrialkylsilyl” denotes at least one of the three alkyl radicals is partially or fully substituted with halogen atoms which may be the same or different. The term”alkoxytrialkylsilyl” denotes at least one of the three alkyl radicals is substituted with one or more alkoxy radicals which may be the same or different. The term “trialkylsilyloxy” denotes a trialkylsilyl moiety attached through oxygen. Non-limiting examples of “alkylcarbonyl” include C(=O)CH3, C(=O)CH2CH2CH3 and C(=O)CH(CH3)2. Non-limiting examples of “alkoxycarbonyl” include CH3OC(=O), CH3CH2OC(=O), CH3CH2CH2OC(=O), (CH3)2CHOC(=O) and the different butoxy -or pentoxycarbonyl isomers. Non- limiting examples of “alkylaminocarbonyl” include CH3NHC(=O), CH3CH2NHC(=O), CH3CH2CH2NHC(=O), (CH3)2CHNHC(=O) and the different butylamino -or pentylaminocarbonyl isomers. Non-limiting examples of “dialkylaminocarbonyl” include (CH3)2NC(=O), (CH3CH2)2NC(=O), CH3CH2(CH3)NC(=O), CH3CH2CH2(CH3)NC(=O) and (CH3)2CHN(CH3)C(=O). Non-limiting examples of “alkoxyalkylcarbonyl” include CH3OCH2C(=O), CH3OCH2CH2C(=O), CH3CH2OCH2C(=O), CH3CH2CH2CH2OCH2C(=O) and CH3CH2OCH2CH2C(=O). Non-limiting examples of “alkylthioalkylcarbonyl” include CH3SCH2C(=O), CH3SCH2CH2C(=O), CH3CH2SCH2C(=O), CH3CH2CH2CH2SCH2C(=O) and CH3CH2SCH2CH2C(=O). The term haloalkylsufonylaminocarbonyl, alkylsulfonylaminocarbonyl, alkylthioalkoxycarbonyl, alkoxycarbonylalkyl amino and the like are defined analogously Non-limiting examples of “alkylaminoalkylcarbonyl” include CH3NHCH2C(=O), CH3NHCH2CH2C(=O), CH3CH2NHCH2C(=O), CH3CH2CH2CH2NHCH2C(=O) and CH3CH2NHCH2CH2C(=O). The term “amide” means A-R'C=ONR''-B, wherein R' and R'' indicates substituents and A and B indicate any group. The term “thioamide” means A-R'C=SNR''-B, wherein R' and R'' indicates substituents and A and B indicate any group. The total number of carbon atoms in a substituent group is indicated by the “Ci-Cj” prefix where i and j are numbers from 1 to 21. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkyl designates CH3OCH2; C3 alkoxyalkyl designates, for example, CH3CH(OCH3), CH3OCH2CH2 or CH3CH2OCH2; and C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH3CH2CH2OCH2 and CH3CH2OCH2CH2. In the above recitations, when a compound of Formula (I) is comprised of one or more heterocyclic rings, all substituents are attached to these rings through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen. When a compound is substituted with a substituent bearing a subscript that indicates the number of said substituents can exceed 1, said substituents (when they exceed 1) are independently selected from the group of defined substituents. Further, when the subscript m in (R)m indicates an integer ranging from for example 0 to 4 then the number of substituents may be selected from the integers between 0 and 4 inclusive. When a group contains a substituent which can be hydrogen, then, when this substituent is taken as hydrogen, it is recognized that said group is being un-substituted. The embodiments herein and the various features and advantageous details thereof are explained with reference to the non-limiting embodiments in the description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skilled in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein. The description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein. Any discussion of documents, acts, materials, devices, articles and the like that has been included in this specification is solely for the purpose of providing a context for the disclosure. It is not to be taken as an admission that any or all of these matters form a part of the prior art base or were common general knowledge in the field relevant to the disclosure as it existed anywhere before the priority date of this application. The numerical values mentioned in the description and the description/claims though might form a critical part of the present invention, any deviation from such numerical values shall still fall within the scope of the present invention if that deviation follows the same scientific principle as that of the present invention disclosed in the present invention.
The inventive compound of the present invention may, if appropriate, be present as mixtures of different possible isomeric forms, especially of stereoisomers, for example E and Z, threo and erythro, and also optical isomers, but if appropriate also of tautomers. Both the E and the Z isomers, and also the threo and erythro isomers, and the optical isomers, any desired mixtures of these isomers and the possible tautomeric forms are disclosed and claimed.
The term “pest” for the purpose of the present disclosure includes but is not limited to fungi, stramenopiles (oomycetes), bacteria, nematodes, mites, ticks, insects and rodents.
The term “plant” is understood here to mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant cultivars which are protectable and non-protectable by plant breeders’ rights.
For the purpose of the present disclosure the term “plant” includes a living organism of the kind exemplified by trees, shrubs, herbs, grasses, ferns, and mosses, typically growing in a site, absorbing water and required substances through its roots, and synthesizing nutrients in its leaves by photosynthesis.
Examples of “plant” for the purpose of the present invention include but are not limited to agricultural crops such as wheat, rye, barley, triticale, oats or rice; beet, e.g. sugar beet or fodder beet; fruits and fruit trees, such as pomes, stone fruits or soft fruits, e.g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit and citrus trees, such as oranges, lemons, grapefruits or mandarins; any horticultural plants, vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; cucurbitaceae; oleaginous plants; energy and raw material plants, such as cereals, corn, soybean, other leguminous plants, rape, sugar cane or oil palm; tobacco; nuts; coffee; tea; cacao; bananas; peppers; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e.g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants. Preferably, the plant for the purpose of the present invention includes but is not limited to cereals, corn, rice, soybean and other leguminous plants, fruits and fruit trees, grapes, nuts and nut trees, citrus and citrus trees, any horticultural plants, cucurbitaceae, oleaginous plants, tobacco, coffee, tea, cacao, sugar beet, sugar cane, cotton, potato, tomato, onions, peppers and vegetables, ornamentals, any floricultural plants and other plants for use of human and animals. The term “plant parts” is understood to mean all parts and organs of plants above and below the ground. For the purpose of the present disclosure the term plant parts include but is not limited to cuttings, leaves, twigs, tubers, flowers, seeds, branches, roots including taproots, lateral roots, root hairs, root apex, root cap, rhizomes, slips, shoots, fruits, fruit bodies, bark, stem, buds, auxillary buds, meristems, nodes and internodes. The term “locus thereof” includes soil, surroundings of plant or plant parts and equipment or tools used before, during or after sowing/planting a plant or a plant part. Application of the compounds of the present disclosure or the compound of the present disclosure in a composition optionally comprising other compatible compounds to a plant or a plant material or locus thereof include application by a technique known to a person skilled in the art which include but is not limited to spraying, coating, dipping, fumigating, impregnating, injecting and dusting. The term “applied” means adhered to a plant or plant part either physically or chemically including impregnation. In view of the above, the present invention provides a compound of formula (I),
Figure imgf000015_0001
Formula (I) wherein, Het represents a five membered aromatic or a non-aromatic heterocyclic ring containing at least two heteroatoms; wherein the heteroatoms of the aromatic or non-aromatic heterocyclic ring are selected from N, O and S; and one or more C atom/s of the ring may be optionally replaced by C(=O) or C(=S); wherein Het is substituted with R1 and may be optionally substituted with one or more groups selected from R1a, R2 or R3; R1 is C1-C6 haloalkyl; R1a is selected from the group consisting of hydrogen, halogen, C1-C6-alkyl and C1-C6- alkylcarbonyloxy; R2 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkylalkyl, C1-C6-alkylcarbonyl and C3-C6-halocycloalkylalkyl; R3 is selected from the group consisting of hydrogen, cyano, halogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C1-C6-alkylsulfinyl, C1-C6- haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl and C1-C6-haloalkoxy; A is a phenyl, naphthyl, or a 5 to 10 membered aromatic heterocyclic or hetero bicyclic ring, wherein the ring member atoms of the aromatic heterocyclic or hetero bicyclic ring include besides carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S; and wherein A may be optionally substituted with one or more groups of RA; RA is selected from the group consisting of halogen, cyano, nitro, thiol, amino, hydroxy, C1- C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, C3-C8-cycloalkylalkyl, C1-C6- haloalkyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-hydroxyalkyl, C2-C6-haloalkenyl, C2-C6- haloalkynyl, C3-C8-halocycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6- haloalkoxycarbonyl, C1-C6-alkylthio, C1-C6-haloalkylthio, C1-C6-haloalkylsulfinyl, C1-C6- haloalkylsulfonyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylamino, C1-C6- dialkylamino, C3-C8-cycloalkylamino, C1-C6-alkyl-C3-C8-cycloalkylamino, C1-C6- alkylcarbonyl, C1-C6-alkoxycarbonyl, C1-C6-alkylaminocarbonyl, C1-C6- dialkylaminocarbonyl, C1-C6-alkoxycarbonyloxy, C1-C6-alkylaminocarbonyloxy and C1-C6- dialkylaminocarbonyloxy; wherein the aliphatic or cyclic moieties of RA may optionally be substituted with one or more groups of Ra; Ra is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6- alkylthio, C1-C6-haloalkylthio, C3-C8-cycloalkyl and C1-C6-alkoxy-C1-C6-alkyl; L1 represents a direct bond, -[C(R4R5)]n-, -[C(R4R5)]n-NR’- or -[C(R4R5)]n-O-; R4 and R5 are independently selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C1-C6-alkyl, C2-C6-alkenyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylamino, C1-C6-dialkylamino, C3-C8-cycloalkylamino and C1-C6-alkyl- C3-C8- cycloalkylamino; or R4 and R5 together with the carbon atom they share form a 3 to 5 membered non-aromatic carbocyclic ring or a heterocyclic ring; wherein the ring member atoms of the heterocyclic ring include besides carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S(O)0-2; and which may be optionally substituted with halogen, C1-C6-alkyl, C2-C6-alkenyl, C1-C6- haloalkyl or C1-C6-alkoxy; R6 and R7 are independently selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C1-C6-haloalkyl, C1-C6-alkylsulfanyl, C1-C6- alkylsulfinyl, C1-C6-alkylsulfonyl, –OR8, -NR9R10, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic groups of R6 and R7 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R7a; R7a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl, hydroxy-C1-C6-alkyl, C(=O)-NH2, C(=O)-NH(C1-C6-alkyl), C1-C6-alkylthio-C1-C6-alkyl, amino-C1-C6-alkyl, C1-C6-alkylamino-C1-C6-alkyl, di-C1-C6- alkylamino-C1-C6-alkyl, aminocarbonyl-C1-C6-alkyl, C1-C6-alkoxy-C1-C6-alkyl, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic moieties of R7a may optionally be substituted with one or more groups of R7aa selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl and C1-C6-alkoxy-C1-C6-alkyl; R8 is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1- C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl, C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic groups of R8 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R8a; R8a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl, hydroxy-C1-C6-alkyl, C(=O)-NH2, C(=O)-NH(C1-C6-alkyl), C1-C6-alkylthio-C1-C6-alkyl, amino-C1-C6-alkyl, C1-C6-alkylamino-C1-C6-alkyl, di-C1-C6- alkylamino-C1-C6-alkyl, aminocarbonyl-C1-C6-alkyl and C1-C6-alkoxy-C1-C6-alkyl; R9 and R10 are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6- alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C(=O)-(C1-C6-alkyl), C(=O)-(C1-C6- alkoxy), C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl, C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic groups of R9 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R9a; or R9 and R10 together with the N atom to which they are attached may form a saturated or partially unsaturated mono- or bicyclic 3 to 10 membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms 1, 2 or 3 heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH2 groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=O) or C(=S); and wherein the heterocycle is unsubstituted or carries 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R9a; R9a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thio, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl, NHSO2-C1-C6-alkyl, -(C=O)C1-C6-alkyl, -C(=O)-C1-C6- alkoxy, C1-C6-alkylsulfonyl, hydroxy-C1-C6-alkyl, -C(=O)-NH2, -C(=O)-NH(C1-C6-alkyl), C1-C6-alkylthio-C1-C6-alkyl, amino-C1-C6-alkyl, C1-C6-alkylamino-C1-C6-alkyl, diC1-C6- alkylamino-C1-C6-alkyl, aminocarbonyl-C1-C6-alkyl and C1-C6-alkoxy-C1-C6-alkyl; each group of R1 to R10; R1a, R7a, R8a and R9a may be optionally substituted by one or more groups selected from the group consisting of halogen, cyano, nitro, R’, OR’, SR’, N(R’)2, COR’ and CON(R’)2; R’ is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6- haloalkoxy, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C6-C10-aryl, C6-C10-aryl-C1-C6-alkoxy, C7-C14-aralkyl and C3-C10-heterocyclyl; n is an integer selected from 0 to 4; and/or N-oxides, metal complexes, isomers, polymorphs or the agriculturally acceptable salts thereof. In one embodiment, Het is selected from the group consisting of Het-1 to Het-6;
Figure imgf000018_0002
wherein, # indicates the point of attachment to A. In one embodinment, the present invention provides a compound of formula (IA),
Figure imgf000018_0001
wherein, R1, A, L1, R6 and R7 are as defined in the above detailed description. In another embodinment, the present invention provides a compound of formula (IA-A),
Figure imgf000019_0001
wherein, m is an integer selected from 0 to 4, and R1, RA, L1, R6, R7 are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A1),
Figure imgf000019_0002
wherein, m is an integer selected from 0 to 4, and R1, RA, R6, R7 are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A2),
Figure imgf000019_0003
wherein, m is an integer selected from 0 to 4; and R1, RA, R4, R5, R6, R7 are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A3),
Figure imgf000020_0001
wherein, m is an integer selected from 0 to 4; and R1, RA, R6, R7 are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A4),
Figure imgf000020_0002
wherein, m is an integer selected from 0 to 4; and R1, RA, R4, R5, R6, R7 are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A5),
Figure imgf000020_0003
wherein, m is an integer selected from 0 to 4; and R1, RA, R4, R5, R6, R’, R7 are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A6),
Figure imgf000021_0001
( ) wherein, R1, RA, R4, R5, R6, R7 and m are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-A7),
Figure imgf000021_0002
wherein, R1, RA, R4, R5, R6, R7 and m are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-B),
Figure imgf000021_0003
wherein, R1, RA, R6, R7 and m are as defined in the above detailed description. In yet another embodinment, the present invention provides a compound of formula (IA-B1),
Figure imgf000021_0004
Formula (IA-B1) wherein, R1, RA, R6, R7 and m are as defined in the above detailed description. In a preferred embodiment, the present invention provides the compound of formula (I), wherein R1 is selected from the group consisting of CF3, CF2H and CF2Cl. In a preferred embodiment, the present invention provides the compound of formula (I), wherein A is phenyl, napthalenyl, furyl, thienyl, pyrrolyl, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, imidazolyl, oxadiazolyl, triazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, quinazolinyl, cinnonyl, imidazo[1,2-a]pyridine, imidazo[1,2-a]pyrimidine, [1,2,4]triazolo[1,5-a]pyrimidine, [1,2,4]triazolo[1,5-b]pyridazine, [1,2,4]triazolo[1,5-a]pyrazine, [1,2,4]triazolo[1,5-a]pyridine, imidazo[1,2-c]pyrimidine, imidazo[1,2-b]pyridazine, [1,2,4]triazolo[1,5-c]pyrimidine, 1-methyl-1H-indole, imidazo[1,2-a]pyrazine, pyrazolo[1,5- a]pyridine and [1,2,4]triazolo[4,3-a]pyridine. In another preferred embodiment, the present invention provides the compound of formula (I), wherein RA is selected from the group consisting of halogen, cyano, nitro, thiol, amino, hydroxy, C1- C6-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkylalkyl, C1-C6-haloalkyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6- hydroxyalkyl, C3-C8-halocycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy and C1-C6-haloalkoxycarbonyl. In another preferred embodiment, the present invention provides the compound of formula (I), wherein R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C1- C6-alkyl, C2-C6-alkenyl, C1-C6-haloalkyl, C1-C6-alkoxy and C1-C6-haloalkoxy. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R6 and R7 are selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C1-C6-haloalkyl, –OR8, -NR9R10, C6-C10-aryl, C7-C14- aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the ring member atoms of the heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from N, O and S; and wherein the aliphatic or cyclic groups of R6 and R7 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R7a. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R7a is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1- C6-haloalkoxy, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic moieties of R7a may optionally be substituted with one or more groups of R7aa selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1-C6- alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C3-C8- cycloalkyl and C1-C6-alkoxy-C1-C6-alkyl. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R8 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl and C1-C6-haloalkyl. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R9 and R10 are selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl, C3-C10- heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic groups of R9 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R9a. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R9 and R10 together with the N atom to which they are attached may form a saturated or partially unsaturated monocyclic 5 to 6 membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms 1, 2 or 3 heteroatoms independently selected from N and O as ring member atoms. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R9a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, C1-C6-alkyl, C1- C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy and C3-C8-cycloalkyl. In yet another preferred embodiment, the present invention provides the compound of formula (I), wherein R’ is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C1-C6- haloalkyl, C1-C6-alkoxy and C1-C6-haloalkoxy. In a more preferred embodiment, the compound of formula (I) of the present invention is selected from ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate, ethyl bis(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate, diethyl (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonate, methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphine oxide, methyl(piperidin-1-yl)(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphine oxide, ethyl methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphinate, N,N,P-trimethyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinic amide, N,N,P-trimethyl-P-(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphinic amide, N-(4-chlorobenzyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide , (3-methoxypyrrolidin-1-yl)(methyl)(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide, methyl(4-methylpiperazin-1-yl)(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide, N-isobutyl-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide , N-(cyclopropylmethyl)-P-methyl-P-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(2-methoxyethyl)-N,P-dimethyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, P-methyl-N-phenyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-benzyl-P-methyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-methoxybenzyl)-P-methyl-P- (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(2-methoxyethyl)-P-methyl- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-allyl-P-methyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, ethyl N-isobutyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-allyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-methylcyclopropyl)-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4-methoxybenzyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-methoxyethyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-methoxyethyl)-N-methyl- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-cyclopropyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N,N-dimethyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl morpholino(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate, ethyl N-(4-methylbenzyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2,4-difluorobenzyl)-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4-fluorobenzyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(pyridin-4-ylmethyl)-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(cyclopropylmethyl)-P- (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-cyclopentyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(3-methoxybenzyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(pyridin-2-ylmethyl)-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-N- methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-phenyl-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(3-fluorophenyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-fluorophenyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl piperidin-1-yl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate, N-(4-methoxyphenyl)-P-methyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-chlorophenyl)-P-methyl-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(3-fluorophenyl)-P-methyl-P- (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-fluorophenyl)-P-methyl- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-methoxyphenyl)-N,P- dimethyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, P-methyl-N-(p- tolyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-chlorophenyl)- N,P-dimethyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(2,4- difluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, diethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate, ethyl N-phenyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-methyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl piperidin-1-yl(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphinate, ethyl N-(4-chlorophenyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(4-fluorophenyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N,N-dimethyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(2-methoxyethyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(3-methoxyphenyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-isopropyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(4-fluorobenzyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-benzyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, diethyl ((7-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, diisopropyl ((7-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, ethyl N-(2,4- difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate, ethyl N-(2-chloro-4-methylphenyl)-P-((7-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-((7- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl N-(4-fluorobenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate, ethyl N-(4-methoxybenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl N-(2-fluorobenzyl)-P-((7-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl methyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, ethyl N-(2,4-difluorobenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate, ethyl N-benzyl-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl hydrogen (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)phosphonate, diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate, ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate, ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-(2-fluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-(3,5-difluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)phosphonamidate, ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-(cyclopropylmethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)phosphonamidate, ethyl N-cyclopropyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-(2,4-difluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)phosphonamidate, ethyl N-benzyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl piperidin-1-yl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphinate, ethyl (1-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)(methyl)phosphinate, diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, dimethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, dimethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, diethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, ethyl isopropyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, ethyl N-phenyl-P-((7-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl P-((7-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(4- (trifluoromethyl)phenyl)phosphonamidate, ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, benzyl ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, ethyl (4-fluorobenzyl) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, ethyl (pyridin-3-ylmethyl) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, N-cyclopropyl-1-ethyl-1-oxo-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-λ5-phosphanediamine, P-ethyl-P-(pyrrolidin-1-yl)-N-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide, 1-ethyl-1-oxo-N-propyl-N'-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)- λ5-phosphanediamine, 1-ethyl-1-oxo-N-isopropyl-N'-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)-λ5-phosphanediamine, 1-ethyl-1-oxo-N-(2-methoxyethyl)-N'-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-λ5-phosphanediamine, 1-ethyl-1-oxo-N-phenyl-N'-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-λ5-phosphanediamine, 1-ethyl-N-(3-fluorophenyl)- 1-oxo-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-λ5-phosphanediamine, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-methylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N- isobutylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-cyclopentylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-isopropylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-ethylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-neopentylphosphonamidate, ethyl N-(tert-butyl)-P-((5- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-phenylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2- fluorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(2,4-difluorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-fluorophenyl)phosphonamidate , ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4- dichlorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin- 2-yl)methyl)-N-(3-methoxyphenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-chlorophenyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(4- chlorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin- 2-yl)methyl)-N-(2-chlorophenyl)phosphonamidate, ethyl N-(4-bromo-2-chlorophenyl)-P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,6- dichlorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin- 2-yl)methyl)-N-(o-tolyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(m-tolyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(pyridin-3-yl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3,4- difluorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin- 2-yl)methyl)-N-(3,5-difluorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(4-(trifluoromethyl)phenyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(p-tolyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)phosphonamidate, ethyl N-(3-chlorobenzyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl N-benzyl-P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl N-(2- chlorobenzyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(3-fluorobenzyl)phosphonamidate , ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4-difluorobenzyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2- fluorobenzyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(3-methoxybenzyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4-dichlorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-methylphosphonamidate , ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-isobutylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N- cyclopentylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-isopropylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorobenzyl)-N-ethylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorobenzyl)-N-neopentylphosphonamidate, ethyl N-(tert-butyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-phenylphosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2- fluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(2,4-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4- dichlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3-methoxyphenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-chlorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(4-chlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2- chlorophenyl)phosphonamidate, ethyl N-(4-bromo-2-chlorophenyl)-P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,6-dichlorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(o-tolyl)phosphonamidate, ethyl P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(m-tolyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(pyridin-3- yl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N- (3,4-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3,5-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(4-(trifluoromethyl)phenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(p-tolyl)phosphonamidate, ethyl N- (4-chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)phosphonamidate, ethyl N-(3-chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl N-benzyl-P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl N-(2-chlorobenzyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4- difluorobenzyl)phosphonamidate , ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)- 2-fluorobenzyl)-N-(2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-methoxybenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4- dichlorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)- N-methylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- isobutylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- cyclopentylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- isopropylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- ethylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- neopentylphosphonamidate, ethyl N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- phenylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2- fluorophenyl)phosphonamidate , ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)- N-(2,4-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(3-fluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(2,4-dichlorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3-methoxyphenyl)phosphonamidate, ethyl P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3-chlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(4- chlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)- N-(2-chlorophenyl)phosphonamidate, ethyl N-(4-bromo-2-chlorophenyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,6-dichlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(o-tolyl)phosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(m-tolyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(pyridin-3-yl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3,4-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3,5- difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)- N-(4-(trifluoromethyl)phenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(p-tolyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-(3-chlorobenzyl)-P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-benzyl-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-(2-chlorobenzyl)-P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3-fluorobenzyl)phosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,4-difluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2- fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N- (3-methoxybenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(2,4-dichlorobenzyl)phosphonamidate, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorophenyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-isopropyl-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N- ethyl-P-methylphosphinic amide , P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-phenylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(2-fluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N- (2,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorophenyl)-N-(3-fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(3-methoxyphenyl)-P- methylphosphinic amide , P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-N-(3-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-N-(4-chlorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(2-chlorophenyl)-P- methylphosphinic amide, N-(4-bromo-2-chlorophenyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-(o-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-(m- tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P- methyl-N-(pyridin-3-yl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-N-(3,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(3,5-difluorophenyl)-P-methylphosphinic amide , P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-(4- (trifluoromethyl)phenyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-P-methyl-N-(p-tolyl)phosphinic amide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorophenyl)(methyl)(piperidin-1-yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)(methyl)(pyrrolidin-1-yl)phosphine oxide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)(methyl)(morpholino)phosphine oxide, azetidin-1-yl(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)(methyl)phosphine oxide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-isopropyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-ethyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N- phenylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2- fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(3-fluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3-methoxyphenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3- chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(4-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2-chlorophenyl)- P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(o-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(pyridin-3- yl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3,4- difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(3,5-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-P-methyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(p-tolyl)phosphinic amide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)(piperidin-1-yl)phosphine oxide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)(pyrrolidin-1-yl)phosphine oxide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)(morpholino)phosphine oxide, azetidin- 1-yl(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)phosphine oxide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N,P-dimethylphosphinic amide, P- ((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-isobutyl-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)- N-cyclopentyl-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-isopropyl-P-methylphosphinic amide , P-((5-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-ethyl-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)- P-methyl-N-phenylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(2-fluorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-fluorophenyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)- N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)pyridin-2-yl)methyl)-N-(3-methoxyphenyl)-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-chlorophenyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)- N-(4-chlorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2- chlorophenyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)- N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)pyridin-2-yl)methyl)-P-methyl-N-(o-tolyl)phosphinic amide, P-((5-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(pyridin-3- yl)phosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N- (3,4-difluorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(3,5-difluorophenyl)-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(4- (trifluoromethyl)phenyl)phosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-P-methyl-N-(p-tolyl)phosphinic amide, ((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)(methyl)(piperidin-1-yl)phosphine oxide, ((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)(methyl)(morpholino)phosphine oxide, ((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)(methyl)(pyrrolidin-1- yl)phosphine oxide, azetidin-1-yl((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)(methyl)phosphine oxide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)- 2-fluorobenzyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-isopropyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-ethyl-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P- methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorobenzyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorobenzyl)-P-methyl-N-phenylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(2-fluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4-difluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3- fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-methoxyphenyl)-P-methylphosphinic amide , P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-chlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(4- chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2-chlorophenyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,6-dichlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P- methyl-N-(o-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-P-methyl-N-(pyridin-3-yl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3,4-difluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N- (3,5-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorobenzyl)-P-methyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P-methyl-N-(p-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N,P-dimethyl-N-(4- (trifluoromethyl)phenyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N,P-dimethyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)(methyl)(piperidin-1-yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)(methyl)(morpholino)phosphine oxide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-isopropyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-ethyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methyl-N-phenylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(2-fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(2,4-difluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(3- fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-(3-methoxyphenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(3-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(4-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(2-chlorophenyl)-P- methylphosphinic amide, N-(4-bromo-2-chlorophenyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-P-methyl-N-(o-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-P-methyl-N-(pyridin-3-yl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)-N-(3,4-difluorophenyl)-P-methylphosphinic amide , P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(3,5-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methyl-N-(4- (trifluoromethyl)phenyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-P-methyl-N-(p-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N,N,P-trimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-isobutyl-N,P-dimethylphosphinic amide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)(methyl)(piperidin-1-yl)phosphine oxide and (4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)(methyl)(morpholino)phosphine oxide. The compounds of the present disclosure may be present either in pure form or as mixtures of different possible isomeric forms such as stereoisomers or constitutional isomers. The various stereoisomers include enantiomers, diastereomers, chiral isomers, atropisomers, conformers, rotamers, tautomers, optical isomers, polymorphs, and geometric isomers. Any desired mixtures of these isomers fall within the scope of the claims of the present disclosure. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other isomer(s) or when separated from the other isomer(s). Additionally, the person skilled in the art knows processes or methods or technology to separate, enrich, and/or to selectively prepare said isomers. An anion part of the salt in case the compound of Formula (I) is a cationic or capable of forming a cation can be inorganic or organic. Alterntively, a cation part of the salt in case the compound of formula (I) is an anionic or capable of forming anion can be inorganic or organic. Examples of inorganic anion part of the salt include but are not limited to chloride, bromide, iodide, fluoride, sulfate, phosphate, nitrate, nitrite, hydrogen carbonates, hydrogen sulfate. Examples of organic anion part of the salt include but are not limited to formate, alkanoates, carbonates, acetates, trifluoroacetate, trichloroacetate, propionate, glycolate, thiocyanate, lactate, succinate, malate, citrates, benzoates, cinnamates, oxalates, alkylsulphates, alkylsulphonates, arylsulphonates aryldisulphonates, alkylphosphonates, arylphosphonates, aryldiphosphonates, p-toluenesulphonate, and salicylate. Examples of inorganic cation part of the salt include but are not limited to alkali and alkaline earth metals. Examples of organic cation part of the salt include but are not limited to pyridine, methyl amine, imidazole, benzimidazole, hitidine, phosphazene, tetramethyl ammonium, tetrabutylammonium, choline and trimethylamine. Metal ions in metal complexes of the compound of formula (I) are especially the ions of the elements of the second main group, especially calcium and magnesium, of the third and fourth main group, especially aluminium, tin and lead, and also of the first to eighth transition groups, especially chromium, manganese, iron, cobalt, nickel, copper, zinc and others. Particular preference is given to the metal ions of the elements of the fourth period and the first to eighth transition groups. Here, the metals can be present in the various valencies that they can assume. The compound selected from formula (I), (including all stereoisomers, N-oxides, and salts thereof), typically may exist in more than one form. Formula (I) thus includes all crystalline and non- crystalline forms of the compound that formula (I) represents. Non-crystalline forms include embodiments which are solids such as waxes and gums as well as embodiments which are liquids such as solutions and melts. Crystalline forms include embodiments which represent essentially a single crystal type and embodiments which represent a mixture of polymorphs (i.e. different crystalline types). The term "polymorph" refers to a particular crystalline form of a chemical compound that can crystallize in different crystalline forms, these forms having different arrangements and/or conformations of the molecules in the crystal lattice. Although polymorphs can have the same chemical composition, they can also differ in composition due to the presence or absence of co- crystallized water or other molecules, which can be weakly or strongly bound in the lattice. Polymorphs can differ in such chemical, physical and biological properties as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspensibility, dissolution rate and biological availability. One skilled in the art will appreciate that a polymorph of a compound represented by formula (I) can exhibit beneficial effects (e.g., suitability for preparation of useful formulations, improved biological performance) relative to another polymorph or a mixture of polymorphs of the same compound represented by formula (I). Preparation and isolation of a particular polymorph of a compound represented by formula (I) can be achieved by methods known to those skilled in the art including, for example, crystallization using selected solvents and temperatures. In an embodiment, the present invention provides a process for the synthesis of a compound of formula (I), wherein the definitions of Het, A, L1, R6, R7, R9 and R10 in the compounds of formula (I) and in the compounds of formula 1 to 16 are as defined in the above detailed description of the invention unless otherwise specifically stated. In one embodiment, the present invention provides a process for preparing the compound of formula (I) comprising the steps of: a) reacting a compound of formula 3 with a compound of formula R6-X wherein X is Cl, Br or I; to affford a compound of formula 4;
Figure imgf000036_0001
b) reacting a compound of formula 4 with hydroxyl amine to afford a compound of formula 5;
Figure imgf000036_0002
c) reacting a compound of formula 5 with a suitable carboxylic acid anhydride of formula (a) or a suitable acid chloride of formula (b) to afford a compound of formula 6, wherein Het is Het- 1;
Figure imgf000036_0003
d) reacting a compound of formula 6 with a suitable chlorinating reagent to afford a compound of formula 7;
Figure imgf000036_0004
wherein, R6 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl and C3-C6-cycloalkenyl; or reacting the compound of formula 6 with a suitable chlorinating reagent followed by hydrolysing the resultanting compound to obtain a compound of formula 15;
Figure imgf000036_0005
R6 is -OEt; e) reacting the compound of formula 7 with a compound of formula HNR9R10 to obtain a compound of formula (I);
Figure imgf000037_0001
wherein, R6 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl and C3-C6-cycloalkenyl;
Figure imgf000037_0002
reacting the compound of formula 15 with a compound of formula HNR9R10 to obtain a compound of formula (I);
Figure imgf000037_0003
wherein, R6 is -OEt; R7 is -NR9R10. In another embodiment, the process for the synthesis of compound of formula (I) further comprising the steps of: f) reacting a compound of formula 15 with a suitable chlorinating reagent to afford a compound of formula (I);
Figure imgf000037_0004
wherein, R6 is -OEt; Het, A, L1, R6, R9 and R10 are as defined in claim 1; g) reacting a compound of formula 14 with a compound of formula HNR9R10 to afford a compound of formula (I);
Figure imgf000037_0005
wherein, R6 is -OEt; R7 is -NR9R10. In yet another embodiment, the present invention provides a process for preparing the compound of formula (I) comprising the steps of: a) reacting a compound of formula 9 with hydroxyl amine to afford a compound of formula 10;
Figure imgf000038_0001
b) reacting a compound of formula 10 with a suitable carboxylic acid anhydride of formula (a) or acid chloride of formula (b) to obtain a compound of formula 11, wherein Het is Het-1;
Figure imgf000038_0002
c) reacting a compound of formula 11 with suitable halogenating reagent to afford a compound of formula 12;
Figure imgf000038_0003
d) reacting the compound of formula 12 with a suitable reagent to afford a compound of formula 13;
Figure imgf000038_0004
e) reacting the compound of formula 13 with suitable chlorinating reagent to afford a compound of formula 14;
Figure imgf000038_0005
f) reacting a compound of formula 14 with a compound of formula HNR9R10 to afford a compound of formula (I);
Figure imgf000039_0001
The following schemes illustrate approaches to generate compounds of formula (I). The following descriptions and examples are provided for illustrative purposes and should not be construed as limiting in terms of substituents or substitution patterns. Further, the mentioned reagents, solvents and reaction conditions are intended for the purpose of exemplification only. The compounds of the present invention as defined by formula (I) and/or in the tables 1 to 8 may be prepared, in known manner, in a variety of ways as described in the schemes 1-6; General scheme: 1
Figure imgf000039_0002
wherein, L1 is CH2; X is Cl, Br or I; and Het is ; R6 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl and C3-C6-cycloalkenyl; A, R1, R7, R9 and R10 are as defined in the detailed description above.
Figure imgf000039_0003
The compound of formula 2 can be obtained by reacting the compound of formula 1 with a preformed complex of anilinium hypophosphite and hexamethyldisilazane. This reaction is typically carried out in a suitable aprotic solvent such as dichloromethane, toluene, acetonitrile, tetrahydrofuran, and the like at a suitable temperature ranging from 0 to 35 °C. The complex of anilinium hypophosphite and hexamethyldisilazane can be prepared by reacting an equimolar mixture of anilinium hypophosphite and hexamethyldisilazane at a suitable temperature ranging from 100 to 110 °C. Step: 2
Figure imgf000040_0001
The compound of formula 3 can be obtained by esterification of the compound of formula 2 with ethanol in the presence of a suitable esterification reagent such as pivaloyl chloride and a suitable solvent such as pyridine. This reaction can be carried out at a temperature ranging from 0 to 35 °C. Alternatively, the compound of formula 3 can also be obtained by reacting the compound of formula 2 with ethanol in the presence of a suitable coupling reagent such as N,N′-dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP), and the like at an ambient temperature (Tetrahedron Letters, 2005, vol.46, issue: 19, p.3359 – 3362). Step: 3
Figure imgf000040_0002
The compound of formula 4 can be obtained by alkylating the compound of formula 3 with a compound of formula R6-X wherein X is Cl, Br or I, in the presence of a suitable base such as lithium bis(trimethylsilyl)amide and in a suitable aprotic solvent such as tetrahydrofuran, at a temperature ranging from -78 °C to 25 °C. Step: 4
Figure imgf000040_0003
The compound of formula 5 can be obtained by reacting the compound of formula 4 with hydroxyl amine in a suitable polar protic solvent such as ethanol, methanol, and the like. Alternatively, this reaction can also be carried out by using hydroxylamine hydrochloride in the presence of a suitable organic and/or inorganic base such as triethylamine, N,N-diisopropylethylamine, sodium bicarbonate, and the like. Step: 5
Figure imgf000041_0001
The compound of formula 6 wherein Het is ; can be obtained by reacting the compound of formula 5 with carboxylic acid anhydride of formula (a) or acid chloride of formula (b). These reactions are typically performed in a suitable aprotic solvent such as tetrahydrofuran, 1,4-dioxane, dichloromethane, and the like optionally in the presence of a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like at a temperature ranging from 0 to 50 °C. Step: 6
Figure imgf000041_0002
The compound of formula 7 can be obtained by reacting the compound of formula 6 with a suitable reagent such as oxalyl chloride or thionyl chloride. This reaction can be carried out in a suitable solvent such as dichloromethane at a temperature ranging from 0 to 40 °C. Step: 7
Figure imgf000041_0003
Figure imgf000042_0001
The compound of formula (I) wherein L1 is CH2; Het is and R6 is methyl can be obtained by reacting the compound of formula 7 with the compound of formula HNR9R10 in the presence of a suitable base such as triethylamine, N,N-diisopropylethylamine, and the like at a temperature ranging from 0 to 50 °C. This reaction is carried out in a suitable solvent such as dichloromethane, tetrahydrofuran, ethyl acetate, and the like. General scheme: 2 Step: 1
Figure imgf000042_0002
The compound of formula 3 can be directly obtained by reacting a compound of formula 1 wherein L1 is CH2 and X is Cl, Br or I with ethyl phosphinate in the presence of a suitable base such as 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU). This reaction can be carried out in a suitable aprotic solvent such as tetrahydrofuran, acetonitrile, and the like. [Tetrahedron Letters, 2012, 53 (37); p. 5000 – 5003; Synthesis, 2006, 2, p.325 – 331]. General scheme: 3 Step 1:
Figure imgf000042_0003
The compound of formula 4 wherein L1 is CH2 can be directly obtained by reacting the compound of formula 1 wherein L1 is CH2 and X is Cl, Br or I, with compound of formula (iii) (Arbuzov reaction) optionally in the presence of a suitable base such as sodium hydroxide. This reaction may optionally be carried out in a suitable solvent such as toulene, acetonitrile, N,N-dimethylformamide, and the like at a temperature ranging from 90 to 120 °C. [Tetrahedron, 1984, 40, p. 2731; Australian Journal of Chemistry, 1983, 36, 12, p.2517 – 2536]. General scheme: 4
Figure imgf000043_0001
wherein, L1 is CH2; X is Cl, Br or I; Het is or wherein R1 is CF3; R6 is -OEt; R7 is -NR9R10; A and R1, are as defined in the detailed description above. Step: 1
Figure imgf000043_0002
The compound of formula 10 can be obtained by reacting the compound of formula 9 with hydroxyl amine in a suitable polar protic solvent such as ethanol, methanol, and the like. Alternatively, this reaction can also be carried out by using hydroxylamine hydrochloride in the presence of suitable organic and/or inorganic bases such as triethylamine, N,N-diisopropylethylamine, sodium bicarbonate, and the like. Step: 2
Figure imgf000043_0003
Figure imgf000044_0001
The compound of formula 11 wherein Het is ; can be obtained by reacting the compound of formula 10 with carboxylic acid anhydride of formula (a) or acid chloride of formula (b). These reactions are typically performed in a suitable aprotic solvent such as tetrahydrofuran, 1,4-dioxane, dichloromethane, and the like optionally in the presence of a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like at temperature ranging from 0 to 50 °C. Step: 3
Figure imgf000044_0002
The compound of formula 12 wherein Het is or in which R1 is CF3; can be obtained by radical halogenation of compound of formula 11 with a suitable halogenating reagent such as N-bromosuccinimide or N-chlorosuccinimide in the presence of a suitable radical initiator such as azobisisobutyronitrile or benzoyl peroxide. This reaction can be carried out in a suitable solvent such as chloroform, carbon tetrachloride and the like at refluxing temperatures. Step: 4
Figure imgf000044_0003
The compound of formula 13 wherein L1 is CH2; Het is or in which R1 is CF3 can be obtained by reacting the compound of formula 12 wherein L1 is CH2; Het
Figure imgf000044_0004
is o wherein R1 is CF3, with triethyl phosphite at a temperature ranging from 30 to 110 °C.
Figure imgf000044_0005
Figure imgf000045_0001
The compound of formula 13 wherein L1 is a direct bond; Het is or wherein R1 is CF3, can be obtained by reacting the compound of formula 12 wherein L1 is a direct bond; Het is
Figure imgf000045_0002
wherein R1 is CF3, with diethyl phosphonate in the presence of Pd (0) catalyst such as tetrakis(triphenylphosphine)palladium. This reaction is typically carried out in presence of a suitable base such as triethylamine, diisopropyl ethyl amine, and the like at temperature ranging from 50 °C to 90 °C. Step: 5
Figure imgf000045_0003
The compound of formula 14 wherein L1 is CH2 or a direct bond; Het is or wherein R1 is CF3; can be obtained by reacting the compound of formula 13 with a suitable chlorinating reagent such as phosphorous oxychloride at temperature ranging from 0 to 80 °C. Step: 6
Figure imgf000045_0004
The compound of formula (I) wherein L1 is CH2 or a direct bond; Het is or wherein R1 is CF3; R6 is -OEt; R7 is -NR9R10; can be obtained by reacting the compound of formula 14 with the compound of formula HNR9R10 in the presence of a suitable base such as triethylamine, N,N- diisopropylethylamine, and the like at a temperature ranging from 0 to 50 °C. This reaction is carried out in a suitable solvent such as dichloromethane, tetrahydrofuran, ethyl acetate, and the like. General Scheme 5
Figure imgf000046_0001
wherein Het is or wherein R1 is CF3; R6 is C1-C6-alkyl ; R7 is -NR9R10. Step: 1
Figure imgf000046_0002
The compound of formula 15 can be obtained by reacting the compound of formula 6 with a suitable chlorinating reagent such as oxalyl chloride to obtain the chloride derivative of compound of formula 15 which was hydrolysed with water at 0-5 °C to obtain compound of formula 15. This reaction is typically carried out in a suitable solvent such as dichloromethane. Alternatively, this reaction can also be carried out by reacting the compound of formula 6 with trimethylsilyl bromide as reported in the Journal of Medicinal Chemistry, 1998, vol. 41, # 5, p. 752 – 759. Step: 2
Figure imgf000046_0003
The compound of formula (I) wherein R7 is -NR9R10 is obtained by reacting compound of formula 15 with a suitable amine of formula HNR9R10 in the presence of a suitable coupling reagent such as 1-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 4-dimethylaminopyridine. This reaction is carried out in a suitable solvent such as tetrahydrofuran at refluxing temperature. General scheme: 6
Figure imgf000047_0001
wherein R6 is -OEt. Step: 1
Figure imgf000047_0002
The compound of formula 15 can be obtained by reacting the compound of formula 6 with lithium bromide. This reaction is typically carried out in a suitable solvent such as 2-pentanone at refluxing temperature. Step: 2
Figure imgf000047_0003
The compound of formula 14 can be obtained by reacting the compound of formula 15 with a suitable chlorinating reagent such as oxalyl chloride or thionyl chloride. This reaction can be carried out in a suitable solvent such as dichloromethane at a temperature ranging from 0 to 40 °C optionally in the presence of a suitable catalyst such as dimethylformamide. In another embodiment, the present invention relates to an agrochemical composition comprising the compound of formula (I), agriculturally acceptable salts, metal complexes, constitutional isomers, stereo-isomers, diastereoisomers, enantiomers, chiral isomers, atropisomers, conformers, rotamers, tautomers, optical isomers, polymorphs, geometric isomers, or N-oxides thereof optionally with one or more additional active ingredient with the auxiliary such as inert carrier or any other essential ingredient such as surfactants, additives, solid diluents and liquid diluents. The compound of formula (I) and the composition according to the invention, respectively, are suitable as fungicides. They are distinguished by their effectiveness against a broad spectrum of phytopathogenic fungi, including soi1-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants. The compound of formula (I) and the composition according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e.g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants. Particularly, the compound of formula (I) and the composition according to the invention are important in the control of phytopathogenic fungi on soybeans and on the plant propagation material, such as seeds, and the crop material of soybeans. Accordingly, the present invention provides a composition comprising at least one compound of formula (I) and seed. The amount of the compound of formula (I) in the composition ranges from 0.1 g ai (gram per active ingredient) to 10 kg ai (kilogram per active ingredient) per 100 kg of seeds. Preferably, the compound of formula (I) and composition thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes. The term "plant propagation material" is to be understood to denote all the generative or reproductive parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts, twigs, flowers, and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring. Preferably, treatment of plant propagation materials with the compound of formula (I), the combination and or the composition thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans. The term "cultivated plants" is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo-or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties. Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleacher herbicides such as hydroxylphenylpyruvate dioxygenase (HPPD) inhibitors or phytoene desaturase (PDS) inhibitors; acetolactate synthase (ALS) inhibitors such as sulfonyl ureas or imidazolinones; enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynil (i. e. bromoxynil or ioxynil) herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or ACCase inhibitors. These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61, 2005, 246; 61, 2005, 258; 61, 2005, 277; 61, 2005, 269; 61, 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1185; and references quoted therein. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun® sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron. Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate-tolerant, Monsanto, U.S.A.), Cultivance® (imidazolinone tolerant, BASF SE, Germany) and LibertyLink® (glufosinate-tolerant, Bayer CropScience, Germany). Furthermore, plants capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus (Bacillus), by the use of recombinant DNA techniques are within the scope of the present invention. The Bacillus are particularly from Bacillus thuringiensis, such as δ- endotoxins, e. g. Cry1A(b), Cry1A(c), Cry1F, Cry1F(a2), Cry11A(b), Cry111A, Cry111B(b1) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1, VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA- reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilbene synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO02/015701). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP374753, WO93/007278, WO95/34656, EP427529, EP451878, WO03/18810 und WO03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of arthropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard® (corn cultivars producing the Cry1Ab toxin), YieldGard® Plus (corn cultivars producing Cry1Ab and Cry3Bb1 toxins), Starlink® (corn cultivars producing the Cry9c toxin), Herculex® RW (corn cultivars producing Cry34Ab1, Cry35Ab1 and the enzyme phosphinothricin-N-acetyltransferase [PAT]); NuCOTN® 33B (cotton cultivars producing the Cry1Ac toxin), Bollgard® I (cotton cultivars producing the Cry1 Ac toxin), Bollgard® II (cotton cultivars producing Cry1Ac and Cry2Ab2 toxins); VIPCOT® (cotton cultivars producing a VIP-toxin); NewLeaf®(potato cultivars producing the Cry3A toxin); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Protecta®, Bt11 (e. g. Agrisure® CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the Cry1Ab toxin and PAT enyzme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the Cry1Ac toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1 F toxin and PAT enzyme). Furthermore, plants capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens by the use of recombinant DNA techniques are also within the scope of the present invention. Examples of such proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, e. g. EP392225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the Mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. Furthermore, plants capable to synthesize one or more proteins, by the use of recombinant DNA techniques, to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants are within the scope of the present invention. Furthermore, plants that contain a modified amount of substances of content or new substances of content, by the use of recombinant DNA techniques, to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera® rape, DOW Agro Sciences, Canada) are also within the scope of the present invention. Furthermore, plants that contain a modified amount of substances of content or new substances of content, by the use of recombinant DNA techniques, to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora® potato, BASF SE, Germany) are also within the scope of the present invention. The present invention also relates to a method for combating infestation of plants by phytopathogenic micro-organisms in agricultural crops and or horticultural crops wherein an effective amount of at least one compound of formula (I) or the combination of the present invention or the composition of the present invention, is applied to the seeds of plants. The compound, the combination and the composition of the present invention can be used for combating plant diseases. The compound of formula (I), the combination and or the composition thereof, respectively, are particularly suitable for controlling the following plant diseases: Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis); Altemaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici (anthracnose) on wheat and A. hordei on barley; Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicola) on corn, e. g. spot blotch (C. sorokiniana) on cereals and e. g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn (e. g. Gray leaf spot: C. zeae-maydis), rice, sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum: leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus (anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. sorokiniana) and rice (e. g. C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnose) on cotton (e. g. C. gossypii), corn (e. g. C. graminicola: Anthracnose stalk rot), soft fruits, potatoes (e. g. C. coccodes: black dot), beans (e. g. C. lindemuthianum) and soybeans (e. g. C. truncatum or C. gloeosporioides); Corticium spp., e. g. C. sasakii (sheath blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamentals; Cycloconium spp., e. g. C. oleaginum on olive trees; Cylindrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.) on fruit trees, vines (e. g. C. liriodendri, teleomorph: Neonectria liriodendri: Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D. phaseolorum (damping off) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (£. pyri), soft fruits (£. veneta: anthracnose) and vines (£. ampelina: anthracnose); Entyloma oryzae (leaf smut) on rice; Epicoccum spp. (black mold) on wheat; Erysiphe spp. (powdery mildew) on sugar beets (£. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E. cichoracearum), cabbages, rape (e. g. E. cruciferarum); Eutypa lata (Eutypa canker or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental woods; Exserohilum (syn. Helminthosporium) spp. on corn (e. g. E. turcicum); Fusarium (teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. solani (f. sp. glycines now syn. F. virguliforme) and F. tucumaniae and F. brasiliense each causing sudden death syndrome on soybeans, and F. verticillioides on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G. zeae) and rice (e. g. G. fujikuroi: Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants and G. gossypii on cotton; Grainstaining complex on rice; Guignardia bidwellii (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G. sabinae (rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochliobolus) on corn, cereals and rice; Hemileia spp., e. g. H. vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn. phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco (P. tabacina) and soybeans (e. g. P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets; Phomopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), soybeans, potatoes and tomatoes (e. g. P. infestans: late blight) and broad-leaved trees (e. g. P. ramorum: sudden oak death); Plasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Plasmopara spp., e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples; Polymyxa spp., e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P. betae) and thereby transmitted viral diseases; Pseudocercosporella herpotrichoides (eyespot, teleomorph: Tapesia yallundae) on cereals, e. g. wheat or barley; Pseudoperonospora (downy mildew) on various plants, e. g. P. cubensis on cucurbits or P. humili on hop; Pseudopezicula tracheiphila (red fire disease or .rotbrenner', anamorph: Phialophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, P. kuehnii (orange rust) on sugar cane and P. asparagi on asparagus; Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ramularia leaf spots, Physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secalis (scald) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckeri) on vines; Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf; Sphacelotheca spp. (smut) on corn, (e. g. S. reiliana: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina spp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans); Tilletia spp. (common bunt or stinking smut) on cereals, such as e. g. T. tritici (syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U. occulta (stem smut) on rye; Uromyces spp. (rust) on vegetables, such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae); Ustilago spp. (loose smut) on cereals (e. g. U. nuda and U. avaenae), corn (e. g. U. maydis: corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears; and Verticillium spp. (wilt) on various plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V. dahliae on strawberries, rape, potatoes and tomatoes. The compound of formula (I), the combination or the composition thereof may be used to treat several fungal pathogens. Non-limiting examples of pathogens of fungal diseases which can be treated in accordance with the invention include: Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts for example those caused by Pucciniales such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp. Hordei, Puccinia striiformis f.sp. Secalis, Pucciniastrum coryli, or Uredinales such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and other rots and diseases such as those caused by Cryptococcus spp., Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, ltersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani, Thanetephorus cucurmeris, Entyloma dahliae, Entylomella microspora, Neovossia moliniae and Tilletia caries. Blastocladiomycetes, such as Physoderma maydis. Mucoromycetes, such as Choanephora cucurbitarum; Mucor spp.; and Rhizopus arrhizus, In another embodiment diseases caused by rust disease pathogens, for example Gymnosporangium species, for example Gymnosporangium sabinae; Hemileia species, for example Hemileia vastatrix; Phakopsora species, for example Phakopsora pachyrhizi or Phakopsora meibomiae; Puccinia species, for example Puccinia recondita, Puccinia graminis oder Puccinia striiformis; Uromyces species, for example Uromyces appendiculatus; In particular, Cronartium ribicola (White pine blister rust); Gymnosporangium juniperi-virginianae (Cedar-apple rust); Hemileia vastatrix (Coffee rust); Phakopsora meibomiae and P. pachyrhizi (Soybean rust); Puccinia coronata (Crown Rust of Oats and Ryegrass); Puccinia graminis (Stem rust of wheat and Kentucky bluegrass, or black rust of cereals); Puccinia hemerocallidis (Daylily rust); Puccinia persistens subsp. triticina (wheat rust or 'brown or red rust'); Puccinia sorghi (rust in corn); Puccinia striiformis ('Yellow rust' in cereals); Uromyces appendiculatus (rust of beans); Uromyces phaseoli (Bean rust); Puccinia melanocephala ('Brown rust' in sugarcane); Puccinia kuehnii ('Orange rust' in sugarcane). Plants which can be treated in accordance with the invention include the following: cotton, flax, grapevine, fruits, vegetables, such as Rosaceae sp (for example pome fruits such as apples, pears, apricots, cherries, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example banana trees and plantations), Rubiaceae sp. (for example coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example lemons, oranges and grapefruit); Vitaceae sp. (for example grapes); Solanaceae sp. (for example tomatoes, peppers), Liliaceae sp., Asteraceae sp. (for example lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (for example cucumber), Alliaceae sp. (for example leek, onion), Papilionaceae sp. (for example peas); major crop plants, such as Poaceae/Gramineae sp. (for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (for example sunflower), Brassicaceae sp. (for example white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes, and oilseed rape, mustard, horseradish and cress), Fabacae sp. (for example bean, peanuts), Papilionaceae sp. (for example soya bean), Solanaceae sp. (for example potatoes), Chenopodiaceae sp. (for example sugar beet, fodder beet, swiss chard, beetroot); Malvaceae (for example cotton); useful plants and ornamental plants for gardens and wooded areas; and genetically modified varieties of each of these plants. More preference is given to controlling the following diseases of soya beans: Fungal diseases on leaves, stems, pods and seeds caused, for example, by Altemaria leaf spot (Altemaria spec. atrans tenuissima), Anthracnose (Colletotrichum gloeosporoides dematium var. truncatum), brown spot (Septoria glycines ), cercospora leaf spot and blight ( Cercospora kikuchii), choanephora leaf blight (Choanephora infundibulifera trispora (Syn.)), dactuliophora leaf spot (Dactuliophora glycines), downy mildew (Peronospora manshurica), drechslera blight (Drechslera glycini), frogeye leaf spot (Cercospora sojina), leptosphaerulina leaf spot (Leptosphaerulina trifolii), phyllostica leaf spot (Phyllosticta sojaecola), pod and stem blight (Phomopsis sojae), powdery mildew (Microsphaera diffusa), pyrenochaeta leaf spot (Pyrenochaeta glycines), rhizoctonia aerial, foliage, and web blight (Rhizoctonia solani), rust (Phakopsora pachyrhizi, Phakopsora meibomiae), scab (Sphaceloma glycines), stemphylium leaf blight (Stemphylium botryosum), target spot (Corynespora cassiicola). Fungal diseases on roots and the stem base caused, for example, by black root rot (Calonectiia crotalariae), charcoal rot (Macrophomina phaseolina), fusarium blight or wilt, root rot, and pod and collar rot (Fusarium oxysporum, Fusarium orthoceras, Fusarium semitectum, Fusarium equiseti), mycoleptodiscus root rot (Mycoleptodiscus terrestris), neocosmospora (Neocosmospora vasinfecta), pod and stem blight (Diaporthe phaseolorum), stem canker (Diaporthe phaseolorum var. caulivora), phytophthora rot (Phytophthora megasperma), brown stem rot (Phialophora gregata), pythium rot (Pythium aphanidennatum, Pythium irregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum), rhizoctonia root rot, stem decay, and damping-off (Rhizoctonia solani), sclerotinia stem decay (Sclerotinia sclerotiorum), sclerotinia southern blight (Sclerotinia rolfsii), thielaviopsis root rot (Thielaviopsis basicola). The present invention also relates to the use of the compound of formula (I), the combination or the composition thereof for combating the following plant diseases: Puccinia spp. (rusts) on various plants, for example, but not limited to P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye and Phakopsoraceae spp. on various plants, in particular Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans, Hemileia vastatrix (Coffee rust), Uromyces appendiculatus, Uromyces fabae and Uromyces phaseoli (rust of beans). The present invention further relates to the use of the compound of formula (I), the combination or the composition thereof for combating against phytopathogenic fungi such as Phakopsora pachyrhizi, Phakopsora meibomiae, of agricultural crops and or horticultural crops. The compound of formula (I), the combination and the composition thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. The term "protection of materials" is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, cooling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. As to the protection of wood and other materials, the particular attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Pora spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichoderma spp., Altemaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., and in addition in the protection of stored products and harvest the following yeast fungi are worthy of note: Candida spp. and Saccharomyces cerevisae. In one embodiment the compound of formula (I), the combination and the composition thereof, respectively, are particularly suitable for controlling the following plant diseases: Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans. The present invention further relates to a method for combating phytopathogenic fungi. The method comprises treating the fungi or the materials, plants, plant parts, locus thereof, soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula (I) or the combination or the composition comprising at least one compound of formula (I). The method of treatment according to the invention can also be used in the field of protecting stored products or harvest against attack of fungi and microorganisms. According to the present invention, the term "stored products" is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired. Stored products of crop plant origin, such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, comminuted, ground, pressed or roasted, which process is also known as post-harvest treatment. Also falling under the definition of stored products is timber, whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as furniture or objects made from wood. Stored products of animal origin are hides, leather, furs, hairs and the like. The combination according to the present invention can prevent disadvantageous effects such as decay, discoloration or mold. Preferably "stored products" is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms. The compound of formula (I), the combination and the composition thereof, respectively, may be used for improving the health of a plant. The invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compound I and the composition thereof, respectively. The term "plant health" is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e. g. increased biomass and/or increased content of valuable ingredients), plant vigor (e. g. improved plant growth and/or greener leaves ("greening effect")), quality (e. g. improved content or composition of certain ingredients) and tolerance to abiotic and/or biotic stress. The above identified indicators for the health condition of a plant may be interdependent or may result from each other. The compound of formula (I) can be present in different crystal modifications or polymorphs whose biological activity may differ. They are likewise subject matter of the present invention. The compounds of formula (I) are employed as such or in the form of a composition for treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active ingredients. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi. Plant propagation materials may be treated with a compound of formula (I), the combination and the composition thereof protectively either at or before planting or transplanting. The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound of formula (I). An agrochemical composition comprises a fungicidally effective amount of a compound of formula (I). The term "effective amount" denotes an amount of the composition or of the compound of formula (I), which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound of formula (I) used. The compound of formula (I), their -oxides, metal complexes, isomers, polymorphs or the agriculturally acceptable salts thereof can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e. g. EW, EO, ES, ME), capsules (e. g. CS, ZC), pastes, pastilles, wettable powders or dusts (e. g. WP, SP, WS, DP, DS), pressings (e. g. BR, TB, DT), granules (e. g. WG, SG, GR, FG, GG, MG), insecticidal articles (e. g. LN), as well as gel Formulations for the treatment of plant propagation materials such as seeds (e. g. GF). These and further compositions types are defined in the "Catalogue of pesticide Formulation types and international coding system", Technical Monograph No.2, 6th Ed. May 2008, CropLife International. The compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product Formulation, Agrow Reports DS243, T&F Informa, London, 2005. Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders. Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e. g. ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; DMSO; ketones, e. g. cyclohexanone; esters, e. g. lactates, carbonates, fatty acid esters, gamma- butyrolactone; fatty acids; phosphonates; amines; amides, e. g. N-methyl pyrrolidone, fatty acid dimethyl amides; and mixtures thereof. Suitable solid carriers or fillers are mineral earths, e. g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof. Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.). Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylaryl sulfonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl-and tridecylbenzenes, sulfonates of naphthalenes and alkyl naphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates. Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinyl pyrrolidone, vinyl alcohols, or vinyl acetate. Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinyl amines or polyethylene amines. Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound of formula (I) on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5. Suitable thickeners are polysaccharides (e. g. xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates. Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones. Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin. Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids. Suitable colorants (e. g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e. g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e. g. alizarin-, azo- and phthalocyanine colorants). Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers. Examples for composition types and their preparation are: i) Water-soluble concentrates (SL, LS) 10-60 wt% of a compound of formula (I) and 5-15 wt% wetting agent (e. g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e. g. alcohols) ad 100 wt%. The active substance dissolves upon dilution with water. ii) Dispersible concentrates (DC) 5-25 wt% of a compound of formula (I) and 1-10 wt% dispersant (e. g. polyvinyl pyrrolidone) are dissolved in organic solvent (e. g. cyclohexanone) ad 100 wt%. Dilution with water gives a dispersion. iii) Emulsifiable concentrates (EC) 15-70 wt% of a compound of formula (I) and 5-10 wt% emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%. Dilution with water gives an emulsion. iv) Emulsions (EW, EO, ES) 5-40 wt% of a compound of formula (I) and 1-10 wt% emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt% water-insoluble organic solvent (e. g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt% by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion. v) Suspensions (SC, OD, FS) In an agitated ball mill, 20-60 wt% of a compound of formula (I) are comminuted with addition of 2- 10 wt% dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate), 0.1-2 wt% thickener (e. g. xanthan gum) and water ad 100 wt% to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt% binder (e. g. polyvinyl alcohol) is added. vi) Water-dispersible granules and water-soluble granules (WG, SG) 50-80 wt% of a compound of formula (I) are ground finely with addition of dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt% and prepared as water- dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance. vii) Water-dispersible powders and water-soluble powders (WP, SP, WS) 50-80 wt% of a compound of formula (I) are ground in a rotor-stator mill with addition of 1-5 wt% dispersants (e. g. sodium lignosulfonate), 1-3 wt% wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance. viii) Gel (GW, GF) In an agitated ball mill, 5-25 wt% of a compound of formula (I) are comminuted with addition of 3-10 wt% dispersants (e. g. sodium lignosulfonate), 1-5 wt% thickener (e. g. carboxymethyl cellulose) and water ad 100 wt% to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance. ix) Microemulsion (ME) 5-20 wt% of a compound of formula (I) are added to 5-30 wt% organic solvent blend (e. g. fatty acid dimethyl amide and cyclohexanone), 10-25 wt% surfactant blend (e. g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100 %. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion. x) Microcapsules (CS) An oil phase comprising 5-50 wt% of a compound of formula (I), 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). Radical polymerization results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt% of a compound of formula (I) according to the invention, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocyanate monomer (e. g. diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). The addition of a polyamine (e. g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt%. The wt% relate to the total CS composition. xi) Dustable powders (DP, DS) 1-10 wt% of a compound of formula (I) are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt%. xii) Granules (GR, FG) 0.5-30 wt% of a compound of formula (I) are ground finely and associated with solid carrier (e. g. silicate) ad 100 wt%. Granulation is achieved by extrusion, spray-drying or fluidized bed. xiii) Ultra-low volume liquids (UL) 1-50 wt% of a compound of formula (I) are dissolved in organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%. The compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1-1 wt% anti-foaming agents, and 0.1-1 wt% colorants. The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active ingredient (ai). The active ingredients (ai) are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum). For the purposes of treatment of plant propagation materials, particularly seeds, solutions for seed treatment (LS), suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC), and gels (GF) are usually employed. The compositions in question give, after two-to-tenfold dilution, active substance concentrations from 0.01 to 60% by weight, preferably from 0.1 to 40%, in the ready-to-use preparations. Application can be carried out before or during sowing. Methods for applying the compound of formula (I), the combination and the composition thereof, respectively, are application onto plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, and soaking as well as in-furrow application methods. Preferably, the compound of formula (I), the combination and the composition thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting. When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 1.0 kg per ha, and in particular from 0.1 to 1.0 kg per ha. In the treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seeds, amounts of active substance from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kg of plant propagation material (preferably seeds) are generally required. When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material. Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e. g. herbicides, insecticides, fungicides, growth regulators, safeners, biopesticides) may be added to the active substances or the compositions comprising them as premix or, if appropriate, not until immediately prior to use (tank mix). These agents can be mixed with the composition according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:20 to 20:1. A pesticide is generally a chemical or biological agent (such as pesticidally active ingredient, compound, composition, virus, bacterium, antimicrobial or disinfectant) that through its effect deters, incapacitates, kills or otherwise discourages pests. Target pests can include insects, plant pathogens, weeds, mollusks, birds, mammals, fish, nematodes (roundworms), and microbes that destroy property, cause nuisance, spread disease or are vectors for disease. The term "pesticide" includes also plant growth regulators that alter the expected growth, flowering, or reproduction rate of plants; defoliants that cause leaves or other foliage to drop from a plant, usually to facilitate harvest; desiccants that promote drying of living tissues, such as unwanted plant tops; plant activators that activate plant physiology for defense against certain pests; safeners that reduce unwanted herbicidal action of pesticides on crop plants; and plant growth promoters that affect plant physiology e.g. to increase plant growth, biomass, yield or any other quality parameter of the harvestable goods of a crop plant. The user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area. According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e. g. seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate. Consequently, one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit comprising a) a composition comprising component 1) as defined herein and at least one auxiliary; and b) a composition comprising component 2) as defined herein and at least one auxiliary; and optionally c) a composition comprising at least one auxiliary and optionally a further active component 3) as defined herein. In one embodiment, the present invention provides a combination comprising the compound of formula (I) and at least one further pesticidally active substance selected from the group consisting of fungicides, insecticides, nematicides, acaricides, biopesticides, herbicides, safeners, plant growth regulators, antibiotics, fertilizers and nutrients. The compound of formula (I), the combination and the composition thereof comprising them in the use as fungicides with other fungicides may result in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, extraordinary and unexpected effects are obtained. The present invention also relates to the combination comprising at least one compound of formula (I) and at least one further pesticidally active substance selected from the group of fungicides, insecticides, nematicides, acaricides, biopesticides, herbicides, safeners, plant growth regulators, antibiotics, fertiliers and nutrients. The pesticidally active substances reported in WO2015185485 pages 36-43 and WO2017093019 pages 42-56 can be used in conjunction with the compound of formula (I). The active substances referred to as component 2, their preparation and their activity e. g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their pesticidal activity are also known (cf. Can. J. Plant Sci.48(6), 587-94, 1968; EP141317; EP152031; EP226917; EP243970; EP256503; EP428941 ; EP532022; EP1028125; EP1035122; EP1201648; EP1122244, JP2002316902; DE19650197; DE10021412; DE102005009458; US3296272; US3325503; WO9846608; WO9914187; WO9924413; WO9927783; WO0029404; WO0046148; WO0065913; WO0154501 ; WO 0156358; WO0222583; WO0240431; WO0310149; WO0311853; WO0314103; WO0316286; WO0353145; WO0361388; WO0366609; WO0374491; WO0449804; WO0483193; WO05120234; WO05123689; WO05123690; WO0563721; WO0587772; WO0587773; WO0615866; WO0687325; WO0687343; WO0782098; WO0790624; WO11028657; WO2012168188; WO2007006670; WO201177514; WO13047749; WO10069882; WO13047441; WO0316303; WO0990181; WO13007767; WO1310862; WO13127704; WO13024009; WO13024010; WO13047441; WO13162072; WO13092224 and WO11135833. The present invention furthermore relates to agrochemical mixtures comprising at least one compound of formula (I) (component 1) and at least one further active substance useful for plant protection. By applying the compound of formula (I) together with at least one pesticidally active compound an additional effect can be obtained. This can be obtained by applying the compound of formula (I) and at least one further pesticidally active substance simultaneously, either jointly (e. g. as tank-mix) or separately, or in succession, wherein the time interval between the individual applications is selected to ensure that the active substance applied first still occurs at the site of action in a sufficient amount at the time of application of the further pesticidally active substance(s). The order of application is not essential for working of the present invention. When applying the compound of formula (I) and a pesticidally active substance sequentially the time between both applications may vary e. g. between 2 hours to 7 days. Also, a broader range is possible ranging from 0.25 hour to 30 days, preferably from 0.5 hour to 14 days, particularly from 1 hour to 7 days or from 1.5 hours to 5 days, even more preferred from 2 hours to 1 day. In the binary mixtures and the composition according to the invention the weight ratio of the component 1) and the component 2) generally depends on the properties of the active components used, usually it is in the range of 1:1000 to 1000:1, often in the range of 1:100 to 100:1, regularly in the range of 1:50 to 50:1, preferably in the range of 1:20 to 20:1, more preferably in the range of 1:10 to 10:1, even more preferably in the range of 1:4 to 4:1 and in particular in the range of 1:2 to 2:1. According to a further embodiment of the binary mixtures and the composition thereof, the weight ratio of the component 1) and the component 2) usually is in the range of 1000:1 to 1:1000, often in the range of 100:1 to 1:100, regularly in the range of 50:1 to 1:50, preferably in the range of 20:1 to 1:20, more preferably in the range of 10:1 to 1:10, even more preferably in the range of 4:1 to 1:4 and in particular in the range of 2:1 to 1:2. In the ternary mixtures, i.e. the composition according to the invention comprising the component 1) and component 2) and a compound III (component 3), the weight ratio of component 1) and component 2) depends from the properties of the active substances used, usually it is in the range of 1:100 to 100:1, regularly in the range of 1:50 to 50:1, preferably in the range of 1:20 to 20:1, more preferably in the range of 1:10 to 10:1 and in particular in the range of 1:4 to 4:1, and the weight ratio of component 1) and component 3) usually it is in the range of 1:100 to 100:1, regularly in the range of 1:50 to 50:1, preferably in the range of 1:20 to 20:1, more preferably in the range of 1:10 to 10:1 and in particular in the range of 1:4 to 4:1. Any further active components are, if desired, added in a ratio of 20:1 to 1:20 to the component 1). These ratios are also suitable for inventive mixtures applied by seed treatment. The invention disclosed in the present disclosure shall now be elaborated with the help of non-limiting examples. CHEMISTRY EXAMPLES: Example 1: Preparation of methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphine oxide (Compound no 4) and methyl(piperidin-1-yl)(1-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphine oxide (Compound no 5) a) Step 1: (4-cyanobenzyl)phosphinic acid A mixture of Anilinium hypophosphite (11.44 g, 72 mmol) and hexamethyldisilazane (15.1 mL, 72 mmol) were taken together and was heated at 110 °C under nitrogen for 3 h till the reaction mixture became clear. The reaction mixture was then cooled to 0 °C, and dichloromethane (50 mL) was added followed by the addition of 4-(bromomethyl) benzonitrile (9.9 g, 50.3 mmol). The resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, 10 % aqueous sodium hydroxide solution (50 mL) was added drop wise to the reaction mixture at 0-5 °C to adjust it to pH 10, and stirring was continued for 10 min. The aqueous layer was separated and acidified to pH 3 by adding of a 4 M aqueous hydrochloric acid solution. This aqueous layer was concentrated to dryness. The obtained solid was stirred with 10 % methanol in dichloromethane solution (100 mL) for 30 min. The suspension was filtered and the filtrate was evaporated to obtain (4-cyanobenzyl)phosphinic acid (9 g, 69 % yield). b) Step 2: ethyl (4-cyanobenzyl)phosphinate (4-Cyanobenzyl) phosphinic acid (8.5g, 47 mmol) was dissolved in ethanol (80 mL) and cooled to 0 °C. Pyridine (8.73 mL, 108 mmol) was added and the reaction mixture was stirred for 10 minutes. To this reaction mixture, pivaloyl chloride (6.9 mL, 56 mmol) was added under nitrogen atmosphere, and the reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was concentrated, and the obtained residue was stirred with ethyl acetate (50 mL) at 25 °C for 1 h. The obtained suspension was filtered and the solid was washed with ethyl acetate (30 mL). The combined filtrates were concentrated and the obtained residue was purified by column chromatography on silica gel to obtain ethyl (4-cyanobenzyl)phosphinate (3.5 g, 36 % yield). c) Step 3: ethyl (4-cyanobenzyl)(methyl)phosphinate and ethyl (1-(4- cyanophenyl)ethyl)(methyl)phosphinate Ethyl (4-cyanobenzyl)phosphinate (3 g, 14.3 mmol) was dissolved in anhydrous tetrahydrofuran (10 mL) under nitrogen atmosphere. The solution was cooled to -78 °C and purged with nitrogen for 5 min. Lithium bis(trimethylsilyl)amide (14.3 mL, 14.3 mmol) was added at -78 °C, and the reaction mixture was stirred for 10 min. Methyl iodide (0.9 mL, 14.3 mmol) was added and the resulting reaction mixture was slowly allowed to warm to 25 °C within 3 h. After completion of the reaction, the reaction mixture was quenched with aqueous saturated ammonium chloride solution (20 mL). The product was extracted twice with ethyl acetate (60 mL). The combined ethyl acetate layers were dried over anhydrous sodium sulphate and concentrated under reduced pressure. The resulting crude product was purified by column chromatography to obtain a 2:1 mixture of ethyl (4- cyanobenzyl)(methyl)phosphinate and ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate (2 g). d) Step 4: ethyl (4-(N'-hydroxycarbamimidoyl)benzyl)(methyl)phosphinate and ethyl (1-(4-(N'- hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate To a solution of a 2:1 mixture of ethyl (4-cyanobenzyl)(methyl)phosphinate and ethyl (1-(4- cyanophenyl)ethyl)(methyl)phosphinate (1.7 g) in ethanol (20 mL), 50 % aqueous hydroxylamine solution (0.906 mL, 14.8 mmol) was added at 25 °C and the reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was concentrated under reduced pressure to obtain 1.8 g of a residue containing a 2:1 mixture of ethyl (4-(N'- hydroxycarbamimidoyl)benzyl)(methyl)phosphinate and ethyl (1-(4-(N'- hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate. It was used as such in the next step. e) Step 5: ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate (Compound no. 1) and ethyl methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphinate (Compound no.6) To a solution of a 2:1 mixture of ethyl (4-(N'-hydroxycarbamimidoyl)benzyl)(methyl)phosphinate and ethyl (1-(4-(N'-hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate (1.8 g) in tetrahydrofuran (15 mL), trifluoroacetic anhydride (1.3 mL, 9.4 mmol) was added at 0 °C under nitrogen atmosphere and the resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was diluted with 50 mL of ethyl acetate and washed with a saturated aqueous solution of sodium bicarbonate (25 mL). The ethyl acetate layer was dried over anhydrous sodium sulphate and concentrated to obtain 2.3 g of a crude product containing a mixture of ethyl methyl(1- (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinate and ethyl methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate.0.4 g of the crude product was purified by prep-HPLC to isolate two pure compounds. Ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate (compound no. 1): 1H- NMR (400 MHz, DMSO-d6) δ 8.00 (d, 2H), 7.51 (dd, 2H), 3.87-4.00 (m, 2H), 3.35 (s, 1H), 1.32-1.37 (m, 3H), 1.18 (t, , 3H); LCMS (M+H): 334.95. Ethyl methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinate (compound no. 6): 1H-NMR (400 MHz, DMSO-d6) δ 8.01 (dd, 2H), 7.55-7.58 (m, 2H), 3.72-3.99 (m, 2H), 3.35-3.45 (m, 1H), 1.47 (ddd, 3H), 1.07-1.37 (m, 6H); LCMS (M+H): 349.00. f) Step 6: methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic chloride and methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinic chloride To a solution of a 2:1 mixture of ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinate and ethyl methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphinate (1.5 g) in dichloromethane (5 mL), oxalyl chloride (2 M in dichloromethane) (4.3 mL, 8.6 mmol) was added at 0 °C, and the resulting reaction mixture was stirred at 25 °C for 3 h. After completion of the reaction, the reaction mixture was concentrated under reduced pressure to obtain a crude product containing a 2:1 mixture of methyl(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphinic chloride and methyl(1-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)ethyl)phosphinic chloride (1.4 g). It was used as such in the next step without purification. g) Step 7: methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide (Compound no 4) and methyl(piperidin-1-yl)(1-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)ethyl)phosphine oxide (Compound no 5) To a solution of piperidine (0.293 mL, 2.9 mmol) and triethylamine (1.0 mL, 7.4 mmol) in dichloromethane (7 mL), a solution of a 2:1 mixture of methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)phosphinic chloride and methyl(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)phosphinic chloride (0.98 g) in dichloromethane (7 mL) was added at 0 °C under nitrogen atmosphere. The resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was diluted with dichloromethane (10 mL) and washed with a saturated aqueous solution of sodium bicarbonate (20 mL). The dichloromethane layer was separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain crude product. The obtained crude product was purified by prep-HPLC to obtain methyl(piperidin-1-yl)(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide (65 mg) and methyl(piperidin-1- yl)(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphine oxide (110 mg). Methyl(piperidin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide: 1H-NMR (400 MHz, DMSO-d6) δ 7.98 (d, 2H), 7.49 (dd, 2H), 3.22 (d, 2H), 2.82-2.98 (m, 4H), 1.30-1.50 (m, 9H); LCMS (M+H): 374.10. Methyl(piperidin-1-yl)(1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphine oxide: 1H-NMR (400 MHz, DMSO-d6) δ 7.99 (d, 2H), 7.52-7.56 (m, 2H), 3.33-3.39 (m, 1H), 2.95-3.03 (m, 1H), 2.76-2.82 (m, 2H), 2.58 (d, 2H), 1.32-1.45 (m, 8H), 1.09 (d, 3H); LCMS (M+H): 388.15. The following compounds in table 1 were prepared by using the procedure analogous to that of the example 1. Table: 1
Figure imgf000069_0001
Figure imgf000070_0001
Figure imgf000071_0001
Example 2: Preparation of ethyl bis(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphinate (Compound no.2) a) Step 1: ethyl bis(4-cyanophenyl)phosphinate To a stirred mixture of 1-bromo-4-iodobenzene (0.3 g, 1.1 mmol) and anilinium hypophosphite (0.337 g, 2.1 mmol) in acetonitrile (10 mL), (3-aminopropyl)triethoxysilane (0.494 mL, 2.1 mmol) was added at 25 °C. The reaction mixture was degassed by nitrogen gas for 10 min. To this reaction mixture, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (0.07 g, 0.085 mmol) was added and the mixture was degassed again for 5 min. The reaction mixture was heated at 80 °C for 3 h. After completion of the reaction, the reaction mixture was basified using sodium bicarbonate and extracted with 10 % ethyl acetate in hexane. The aqueous layer was acidified using 10 % aqueous hydrochloric acid to pH 3 and extracted by 10 % methanol in dichloromethane (20 mL). The organic layer was dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product. The obtained crude product was purified by column chromatography on silica gel using 70 % ethyl acetate in hexane as an eluent to obtain ethyl bis(4- cyanophenyl)phosphinate (0.156 g, 50 % yield). b) Step 2: ethyl bis(4-(N'-hydroxycarbamimidoyl)phenyl)phosphinate To a solution of ethyl bis(4-cyanophenyl)phosphinate (0.35 g, 1.2 mmol) in ethanol (10 mL), hydroxylamine (50 % aqueous solution) (0.762 mL, 5.9 mmol) was added at 25 °C and stirred for 16 h. After completion of the reaction, the reaction mixture was concentrated to obtain ethyl bis(4-(N'- hydroxycarbamimidoyl)phenyl)phosphinate (0.42 g, 98 % yield). c) Step 3: ethyl bis(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate To a stirred solution of ethyl bis(4-(N'-hydroxycarbamimidoyl)phenyl)phosphinate (0.428 g, 1.2 mmol) in tetrahydrofuran (5 mL), trifluoroacetic anhydride (0.5 mL, 3.5 mmol) was added at 0 °C and stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was poured into ice cold saturated solution of sodium bicarbonate in water (20 mL). The product was extracted by ethyl acetate (20 mL). The ethyl acetate layer was dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography on silica gel using 50 % ethyl acetate in hexane as an eluent to obtain ethyl bis(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate (0.25 g, 41 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.23 (qd, 4H), 8.02-8.07 (m, 4H), 4.04-4.13 (m, 2H), 1.33 (t, 3H); LCMS (M+H): 518.95. Example 3: Preparation of ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate (Compound no.20) a) Step 1: diethyl (4-cyanobenzyl)phosphonate A solution of 4-(bromomethyl)benzonitrile (5 g, 25.5 mmol) and triethyl phosphite (8.92 mL, 51 mmol) was stirred at 110 °C for 16 h. After completion of the reaction, the reaction mixture was directly loaded on column and purified on silica gel using 60 % ethyl acetate to obtain diethyl (4- cyanobenzyl)phosphonate (6 g, 93 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 7.78 (d, 2H), 7.47 (dd2H), 3.95 (ddd, 4H), 3.37 (d, 2H), 1.15 (q, 6H); 31P-NMR (162 MHz, DMSO-d6) δ 25.84, 25.78; LCMS (M+1): 254.05. b) Step 2: (4-(N'-hydroxycarbamimidoyl)benzyl)phosphonate To a stirred solution of diethyl (4-cyanobenzyl)phosphonate (5 g, 19.7 mmol) in ethanol (15 mL), hydroxylamine (50% aqueous solution) (1.815 mL, 29.6 mmol) was added at 25 °C. The resulting reaction mixture was stirred at 60 °C for 10 h. After completion of the reaction, the reaction mixture was concentrated under reduced pressure to remove the volatiles and to obtain diethyl (4-(N'- hydroxycarbamimidoyl)benzyl)phosphonate (5 g, 88 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 9.55 (s, 1H), 7.59 (d, 2H), 7.25 (dd, 2H), 5.79 (d, 2H), 3.89-4.05 (m, 4H), 3.23 (d, 2H), 1.13-1.19 (m, 6H). c) Step 3: diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonate (compound no.3) To a stirred solution of diethyl (4-(N'-hydroxycarbamimidoyl)benzyl)phosphonate (5 g, 17.47 mmol) in tetrahydrofuran (20 mL), trifluoroacetic anhydride (4.44 mL, 31.4 mmol) was added slowly at 0-5 °C under nitrogen atmosphere. The resulting reaction mixture was stirred for 12 h at 25 °C. After completion of the reaction, the reaction mixture was concentrated under reduced pressure to remove the volatiles and to obtain diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonate (5 g, 79 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 7.99-8.02 (m, 2H), 7.49-7.53 (m, 2H), 3.92-4.00 (m, 4H), 3.37 (d, 2H), 1.16 (t, 6H); LCMS (M+H): 364.95. d) Step 4: ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate Phosphorous oxychloride (138 µl, 1.482 mmol) was added to diethyl (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonate (450 mg, 1.235 mmol) at 5-10 °C. To this reaction mixture, N,N- dimethylformamide (0.053 mL, 0.686 mmol) was added and the resulting reaction mixture was stirred at 80 °C for 6 h under nitrogen atmosphere. After completion of the reaction, the reaction mixture was cooled to 25 °C and concentrated under reduced pressure to remove the volatiles. The obtained ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate (300 mg, 68 % yield) was used as such for the next reaction. e) Step 5: ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate To a stirred solution of ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate (150 mg, 0.423 mmol) in dichloromethane (5 mL), 2-methylpropan-1-amine (0.063 mL, 0.6 mmol) and triethylamine (0.088 mL, 0.6 mmol) were added slowly at 0-5 °C. The resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was diluted with ethyl acetate (10 mL) and washed twice with water (10 mL). The ethyl acetate layer was separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product. The obtained crude product was purified by flash column chromatography on silica gel using eluent 60 % ethyl acetate/hexane to obtain ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)phosphonamidate (60 mg, 36 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 7.97 (d, 2H), 7.50 (dd, 2H), 4.58-4.65 (m, 1H), 3.83-3.91 (m, 2H), 3.11-3.24 (m, 2H), 2.52-2.56 (m, 2H), 1.45-1.55 (m, 1H), 1.15-1.20 (m, 3H), 0.77-0.85 (m, 6H); LCMS (M+H): 392.10. The following compounds in table 2 were prepared by using the analogous procedure as described in example 3. Table: 2
Figure imgf000073_0001
Figure imgf000074_0001
Figure imgf000075_0001
Figure imgf000076_0001
Example 4: Preparation of N-(4-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide (Compound no.46) a) Step 1 : methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic acid To a solution of ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate (8.2 g, 24.5 mmol) in dichloromethane (60 mL), oxalyl chloride (5.37 mL, 61.3 mmol) was added at 0 °C. The resulting reaction mixture was stirred at 25 °C for 16 h. After completion of reaction, the reaction mixture was cooled to 0 °C, water (6 mL) was added dropwise until all the effervescences ceases. Volatiles were removed under reduced pressure and the crude was co-distilled with toluene to remove traces of water to obtain methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic acid (7 g, 93 % yield). 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.05-8.01 (m, 4H), 7.41-7.36 (m, 1H), 3.15-3.08 (m, 2H), 1.44-1.35 (m, 3H); LCMS (M+1): 306.85. b) Step 2: N-(4-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinic amide (Compound no.46) To a solution of 4-fluoroaniline (0.44 g, 3.9 mmol) in tetrahydrofuran (15 mL), methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic acid (0.4 g, 1.3 mmol) followed by 4- dimethylaminopyridine (0.319 g, 2.6 mmol) were added at 25 °C. After 10 min. of stirring, 1-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.501 g, 2.6 mmol) was added at 25 °C and the resulting reaction mixture was stirred at 80 °C for 48 h. After completion of the reaction, dichloromethane (10 mL) was added followed by addition of 10 % hydrochloric acid (10 mL). The organic layer was separated, washed with brine solution (15 mL) and dried over anhydrous sodium sulphate. The crude obtained after evaporation of organic solvent under reduced pressure was purified by column chromatography using ethyl acetate to 10 % methanol in ethyl acetate as an eluent to get N-(4-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide (0.23 g, 44 % yield). 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.04 (d, 2H), 7.31 (dd, 2H), 7.08- 7.04 (m, 2H), 6.99-6.94 (m, 2H), 5.03 (d, 1H), 3.46-3.33 (m, 2H), 1.55-1.50 (m, 3H); LCMS (M+1): 399.9. The following compounds in table 3 were prepared by using the analogous procedure as described in example 4. Table: 3
Figure imgf000077_0001
Figure imgf000078_0001
Example 5: Preparation of N-phenyl-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2- yl)benzyl)phosphonamidate (Compound no.52) a) Step 1: 5-(p-tolyl)-1H-tetrazole To a stirred solution of 4-methylbenzonitrile (40 g, 341 mmol) in N,N-dimethylformamide (150 mL), sodium azide (24.42 g, 376 mmol) was added at 25 °C and cooled to 0 °C. To the obtained mixture, ceric ammonium nitrate (28 g, 51 mmol) was slowly added. The resulting reaction mixture was stirred at 120 °C for 6 h. After completion of the reaction, the reaction mixture was cooled to 25 °C and crushed ice (300g) was added portion wise into it under stirring. Stirring was continued for 10 minutes to obtain a precipitate. The precipitate was filtered, washed with water and dried under reduced pressure to obtain 5-(p-tolyl)-1H-tetrazole (42 g, 77 % yield). b) Step: 2-(p-tolyl)-5-(trifluoromethyl)-1,3,4-oxadiazole To a stirred solution of 5-(p-tolyl)-1H-tetrazole (25 g, 156 mmol) and pyridine (150 mL), trifluoroacetic anhydride (110 mL, 780 mmol) was added. The resulting reaction mixture was stirred at 100 °C for 4 h. The reaction mixture was cooled to 25 °C, diluted with 5% aqueous hydrochloric acid (1000 mL) and extracted with ethyl acetate (2 x 500 mL). The ethyl acetate layer was dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain 2-(p-tolyl)-5- (trifluoromethyl)-1,3,4-oxadiazole (28 g, 79 % yield). c) Step 3: 2-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)-1,3,4-oxadiazole To a stirred solution of 2-(p-tolyl)-5-(trifluoromethyl)-1,3,4-oxadiazole (15 g, 66 mmol) and chloroform (200 mL), N-bromosuccinimide (12.87 g, 72.3 mmol) was added and stirred at 70 °C for 10 minutes. To this reaction mixture, 2,2′-azobis(2-methylpropionitrile) (1.295 g, 7.89 mmol) was added, and the resulting reaction mixture was stirred at 65 °C for 4 h. The reaction mixture was cooled to 25 °C and saturated aqueous bicarbonate solution (300 mL) was added. The product was extracted with ethyl acetate (500 mL). The ethyl acetate layer was dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain 2-(4-(bromomethyl)phenyl)-5- (trifluoromethyl)-1,3,4-oxadiazole (16 g, 79 % yield). d) Step 4: diethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate A mixture of triethyl phosphate (1 g, 5.5 mmol) and 2-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)- 1,3,4-oxadiazole (1.69 g, 5.49 mmol) was stirred at 70 °C for 2 h. The mixture was concentered under reduced pressure to obtain diethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate (1.6 g, 80 % yield). e) Step 5: (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonochloridate Phosphorus oxychloride (1.54 mL, 16.47 mmol) was added dropwise at 0 °C to diethyl (4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate (2 g, 5.5 mmol) and stirred for 15 min. Then to this solution, N,N-dimethylformamide (0.043 mL, 0.55 mmol) was added dropwise at 0 °C, and the resulting reaction mixture was stirred at 80 °C for 4 h. The volatiles were removed under reduce pressure to obtain crude ethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2- yl)benzyl)phosphonochloridate. f) Step 6: N-phenyl-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate (compound no.52) To a stirred solution of aniline (131 mg, 1.41 mmol) in pyridine (5 mL), 4-(dimethylamino)pyridine (345 mg, 2.82 mmol) was added followed by ethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2- yl)benzyl)phosphonochloridate (751 mg, 2.12 mmol) at 0 °C. The resulting reaction mixture was stirred at 25 °C for 48 h. After completion of the reaction, the reaction mixture was quenched by pouring into 10 % aqueous hydrochloric acid solution (50 mL) at 0-5 °C. The product was extracted by ethyl acetate (150 mL). The ethyl acetate layer was washed with water (50 mL), dried over anhydrous sodium sulphate and concentrated under reduce pressure to obtain a crude product. The crude product was purified by column chromatography to obtain ethyl N-phenyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate (220 mg, 39 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 7.96 (t, 2H), 7.76 (d, 1H), 7.43 (dd, 2H), 7.20 (t, 2H), 7.07-7.05 (m, 2H), 6.88- 6.84 (m, 1H), 4.06-3.89 (m, 2H), 3.41 (d, 2H), 1.20 (t, 3H); LCMS (M+1): 411.9. The following compounds were prepared by using the procedure analogous to that of the example 5. Table: 4
Figure imgf000080_0001
Figure imgf000081_0001
Example 6: Preparation of ethyl N-(2,4-difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate (Compound no.66) a) Step 1: 2-(Chloromethyl)imidazo[1,2-a]pyridine-7-carbonitrile To a stirred solution of 2-aminoisonicotinonitrile (5 g, 42.0 mmol) in ethanol (30 mL), 1,3- dichloropropan-2-one (10.66 g, 84 mmol) was added, and stirred was continued at 90 °C for 36 h. The reaction was discontinued by addition of saturated aqueous sodium hydrogen carbonate solution, and the resulting precipitate was collected by filtration. The obtained residue 2- (chloromethyl)imidazo[1,2-a]pyridine-7-carbonitrile (4 g, 50% yield) was used for further reaction. b) Step 2: Diethyl ((7-cyanoimidazo[1,2-a]pyridin-2-yl)methyl)phosphonate A solution of 2-(chloromethyl)imidazo[1,2-a]pyridine-7-carbonitrile (5 g, 26.1 mmol) and triethyl phosphite (8.95 mL, 52.2 mmol) was stirred at 140 °C for 2 h. After cooling, the reaction mixture was diluted with dichloromethane and filtered. The filtrate was dried under reduced pressure. The obtained residue was washed with hexane (30 mL) and dried under reduced pressure to obtain diethyl ((7- cyanoimidazo[1,2-a]pyridin-2-yl)methyl)phosphonate (4 g, 54% yield). c) Step 3: Diethyl ((7-(N'-hydroxycarbamimidoyl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate. To a stirred solution of diethyl ((7-cyanoimidazo[1,2-a]pyridin-2-yl)methyl)phosphonate (3.8 g, 13 mmol) in ethanol (30 mL), hydroxylamine solution 50 % w/w in water (3 mL, 45.4 mmol) was added at 25 °C and the resulting reaction mixture was stirred at 60 °C for 3 h. The volatiles were removed under reduced pressure to obtain a crude product. The crude product was purified by prep-HPLC to obtain diethyl ((7-(N'-hydroxycarbamimidoyl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate (3.9 g, 92 % yield). d) Step 4: Diethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (Compound no.64) To a stirred solution of diethyl ((7-(N'-hydroxycarbamimidoyl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.4 g, 1.2 mmol) in tetrahydrofuran (10 mL), trifluoroacetic anhydride (0.312 mL, 2.2 mmol) was added slowly at 0-5 °C under nitrogen atmosphere and stirred for 18 h at 25 °C. The reaction mixture was quenched by pouring in saturated aqueous sodium bicarbonate solution (20 mL) at 0-5 °C. The product was extracted with ethyl acetate (20 mL). The ethyl acetate layer was washed with water (20 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography on silica gel to obtain diethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.12 g, 24% yield). e) Step 5: Ethyl hydrogen ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin- 2-yl)methyl)phosphonate To a stirred solution of diethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.200 g, 0.5 mmol) in 2-pentanone (3 mL), lithium bromide (0.052 g, 0.6 mmol) was added in one portion at 25 °C and stirred for 2 h at 110 °C. The solvent was evaporated under reduced pressure, and the solid residue obtained was suspended in dichloromethane (10 mL), 10% aqueous hydrochloric acid solution was added to the suspension until the pH of the solution reaches 1. The organic layer was separated and the aqueous layer was dried under reduced pressure to obtain pure ethyl hydrogen ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate (0.116 g, 62% yield). f) Step 6: Ethyl hydrogen ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin- 2-yl)methyl)phosphonate To a stirred solution of ethyl hydrogen ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2- a]pyridin-2-yl)methyl)phosphonate (0.15 g, 0.4 mmol), one drop of dimethylformamide in dichloromethane (3 mL) and oxalyl chloride (0.09 mL, 1 mmol) were added at 0 °C. The reaction mixture was stirred for 30 min at 0 °C and stirred for 2 h at 25 °C. Then the volatile material was evaporated under reduced pressure. The obtained crude ethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonochloridate (0.154 g, 98% yield) was used as such for the next step. g) Step 7: Ethyl N-(2,4-difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate (Compound no.66) To a stirred solution of ethyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonochloridate (0.3 g, 0.7 mmol) in dichloromethane (3 mL), triethylamine (0.212 mL, 1.5 mmol) and 2,4-difluoroaniline (0.118 g, 0.9 mmol) were added at 0 °C. The reaction mixture was stirred for 30 min at 0 °C and stirred for further 2 h at 25 °C. The volatile materials were removed under reduced pressure. The crude product obtained was purified by prep-HPLC to obtain ethyl N- (2,4-difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate (0.135 g, 36% yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.74 (dd, 1H), 8.11 (t, 1H), 8.03 (d, 1H), 7.52 (d, 1H), 7.46-7.37 (m, 2H), 7.21-7.16 (m, 1H), 6.93-6.88 (m, 1H), 4.07-3.98 (m, 2H), 3.58-3.44 (m, 2H), 1.20 (t, 3H); LCMS (M+1): 487.60. The following compounds in table 5 were prepared by using the analogous procedure as described in example 6.
Figure imgf000083_0001
Figure imgf000084_0001
Figure imgf000085_0001
Example 7: Preparation of ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)phosphonamidate (Compound no.78) a) Step 1: N'-hydroxy-4-iodobenzimidamide To a stirred solution of 4-iodobenzonitrile (5 g, 21.8 mmol) in methanol (50 mL), hydroxylamine (7.4 mL, 26.2 mmol) was added slowly at 25 °C under nitrogen atmosphere and stirred for 12 h at 25 °C. After completion of the reaction, the reaction mixture was evaporated under reduced pressure to obtain crude N'-hydroxy-4-iodobenzimidamide (5 g, 87 % yield). b) Step 2: 3-(4-iodophenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole To a stirred solution of N'-hydroxy-4-iodobenzimidamide (11.5 g, 44 mmol) in tetrahydrofuran (120 mL), trifluoroacetic anhydride (11.16 mL, 79 mmol) was added slowly at 0-5 °C under nitrogen atmosphere and the resulting reaction mixture was stirred for 12h at 25 °C. After completion of the reaction, the reaction mixture was quenched by addition of saturated sodium bicarbonate solution (300 mL) and extracted with ethyl acetate (3 x 200 mL). The combined organic layer was washed with brine (250 mL), dried over anhydrous sodium sulphate and evaporated under reduced pressure. The crude residue obtained was purified by column chromatography to obtain 3-(4-iodophenyl)-5- (trifluoromethyl)-1,2,4-oxadiazole (11 g, 74% yield). c) Step 3: diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonate (compound no.76) To a stirred solution of 3-(4-iodophenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole (14 g, 41.2 mmol) in diethyl phosphonate (6.38 mL, 49.4 mmol), triethylamine (7.19 mL, 41.2 mmol) was added at 25 °C under nitrogen atmosphere followed by the addition of tetrakis(triphenylphosphine)palladium (1.9 g, 1.6 mmol) at 25 °C. The reaction mixture was allowed to stir for 3 h at 90 °C. The reaction mixture was diluted with water 50 mL, extracted with ethyl acetate (3 x 35 mL) and washed with saturated aqueous sodium chloride solution. The combined ethyl acetate layer was dried over anhydrous sodium sulphate and evaporated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography to obtain diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate (7 g, 49 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.21 (qd, 2H), 7.95 (qd, 2H), 4.13-4.00 (m, 4H), 1.25 (t, 6H); LCMS(M+1): 350.85. d) Step 4: ethyl hydrogen (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonate (Compound no.75) To a stirred solution of diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonate (4.5 g, 12.85 mmol) in 2-pentanone (30 mL), lithium bromide (103 mg, 1.2 mmol) was added in one portion at 25 °C and stirred for 2 h at 110 °C. Volatiles were removed under reduced pressure. The solid residue obtained was suspended in dichloromethane (30 mL), and 10 % aqueous hydrochloric acid solution was added to the suspension until pH of the solution reached at 1. The aqueous layer was isolated and dried under reduced pressure to give ethyl hydrogen (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)phosphonate (3.8 g, 92 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 7.97 (d, 2H), 7.85-7.80 (m, 2H), 7.58 (s, 1H), 3.64-3.57 (m, 2H), 1.01 (t, 3H); LCMS(M-1): 320.40. e) Step 5: ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonochloridate To a stirred solution of ethyl hydrogen (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate (250 mg, 0.8 mmol) and one drop of dimethylformamide in dichloromethane (3 mL), oxalyl chloride (0.17 mL, 1.9 mmol) was added at 0 °C. The reaction mixture was stirred for 30 min at 0 °C and stirred for 2 h at 25 °C. Then the volatiles were removed under reduced pressure. The obtained crude ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonochloridate (170 mg, 64 % yield). f) Step 6: ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate (Compound no.78) To a stirred solution of ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonochloridate (250 mg, 0.7 mmol) in dichloromethane (3 mL), 2-methoxyethan-1- amine (66.2 mg, 0.88 mmol) and triethylamine (0.256 mL, 1.8 mmol) were added at 0 °C. The reaction mixture was stirred for 30 min at 0 °C and then at 25 °C for 2 h. The volatile materials were removed under reduced pressure to obtain a crude product which was purified by prep-HPLC to obtain ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate (140 mg, 50% yield) . 1H-NMR (400 MHz, DMSO-d6) δ 8.16 (dd, 2H), 7.92 (dd 2H), 5.26-5.20 (m, 1H), 4.04-3.94 (m, 2H), 3.29-3.25 (m, 2H), 3.16 (d, 3H), 2.98-2.90 (m, 2H), 1.25 (t, 3H); LCMS (M+1): 380.05. The following compounds were prepared by the procedure analogous to that of the example 7. Table: 6
Figure imgf000087_0001
Figure imgf000088_0001
Example 8: Preparation of diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.88) a) Step 1: tert-butyl (tert-butoxycarbonyl)(4-cyanobenzyl)carbamate To a stirred solution of di-tert-butyl iminodicarbonate (22.16g, 102 mmol) in N,N-dimethylformamide (200 mL), potassium carbonate (21.15 g, 153 mmol) was added at 0 °C, and the reaction mixture was stirred at same temperature for 15 min. 4-(Bromomethyl)benzonitrile (20 g, 102 mmol) was added and the resulting reaction mixture was allowed to warm to 25 °C and further stirred at 90 °C for 2h. The reaction was quenched with cold water (500 mL), the precipitated solid was filtered, washed with water (3 x 250 mL), followed by hexane (2 x 50 mL). The solid obtained was dried under reduced pressure to obtain tert-butyl (tert-butoxycarbonyl)(4-cyanobenzyl)carbamate (22.5 g, 66% yield) as a white solid. b) Step 2: tert-butyl-(tert-butoxycarbonyl)(4-(N'-hydroxycarbamimidoyl)benzyl)carbamate To a stirred solution of tert-butyl (tert-butoxycarbonyl)(4-cyanobenzyl)carbamate (22 g, 66 mmol) in methanol (200 mL), hydroxylamine (50% aq solution) (12.15 mL, 199 mmol) was added at 0 °C and stirred at same temperature for 16 h. Volatiles were evaporated under reduced pressure to dryness. The solid obtained was co-distilled with toluene (2 x 50 mL) to obtain tert-butyl-(tert- butoxycarbonyl)(4-(N'-hydroxycarbamimidoyl)benzyl)carbamate (20 g,83 % yield). c) Step 3: tert-butyl (tert-butoxycarbonyl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)carbamate To a stirred solution tert-butyl-(tert-butoxycarbonyl)(4-(N'-hydroxycarbamimidoyl)benzyl)carbamate (20 g, 55 mmol) in tetrahydrofuran (200 mL), trifluoroacetic anhydride (15.46 mL, 109 mmol) was added at 0 °C. The resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction was quenched by addition of saturated sodium bicarbonate (500 mL) and extracted with ethyl acetate (3 x 200 mL). The combined organic layer was washed with brine solution (2 x 200 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain tert-butyl (tert-butoxycarbonyl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)carbamate (20 g, 82 % yield). d) Step 4: (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride To a stirred solution of tert-butyl (tert-butoxycarbonyl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)carbamate (20 g, 45.1 mmol) in tetrahydrofuran (200 mL), hydrogen chloride (4M in 1,4- dioxane) (45.1 mL, 180 mmol) was added at 0 °C. The resulting reaction mixture was stirred at 70 °C for 16 h. The reaction mixture was then cooled to 20 °C and evaporated to dryness under reduced pressure. The residue was co-distilled twice with toluene (20 mL) to obtain (4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (9 g, 71 % yield) as a white solid. e) Step 5: diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (Compound no.88) To a stirred solution of (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (0.3 g, 1.1 mmol) in tetrahydrofuran (10 mL), triethylamine (0.449 mL, 3.2 mmol) was added, followed by diethyl phosphorochloridate (0.202 mL, 1.4 mmol) at 0 °C. The resulting reaction mixture was stirred at 25 °C for 2 h. After completion of the reaction, the reaction mixture was quenched by addition of water (100 mL) and extracted with ethyl acetate (2 x 100 mL). The combined organic layer was dried over anhydrous sodium sulphate and evaporated to dryness under reduced pressure to obtain a crude product. The crude product was purified by prep-HPLC to afford diethyl (4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (0.278 g, 68 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.02 (dd, 2H), 7.57 (d, 2H), 5.62-5.55 (m, 1H), 4.05 (dd, 2H), 3.93-3.82 (m, 4H), 1.16 (td, 6H); LCMS (M+1): 379.60. Example 9: Preparation of dimethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.89) To a stirred solution of (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (0.3 g, 1.1 mmol) in tetrahydrofuran (10 mL), triethylamine (0.45 mL, 3.2 mmol) was added, followed by dimethyl phosphorochloridate (0.202 g, 1.4 mmol) at 0 °C. The reaction mixture was stirred at 25 °C for 2 h. After completion of the reaction, the reaction mixture was quenched with water (100 mL) and extracted with ethyl acetate (2 x 100 mL). The combined organic layer was dried over anhydrous sodium sulphate and evaporated to dryness under reduced pressure to obtain a crude product which was purified by prep-HPLC to afford dimethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)phosphoramidate (0.246 g, 65 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.04-8.02 (m, 2H), 7.57 (d, 2H), 5.71-5.64 (m, 1H), 4.06 (dd, 2H), 3.54 (s, 3H), 3.52 (s, 3H); LCMS (M+1): 351.55. Example 10: Preparation of dimethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.90) a) Step 1: N'-hydroxy-4-methylbenzimidamide To a stirred solution of 4-methylbenzonitrile (5 g, 42.7 mmol) in ethanol (50 mL), 50% aqueous solution of hydroxylamine (3.92 mL, 64 mmol) was added. The reaction mixture was heated to 70 °C under nitrogen atmosphere for 16 h. The reaction mixture was evaporated under reduced pressure to dryness to obtain N'-hydroxy-4-methylbenzimidamide (6 g, 94 % yield) as a white solid. b) Step 2: 3-(p-tolyl)-5-(trifluoromethyl)-1,2,4-oxadiazole To a stirred solution of N'-hydroxy-4-methylbenzimidamide (6 g, 40 mmol) in tetrahydrofuran (60 mL), trifluoroacetic anhydride (8.46 mL, 59.9 mmol) was added dropwise at 0 °C. The resulting reaction mixture was stirred at 25 °C for 16 h. The reaction mixture was diluted with water (100 mL) and the product was extracted with ethyl acetate (3 X 50 mL). The combined organic layer was washed by saturated aqueous solution of sodium bicarbonate (2 X 50 mL), water (50 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain 3-(p-tolyl)-5- (trifluoromethyl)-1,2,4-oxadiazole (8.9 g, 98 % yield). c) Step 3: 3-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole To a stirred solution of 3-(p-tolyl)-5-(trifluoromethyl)-1,2,4-oxadiazole (9 g, 39.4 mmol) in dichloromethane (100 mL), N-bromosuccinimide (6.67 g, 37.5 mmol) followed by 2,2′-azobis(2- methylpropionitrile) (0.32 g, 1.97 mmol) were added. The reaction mixture was heated to 48 °C for 10 h. The reaction mixture was cooled to 25 °C, diluted with water (100 mL) and extracted with dichloromethane (3 X 50 mL). The combined dichloromethane layer were dried over anhydrous sodium sulphate and evaporated under reduced pressure to obtain a crude product. The obtained crude product was purified by flash column chromatography to obtain 3-(4-(bromomethyl)phenyl)-5- (trifluoromethyl)-1,2,4-oxadiazole (6.57 g, 54.2 % yield) as white solid. d) Step 4: N-methyl-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine To a stirred solution of 3-(4-(bromomethyl)phenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole (1 g, 3.26 mmol) in tetrahydrofuran (10 mL) 2 M methanamine in tetrahydrofuran solution (8.14 mL, 16.28 mmol) was added at 0 °C . The resulting solution was allowed to stir for 24 h at 25 °C. After completion of the reaction, the volatiles were evaporated. The crude product obtained was dissolved in ethyl acetate (25 mL) followed by dropwise addition of saturated sodium bicarbonate until the effervescence ceases. The ethyl acetate layer was washed with brine solution (10 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain N-methyl-1-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine (0.83 g, 99 % yield). e) Step 5: dimethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate (Compound no.90) To a stirred solution of N-methyl-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (0.3 g, 1.12 mmol) in tetrahydrofuran (10 mL), triethylamine (0.71 mL, 5.1 mmol) was added, followed by addition of dimethyl phosphorochloridate (0.186 mL, 1.5 mmol) at 0 °C. The resulting reaction mixture was stirred at 25 °C for 2 h. The reaction was quenched with water (100 mL) and extracted twice with ethyl acetate (100 mL). The combined ethyl acetate layer was dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure to obtain a crude product. The crude product was purified by column chromatography to obtain dimethyl methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (0.204 g, 55 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.07 (d, 2H), 7.56 (d, 2H), 4.24 (d, 2H), 3.61 (d, 6H), 2.51 (s, 1H), 2.47-2.48 (2H); LCMS (M+1): 366.25. Example 11: Preparation of ethyl N-(2,4-difluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonamidate (Compound no.91) To a stirred solution of N-methyl-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (0.4 g, 1.3 mmol) in tetrahydrofuran (10 mL), triethylamine (0.949 mL, 6.8 mmol) was added, followed by addition of diethyl phosphorochloridate (0.296 mL, 2.0 mmol) at 0 °C. The resulting reaction mixture was stirred at 25 °C for 2 h. The reaction mixture was quenched with water (100 mL) and extracted with ethyl acetate (2 x 100 mL). The combined organic layer was dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure to obtain a crude product. The crude product was purified by column chromatography to obtain diethyl methyl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphoramidate (0.16 g, 30 % yield). 1H-NMR (400 MHz, DMSO-d6) δ 8.06 (dt, 2H), 7.56 (d, 2H), 4.22 (d, 2H), 4.02-3.89 (m, 4H), 2.50 (s, 2H), 2.47 (s, 1H), 1.23 (td, 6H); LCMS (M+1): 394.40. Example 12: Preparation of ethyl (1-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)(methyl)phosphinate (compound no.87) a) Step 1: ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate To a degassed solution of ethyl (4-cyanobenzyl)phosphinate (0.8 g, 3.4 mmol) in anhydrous tetrahydrofuran (10 mL), lithium bis(trimethylsilyl)amide (4.85 mL, 5.2 mmol) was added at -78 °C under nitrogen atmosphere. After 10 min, iodomethane (0.28 mL, 4.47 mmol) was added and the resulting reaction mixture was slowly allowed to warm up to 25 °C. The reaction mixture was stirred at 25 °C for 3 h. The reaction mixture was quenched with a saturated solution of ammonium chloride (15 mL), extracted with ethyl acetate (30 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography to obtain ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate (500 mg, 61 % yield). b) Step 2: ethyl-(1-(4-(N'-hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate To a stirred solution of ethyl (1-(4-cyanophenyl)ethyl)(methyl)phosphinate (0.57 g, 2.403 mmol) in ethanol (60 mL), a 50% aqueous solution of hydroxylamine (0.308 mL, 4.8 mmol) was added, and the resulting reaction mixture was stirred further at 25 °C for 16 h. After completion of the reaction, the reaction mixture was concentrated and three times co-evaporated with ethyl acetate (each 30 mL) under reduced pressure to obtain ethyl-(1-(4-(N'- hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate (0.43 g, 66 % yield). a) Step 3: ethyl (1-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)ethyl)(methyl)phosphinate (Compound no.87) To a stirred solution of ethyl-(1-(4-(N'-hydroxycarbamimidoyl)phenyl)ethyl)(methyl)phosphinate (0.350 g, 1.295 mmol) and tetrahydrofuran (4 mL), 2-chloro-2,2-difluoroacetic anhydride (0.315 g, 1.3 mmol) was added at 0 °C under nitrogen atmosphere. The resulting reaction mixture was stirred at 25 °C for 16 h. After completion of the reaction, the reaction mixture was poured into a mixture of ethyl acetate (100 mL) and an aqueous saturated solution of sodium bicarbonate (75 mL) and stirred for 10 min. The organic layer was isolated, washed by saturated solution of sodium bicarbonate (100 mL), dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain a crude product. The crude product was purified to obtain ethyl(1-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)ethyl)(methyl)phosphinate (157 mg, 33 % yield). 1H-NMR (400 MHz, DMSO- d6) δ 8.01 (dd, 2H), 7.56 (qd, 2H), 3.95 (dt, 1H), 3.89-3.70 (m, 1H), 3.45-3.35 (m, 1H), 1.47 (ddd, 3H), 1.37-1.07 (m, 6H); LCMS (M+1): 364.90. Example 13: Preparation of ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate (compound no.95) To a stirred solution of ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonochloridate (0.25 g, 0.71 mmol) in dichloromethane (3 ml), 4-dimethylaminopyridine (0.09 g, 0.71 mmol) and methanol (0.027 g, 0.85 mmol) were added at 0 °C. The reaction mixture was stirred for 30 min at 0 °C and stirred for 2 h at 25 °C. The volatiles were removed under reduced pressure. The crude product was purified by prep-HPLC to obtain ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate (0.15 g, 60% yield) . 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.07 (dd, 2H), 7.47 (dd, 2H), 4.10-4.01 (m, 2H), 3.69 (d, 3H), 3.23 (d, 2H), 1.28-1.24 (m, 3H); LCMS (M+1): 350.90. The following compounds in table 7 were prepared by suing the analogous procedure as described in the example 13. Table: 7
Figure imgf000093_0001
Example 14: Preparation of N-cyclopropyl-1-ethyl-1-oxo-N'-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-λ5-phosphanediamine (compound no 99) To a stirred solution of (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (0.14 g, 0.5 mmol) in dichloromethane (10 mL), triethylamine (0.21 mL, 1.5 mmol) and cyclopropylamine (0.053 ml, 0.75 mmol) were added at 0-5 °C. After 30 min of stirring, ethylphosphonic dichloride (0.16 ml, 1.5 mmol) was added at 0-5 °C and the reaction mixture was stirred at 25 °C for 1-2 h. Volatiles were removed under reduced pressure and crude was purified by preparative HPLC to obtain N-cyclopropyl-1-ethyl-1-oxo-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)- λ5-phosphanediamine (80 mg, 43 % yield). 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.09 (d, 2H), 7.54 (d, 2H), 4.31-4.17 (m, 2H), 2.71-2.63 (m, 2H), 2.41-2.36 (m, 1H), 1.87-1.71 (m, 2H), 1.17 (dt, 3H), 0.63-0.48 (m, 4H); LCMS (M+1): 375.0. The following compounds in table 8 were prepared by using the analogous procedure as described in example 14. Table: 8
Figure imgf000094_0001
Figure imgf000095_0001
The following compounds (Table-9) can be obtained using analogue procedures as described in the schemes 1-6 or in the examples. Table: 9
Figure imgf000095_0002
Figure imgf000096_0001
Figure imgf000097_0001
Figure imgf000098_0001
Figure imgf000099_0001
Figure imgf000100_0001
Figure imgf000101_0001
Figure imgf000102_0001
Figure imgf000103_0001
Figure imgf000104_0001
Figure imgf000105_0001
Figure imgf000106_0001
Figure imgf000107_0001
Figure imgf000108_0001
BIOLOGY EXAMPLES:
As described herein the compounds of general formula (I) show fungicidal activities which are exerted with respect to numerous phytopathogenic fungi which attack on important agricultural crops. The compounds of the present invention were assessed for their activity as described in the following tests:
Example 1: Pyricularia oryzae (Rice blast):
Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired test concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 25 °C temperature and 60% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control. Compounds 3 4 5 20 21 22 27 31 34 36 38 39 40 43 44 46 47 49 50 51 54 71 74 91 at 300ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive pathogen growth. Example 2: Botrytis cinerea (Gray mold): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 22 °C temperature and 90% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control. Compounds 3 44 46 47 74 at 300ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive pathogen growth. Example 3: Alternaria solani (early blight of tomato/potato): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 25 °C temperature and 60% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control. Compounds 4 5 27 34 35 38 46 74 91 at 300ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive pathogen growth. Example 4: Colletotrichum capsici (anthracnose): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 25 °C temperature and 60% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control. Compounds 14 15 at 300ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive pathogen growth. Example 5: Corynespora cassiicola (Leaf spot of tomato): Compounds were dissolved in 0.3% dimethyl sulfoxide and then added to potato dextrose agar medium just prior to dispensing it into petri dishes. 5 mL medium with the compound in the desired concentration was dispensed into 60 mm sterile petri-plates. After solidification, each plate was seeded with a 5 mm size mycelial disc taken from the periphery of an actively growing virulent culture plate. Plates were incubated in growth chambers at 25 °C temperature and 70% relative humidity for seven days and the radial growth was measured and compared to the one of the untreated control. Compounds 46 74 at 300ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive pathogen growth. Biological Test Examples on plants The compounds were further selected for in vivo (Greenhouse) testing. The methods followed to check the preventive efficacy of compounds on the respective pathogens were as following: Example 1: Phakopsora pachyrhizi test in Soybean Compounds were dissolved in 2 % dimethyl sulfoxide/acetone and then mixed with water containing emulsifier to the calibrated spray volume of 50 mL. Each spray solution was poured into a spray bottle for further application. To test the preventive activity of the compound, healthy young Soybean plants, raised in the greenhouse, were sprayed with the active compound preparation at the stated application rate inside the spray cabinets using hollow cone nozzles. One day after treatment, the plants were inoculated with a conidial suspension containing 2 x105 Phakopsora pachyrhizi inoculum. The inoculated plants were then kept in a greenhouse chamber at 22-24 °C temperature and 80-90 % relative humidity for disease expression. A visual assessment of the compound’s performance was carried out by rating the disease severity (0- 100% scale) on treated plants 3, 7, 10 and 15 days after application. Efficacy (% control) of the compound was calculated by comparing the disease rating in the treatment with the one of the untreated control. The sprayed plants were also assessed for plant damage by recording symptoms like necrosis, chlorosis and stunting. Compounds 1 2 3 4 5 6 7 8 12 13 14 15 16 17 18 20 21 22 23 24 25 26 27 28 29 31 32 34 35 36 39 41 42 43 45 48 49 50 58 59 60 61 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 87 88 89 90 91 at 300 ppm gave more than or equal to 70% control in these tests when compared to the untreated check which showed extensive disease development. Having described the invention with reference to certain preferred aspects, other aspects will become apparent to one skilled in the art from consideration of the specification. It will be apparent to those skilled in the art that many modifications, both to materials and methods, may be practiced without departing from the scope of the invention.

Claims

CLAIM: 1) A compound of formula (I),
Figure imgf000112_0001
wherein, Het represents a five membered aromatic or a non-aromatic heterocyclic ring containing at least two heteroatoms; wherein the heteroatoms of the aromatic or non-aromatic heterocyclic ring are selected from N, O and S; and one or more C atom/s of the ring may be optionally replaced by C(=O) or C(=S); wherein Het is substituted with R1 and may be optionally substituted with one or more groups selected from R1a, R2 or R3; R1 is C1-C6 haloalkyl; R1a is selected from the group consisting of hydrogen, halogen, C1-C6-alkyl and C1-C6- alkylcarbonyloxy; R2 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkylalkyl, C1-C6-alkylcarbonyl and C3-C6- halocycloalkylalkyl; R3 is selected from the group consisting of hydrogen, cyano, halogen, C1-C6-alkyl, C1-C6- haloalkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C1-C6- alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl and C1-C6- haloalkoxy; A is a phenyl, naphthyl, or a 5 to 10 membered aromatic heterocyclic or hetero bicyclic ring, wherein the ring member atoms of the aromatic heterocyclic or hetero bicyclic ring include besides carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S; and wherein A may be optionally substituted with one or more groups of RA; RA is selected from the group consisting of halogen, cyano, nitro, thiol, amino, hydroxy, C1- C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, C3-C8-cycloalkylalkyl, C1-C6- haloalkyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-hydroxyalkyl, C2-C6-haloalkenyl, C2-C6- haloalkynyl, C3-C8-halocycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6- haloalkoxycarbonyl, C1-C6-alkylthio, C1-C6-haloalkylthio, C1-C6-haloalkylsulfinyl, C1-C6- haloalkylsulfonyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylamino, C1-C6- dialkylamino, C3-C8-cycloalkylamino, C1-C6-alkyl-C3-C8-cycloalkylamino, C1-C6- alkylcarbonyl, C1-C6-alkoxycarbonyl, C1-C6-alkylaminocarbonyl, C1-C6- dialkylaminocarbonyl, C1-C6-alkoxycarbonyloxy, C1-C6-alkylaminocarbonyloxy and C1-C6- dialkylaminocarbonyloxy; wherein the aliphatic or cyclic moieties of RA may optionally be substituted with one or more groups of Ra; or Ra is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6- alkylthio, C1-C6-haloalkylthio, C3-C8-cycloalkyl and C1-C6-alkoxy-C1-C6-alkyl; L1 represents a direct bond, -[C(R4R5)]n-, -[C(R4R5)]n-NR’- or -[C(R4R5)]n-O-; R4 and R5 are independently selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C1-C6-alkyl, C2-C6-alkenyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylamino, C1-C6-dialkylamino, C3-C8-cycloalkylamino and C1-C6-alkyl-C3-C8- cycloalkylamino; or R4 and R5 together with the carbon atom they share form a 3 to 5 membered non-aromatic carbocyclic ring or a heterocyclic ring; wherein the ring member atoms of the heterocyclic ring include besides carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S(O)0-2; and which may be optionally substituted with halogen, C1-C6-alkyl, C2-C6-alkenyl, C1-C6- haloalkyl or C1-C6-alkoxy; R6 and R7 are independently selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2- C6-alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C1-C6-haloalkyl, C1-C6-alkylsulfanyl, C1-C6- alkylsulfinyl, C1-C6-alkylsulfonyl, –OR8, -NR9R10, C6-C10-aryl, C7-C14-aralkyl, C3-C10- heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the ring member atoms of the heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from N, O and S; and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=O) or C(=S); and wherein the aliphatic or cyclic groups of R6 and R7 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R7a; R7a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl, hydroxy-C1-C6-alkyl, C(=O)-NH2, C(=O)-NH(C1-C6-alkyl), C1-C6-alkylthio-C1-C6-alkyl, amino-C1-C6-alkyl, C1-C6-alkylamino-C1-C6-alkyl, di-C1-C6- alkylamino-C1-C6-alkyl, aminocarbonyl-C1-C6-alkyl, C1-C6-alkoxy-C1-C6-alkyl, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic moieties of R7a may optionally be substituted with one or more groups of R7aa selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl and C1-C6-alkoxy-C1-C6-alkyl; R8 is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C6-C10-aryl, C7-C14-aralkyl, C3-C10- heterocyclyl, C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic groups of R8 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R8a; R8a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio or C3-C8-cycloalkyl, hydroxy-C1-C6-alkyl, C(=O)-NH2, C(=O)-NH(C1-C6- alkyl), C1-C6-alkylthio-C1-C6-alkyl, amino-C1-C6-alkyl, C1-C6-alkylamino-C1-C6-alkyl, di-C1- C6-alkylamino-C1-C6-alkyl, aminocarbonyl-C1-C6-alkyl and C1-C6-alkoxy-C1-C6-alkyl; R9 and R10 are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6- alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C(=O)-(C1-C6-alkyl), C(=O)-(C1- C6-alkoxy), C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl, C3-C10-heterocyclyl-C1-C6-alkyl; wherein the aliphatic or cyclic groups of R9 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R9a; or R9 and R10 together with the N atom to which they are attached may form a saturated or partially unsaturated mono- or bicyclic 3 to 10 membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms 1, 2 or 3 heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH2 groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=O) or C(=S); and wherein the heterocycle is unsubstituted or carries 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R9a; R9a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1- C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6- haloalkylthio, C3-C8-cycloalkyl, NHSO2-C1-C6-alkyl, -(C=O)C1-C6-alkyl, -C(=O)-C1-C6- alkoxy, C1-C6-alkylsulfonyl, hydroxy-C1-C6-alkyl, -C(=O)-NH2, -C(=O)-NH(C1-C6-alkyl), C1-C6-alkylthio-C1-C6-alkyl, amino-C1-C6-alkyl, C1-C6-alkylamino-C1-C6-alkyl, diC1-C6- alkylamino-C1-C6-alkyl, aminocarbonyl-C1-C6-alkyl and C1-C6-alkoxy-C1-C6-alkyl; each group of R1 to R10; R1a, R7a, R8a and R9a may be optionally substituted by one or more groups selected from the group consisting of halogen, cyano, nitro, R’, OR’, SR’, N(R’)2, COR’ and CON(R’)2; R’ is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6- haloalkoxy, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C6-C10-aryl, C6-C10-aryl-C1-C6-alkoxy, C7-C14-aralkyl and C3-C10-heterocyclyl; n is an integer selected from 0 to 4; and/or N-oxides, metal complexes, isomers, polymorphs or the agriculturally acceptable salts thereof. 2) The compound formula (I) according to claim 1, wherein Het is selected from the group consisting of Het-1 to Het-6;
Figure imgf000115_0001
wherein, # indicates the point of attachment to A. 3) The compound formula (I) according to claim 1, wherein Het represents Het 1 or Het 2; R1 is selected from the group consisting of CF3, CF2H and CF2Cl; A is a phenyl, pyridyl or a imidazo[1,2-a]pyridine, wherein A may be optionally substituted with one or more groups of RA; RA is selected from the group consisting of halogen, cyano, nitro, thiol, amino, hydroxy, C1- C6-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkylalkyl, C1-C6-haloalkyl, C1-C6-alkoxy-C1-C6- alkyl, C1-C6-hydroxyalkyl, C3-C8-halocycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy and C1-C6- haloalkoxycarbonyl; R4 and R5 are independently selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy and C1-C6-haloalkoxy; or wherein R6 and R7 are selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C1-C6-haloalkyl, –OR8, -NR9R10, C6-C10-aryl, C7- C14-aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1-C6-alkyl; wherein the ring member atoms of the heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from N, O and S; and wherein the aliphatic or cyclic groups of R6 and R7 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R7a; R7a is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1- C6-haloalkoxy, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl and C3-C10-heterocyclyl-C1- C6-alkyl; wherein the aliphatic or cyclic moieties of R7a may optionally be substituted with one or more groups of R7aa selected from the group consisting of halogen, cyano, nitro, hydroxyl, thiol, amino, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6- alkylthio, C1-C6-haloalkylthio, C3-C8-cycloalkyl and C1-C6-alkoxy-C1-C6-alkyl; R8 is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C1-C6-haloalkyl, C3-C6-cycloalkyl; R9 and R10 are selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl, C6-C10-aryl, C7-C14-aralkyl, C3-C10-heterocyclyl, C3-C10-heterocyclyl- C1-C6-alkyl; wherein the aliphatic or cyclic groups of R9 are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R9a; or R9 and R10 together with the N atom to which they are attached may form a saturated or partially unsaturated monocyclic 5 to 6 membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms 1, 2 or 3 heteroatoms independently selected from N and O as ring member atoms; and wherein the heterocycle is unsubstituted or carries 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R9a; R9a is selected from the group consisting of halogen, cyano, nitro, hydroxyl, C1-C6-alkyl, C1- C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy and C3-C8-cycloalkyl; each group of R1 to R10; R1a, R7a, R8a and R9a may be optionally substituted by one or more groups selected from the group consisting of halogen, cyano, nitro, R’, OR’, SR’, N(R’)2, COR’ and CON(R’)2; R’ is selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C1-C6- haloalkyl, C1-C6-alkoxy and C1-C6-haloalkoxy; n is an integer selected from 0 to 4; and/or N-oxides, metal complexes, isomers, polymorphs or the agriculturally acceptable salts thereof. 4) The compound of formula (I) according to claim 1, wherein said compound of formula (I) is selected from ethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate, ethyl bis(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate, diethyl (4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonate, methyl(piperidin-1-yl)(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide, methyl(piperidin-1-yl)(1-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphine oxide , ethyl methyl(1-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinate, N,N,P-trimethyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N,N,P-trimethyl-P-(1-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)phosphinic amide, N-(4-chlorobenzyl)-P- methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide , (3- methoxypyrrolidin-1-yl)(methyl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphine oxide, methyl(4-methylpiperazin-1-yl)(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphine oxide, N-isobutyl-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinic amide , N-(cyclopropylmethyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide, N-(2-methoxyethyl)-N,P-dimethyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, P-methyl-N-phenyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-benzyl-P-methyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-methoxybenzyl)-P-methyl- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(2-methoxyethyl)-P- methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-allyl-P- methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, ethyl N-isobutyl- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-allyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-methylcyclopropyl)- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4- chlorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N- (4-methoxybenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-methoxyethyl)-N-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate, ethyl N-cyclopropyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate, ethyl N,N-dimethyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate, ethyl morpholino(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinate, ethyl N-(4-methylbenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonamidate, ethyl N-(2,4-difluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4-fluorobenzyl)-P-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(pyridin-4-ylmethyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(cyclopropylmethyl)-P- (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-cyclopentyl-P-(4- (5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(3-methoxybenzyl)- P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(pyridin-2- ylmethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(4- chlorobenzyl)-N-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-phenyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N- (3-fluorophenyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl N-(2-fluorophenyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphonamidate, ethyl piperidin-1-yl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinate, N-(4- methoxyphenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-chlorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphinic amide, N-(3-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-fluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-methoxyphenyl)-N,P-dimethyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, P-methyl-N-(p-tolyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(4-chlorophenyl)-N,P- dimethyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, N-(2,4- difluorophenyl)-P-methyl-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)phosphinic amide, diethyl (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonate, ethyl N-phenyl- P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-methyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl piperidin-1-yl(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphinate, ethyl N-(4-chlorophenyl)-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(4-fluorophenyl)-P-(4- (5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N,N-dimethyl-P-(4-(5- (trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(2-methoxyethyl)-P-(4- (5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P- (4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(3- methoxyphenyl)-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-isopropyl-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N-(4- fluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, ethyl N- benzyl-P-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)phosphonamidate, diethyl ((7-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, diisopropyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonate, ethyl N-(2,4-difluorophenyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl N-(2-chloro-4-methylphenyl)-P- ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl N-(4-fluorobenzyl)-P-((7-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl N-(4-methoxybenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate, ethyl N-(2-fluorobenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl methyl ((7-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, ethyl N-(2,4- difluorobenzyl)-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2- yl)methyl)phosphonamidate, ethyl N-benzyl-P-((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl hydrogen (4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)phosphonate, diethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate, ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonate, ethyl N-(2-methoxyethyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-(2-fluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)phosphonamidate, ethyl N-(3,5-difluorobenzyl)-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-isobutyl-P-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-(cyclopropylmethyl)-P-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-cyclopropyl-P-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-(2,4-difluorobenzyl)-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-benzyl-P-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl piperidin-1-yl(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphinate, ethyl (1-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)ethyl)(methyl)phosphinate, diethyl (4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphoramidate, dimethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, dimethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, diethyl methyl(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphoramidate, ethyl isopropyl ((7-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonate, ethyl N-phenyl-P-((7-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)phosphonamidate, ethyl P-((7-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(4- (trifluoromethyl)phenyl)phosphonamidate, ethyl methyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)phosphonate, benzyl ethyl (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, ethyl (4-fluorobenzyl) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, ethyl (pyridin-3-ylmethyl) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)phosphonate, N-cyclopropyl-1-ethyl-1-oxo-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)-λ5-phosphanediamine, P-ethyl-P-(pyrrolidin-1-yl)-N-(4-(5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)phosphinic amide, 1-ethyl-1-oxo-N-propyl-N'-(4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)- λ5-phosphanediamine, 1-ethyl-1-oxo-N-isopropyl-N'-(4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-λ5-phosphanediamine, 1-ethyl-1-oxo-N-(2- methoxyethyl)-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-λ5-phosphanediamine, 1- ethyl-1-oxo-N-phenyl-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-λ5- phosphanediamine, 1-ethyl-N-(3-fluorophenyl)-1-oxo-N'-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl)benzyl)-λ5-phosphanediamine, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-methylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-isobutylphosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N- cyclopentylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin- 2-yl)methyl)-N-isopropylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-ethylphosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-neopentylphosphonamidate, ethyl N-(tert-butyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin- 2-yl)methyl)-N-phenylphosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)pyridin-2-yl)methyl)-N-(2-fluorophenyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4- difluorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(3-fluorophenyl)phosphonamidate , ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4- dichlorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(3-methoxyphenyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3- chlorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(4-chlorophenyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2- chlorophenyl)phosphonamidate, ethyl N-(4-bromo-2-chlorophenyl)-P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl P-((5- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,6- dichlorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(o-tolyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(m-tolyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(pyridin-3- yl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(3,4-difluorophenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3,5-difluorophenyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(4- (trifluoromethyl)phenyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)pyridin-2-yl)methyl)-N-(p-tolyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl N-(3- chlorobenzyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)phosphonamidate, ethyl N-benzyl-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)phosphonamidate, ethyl N-(2-chlorobenzyl)-P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)phosphonamidate, ethyl P-((5- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3- fluorobenzyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(2,4-difluorobenzyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2- fluorobenzyl)phosphonamidate, ethyl P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(3-methoxybenzyl)phosphonamidate, ethyl P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4- dichlorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-methylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorobenzyl)-N-isobutylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-cyclopentylphosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-isopropylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-ethylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N- neopentylphosphonamidate, ethyl N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorobenzyl)-N-phenylphosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(2-fluorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4- difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3-fluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4-dichlorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3- methoxyphenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3-chlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(4-chlorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2- chlorophenyl)phosphonamidate, ethyl N-(4-bromo-2-chlorophenyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,6- dichlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(o-tolyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorobenzyl)-N-(m-tolyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(pyridin-3-yl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3,4- difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3,5-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(4-(trifluoromethyl)phenyl)phosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(p-tolyl)phosphonamidate, ethyl N-(4-chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)phosphonamidate, ethyl N-(3-chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate, ethyl N-benzyl-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)phosphonamidate , ethyl N-(2- chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3-fluorobenzyl)phosphonamidate , ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4-difluorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2- fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N-(3-methoxybenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4-dichlorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-methylphosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-isobutylphosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-cyclopentylphosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-isopropylphosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-ethylphosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-neopentylphosphonamidate, ethyl N-(tert- butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-phenylphosphonamidate, ethyl P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2-fluorophenyl)phosphonamidate , ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,4- difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(3-fluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(2,4-dichlorophenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3-methoxyphenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3- chlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(4-chlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(2-chlorophenyl)phosphonamidate, ethyl N-(4-bromo-2-chlorophenyl)- P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,6-dichlorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(o-tolyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(m-tolyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(pyridin-3- yl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3,4- difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(3,5-difluorophenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(4-(trifluoromethyl)phenyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(p-tolyl)phosphonamidate, ethyl N-(4- chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)phosphonamidate, ethyl N-(3-chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-benzyl-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)phosphonamidate, ethyl N-(2-chlorobenzyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(3-fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(2,4-difluorobenzyl)phosphonamidate, ethyl P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2-fluorobenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3- methoxybenzyl)phosphonamidate, ethyl P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(2,4-dichlorobenzyl)phosphonamidate, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-isopropyl-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)- N-ethyl-P-methylphosphinic amide , P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methylphosphinic amide, P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-phenylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(2-fluorophenyl)- P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(3-fluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)- N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-N-(3-methoxyphenyl)-P-methylphosphinic amide , P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(3-chlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)- N-(4-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)-2-fluorophenyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2- chlorophenyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)- N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-(o-tolyl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N- (pyridin-3-yl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)-N-(3,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)-N-(3,5-difluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)- P-methyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorophenyl)-P-methyl-N-(p-tolyl)phosphinic amide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)(methyl)(piperidin-1-yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorophenyl)(methyl)(pyrrolidin-1- yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorophenyl)(methyl)(morpholino)phosphine oxide, azetidin-1-yl(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorophenyl)(methyl)phosphine oxide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-isopropyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-ethyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N- neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-P-methyl-N-phenylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)phenyl)-N-(2-fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)-N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3-fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2,4-dichlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3- methoxyphenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(3-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)phenyl)-N-(4-chlorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2-chlorophenyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(o-tolyl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(m-tolyl)phosphinic amide, P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(pyridin-3-yl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3,4-difluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-N-(3,5- difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)phenyl)-P-methyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)-P-methyl-N-(p-tolyl)phosphinic amide, (4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)(piperidin-1-yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)(pyrrolidin-1-yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)(morpholino)phosphine oxide, azetidin-1-yl(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)(methyl)phosphine oxide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N,P- dimethylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-isobutyl-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-cyclopentyl-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-isopropyl-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-ethyl-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol- 3-yl)pyridin-2-yl)methyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methylphosphinic amide, P- ((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N- phenylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(2-fluorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-fluorophenyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-methoxyphenyl)-P-methylphosphinic amide, P- ((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3-chlorophenyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(4-chlorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4- bromo-2-chlorophenyl)-P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)pyridin-2-yl)methyl)-N-(2,6-dichlorophenyl)-P-methylphosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(o- tolyl)phosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(pyridin-3-yl)phosphinic amide, P-((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-N-(3,4-difluorophenyl)-P- methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)-N-(3,5-difluorophenyl)-P-methylphosphinic amide, P-((5-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, P-((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)-P-methyl-N-(p- tolyl)phosphinic amide, ((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)(methyl)(piperidin-1-yl)phosphine oxide, ((5-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)pyridin-2-yl)methyl)(methyl)(morpholino)phosphine oxide, ((5-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2-yl)methyl)(methyl)(pyrrolidin-1- yl)phosphine oxide, azetidin-1-yl((5-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)pyridin-2- yl)methyl)(methyl)phosphine oxide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorobenzyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-cyclopentyl-P-methylphosphinic amide , P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-isopropyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-ethyl-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)- P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P-methyl-N-phenylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2-fluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)- N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,4-dichlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)- N-(3-methoxyphenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-N-(3-chlorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(4-chlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)- N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2-chlorophenyl)-P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P-methylphosphinic amide, P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(2,6-dichlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)- P-methyl-N-(o-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)-P-methyl-N-(m-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-P-methyl-N-(pyridin-3-yl)phosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N-(3,4-difluorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)- N-(3,5-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)-2-fluorobenzyl)-P-methyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, P-(4- (5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-P-methyl-N-(p-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)-N,P-dimethyl-N-(4- (trifluoromethyl)phenyl)phosphinic amide , P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)-2-fluorobenzyl)-N,P-dimethyl-N-(4-(trifluoromethyl)phenyl)phosphinic amide, (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2-fluorobenzyl)(methyl)(piperidin-1-yl)phosphine oxide, (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)-2- fluorobenzyl)(methyl)(morpholino)phosphine oxide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N,P-dimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-isobutyl-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)-N-cyclopentyl-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-isopropyl-P-methylphosphinic amide, P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-ethyl-P-methylphosphinic amide, P- (4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methyl-N-neopentylphosphinic amide, N-(tert-butyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methyl- N-phenylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(2- fluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-(2,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)-N-(3-fluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(2,4-dichlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(3-methoxyphenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(3- chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-N-(4-chlorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-(2-chlorophenyl)-P-methylphosphinic amide, N-(4-bromo-2- chlorophenyl)-P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(2,6-dichlorophenyl)-P- methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methyl- N-(o-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P- methyl-N-(m-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-P-methyl-N-(pyridin-3-yl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-(3,4-difluorophenyl)-P-methylphosphinic amide, P-(4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-N-(3,5-difluorophenyl)-P-methylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-P-methyl-N-(4- (trifluoromethyl)phenyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4-oxadiazol-3- yl)benzyl)-P-methyl-N-(p-tolyl)phosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N,N,P-trimethylphosphinic amide, P-(4-(5-(chlorodifluoromethyl)-1,2,4- oxadiazol-3-yl)benzyl)-N-isobutyl-N,P-dimethylphosphinic amide, (4-(5-(chlorodifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzyl)(methyl)(piperidin-1-yl)phosphine oxide and (4-(5- (chlorodifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)(methyl)(morpholino)phosphine oxide. 5) A combination comprising the compound of formula (I) according to claim 1 and at least one further pesticidally active substance selected from the group consisting of fungicides, insecticides, nematicides, acaricides, biopesticides, herbicides, safeners, plant growth regulators, antibiotics, fertilizers and nutrients. 6) An agrochemical composition comprising the compound of formula (I) according to claim 1 and at least one agrochemically acceptable auxiliary. 7) The composition according to claim 6, wherein said composition may further comprises at least one additional active ingredient. 8) The composition according to claim 6, wherein said composition is applied to seed and the amount of compound of the formula (I) in said composition ranges from 0.1 g a.i. to 10 kg a.i .per 100 kg of seeds. 9) A method for controlling or preventing phytopathogenic microorganisms, wherein the method comprises treating the fungi or the materials, plants, plant parts, locus thereof, soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula (I) according to claim 1 or the combination according to claim 5 or the composition according to claim 6. 10) A method for controlling or preventing infestation of plants by phytopathogenic microorganisms in agricultural crops and/or horticultural crops wherein an effective amount of at least one compound of formula (I) according to claim 1 or the combination according to claim 5 or the composition according to claim 6, is applied to the plants, to parts thereof or locus thereof. 11) A method according to claim 10, wherein the phytopathogenic microorganisms are selected from the group comprising of Hemileia vastatrix (Coffee rust), Uromyces appendiculatus/fabae/ phaseoli (rust of beans) Puccinia spp. (rusts) on various plants selected from P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. Hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals selected from wheat, barley or rye and Phakopsora spp. on various plants, in particular Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans. 12) Use of a compound of formula (I) according to claim 1 as a fungicide. 13) A process for preparing the compound of formula (I) according to claim 1, wherein said process comprising the steps of: a) reacting a compound of formula 3 with a compound of formula R6-X wherein X is Cl, Br or I; to affford a compound of formula 4;
Figure imgf000129_0001
wherein, L1 is CH2; R6 is C1-C6-alkyl; A are as defined in claim 1; b) reacting a compound of formula 4 with hydroxyl amine to afford a compound of formula 5;
Figure imgf000129_0002
wherein, L1 is CH2; A and R6 are as defined in claim 1; c) reacting a compound of formula 5 with a suitable carboxylic acid anhydride of formula (a) or a suitable acid chloride of formula (b) to afford a compound of formula 6;
Figure imgf000129_0003
wherein, L1 is CH2; Het is Het-1, R1, A and R6 are as defined in claim 1; d) reacting a compound of formula 6 with a suitable chlorinating reagent to afford a compound of formula 7;
Figure imgf000129_0004
wherein, R6 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl and C3-C6-cycloalkenyl; or reacting the compound of formula 6 with a suitable chlorinating reagent followed by hydrolysing the resultanting compound to obtain a compound of formula 15;
Figure imgf000130_0001
R6 is -OEt; e) reacting the compound of formula 7 with a compound of formula HNR9R10 to obtain a compound of formula (I);
Figure imgf000130_0002
wherein, R6 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl and C3-C6-cycloalkenyl R7 is -NR9R10; Het, A, L1, R9 and R10 are as defined in claim 1; or reacting the compound of formula 15 with a compound of formula HNR9R10 to obtain a compound of formula (I);
Figure imgf000130_0003
wherein, R6 is -OEt; R7 is -NR9R10; Het, A, L1, R6, R9 and R10 are as defined in claim 1. 14) The process according to claim 13, wherein said process may additionally comprises the steps of: f) reacting a compound of formula 15 with a suitable chlorinating reagent to afford a compound of formula (I);
Figure imgf000130_0004
wherein, R6 is -OEt; Het, A, L1, R6, R9 and R10 are as defined in claim 1; g) reacting a compound of formula 14 with a compound of formula HNR9R10 to afford a compound of formula (I); wherein, R6 is -OEt; R7 is -NR9R10; Het, A, L1, R6, R9 and R10 are as defined in claim 1. 15) A process for the synthesis of compound of formula (I) according to claim 1, wherein said process comprising the steps of: a) reacting a compound of formula 9 with hydroxyl amine to afford a compound of formula 10; b) reacting a compound of formula 10 with a suitable carboxylic acid anhydride of formula (a) or acid chloride of formula (b) to obtain a compound of formula 11; wherein, Het is Het-1, A and R1, as defined in claim 1; c) reacting a compound of formula 11 with suitable halogenating reagent to afford a compound of formula 12; wherein, L1 is CH2; Het, A and R1, as defined in claim 1; d) reacting the compound of formula 12 with a suitable reagent to afford a compound of formula 13; wherein, L1 is CH2; X is Cl, Br or I; Het and A as defined in claim 1; e) reacting the compound of formula 13 with suitable chlorinating reagent to afford a compound of formula 14;
Figure imgf000132_0001
wherein, L1 is CH2; R6 is -OEt; Het and A as defined in claim 1; f) reacting a compound of formula 14 with a compound of formula HNR9R10 to afford a compound of formula (I);
Figure imgf000132_0002
wherein, L1 is CH2; X is Cl, Br or I; R6 is -OEt; Het, A and R7 as defined in claim 1.
PCT/IB2021/057545 2020-08-18 2021-08-17 Novel heterocyclic compounds for combating phytopathogenic fungi Ceased WO2022038500A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202011035517 2020-08-18
IN202011035517 2020-08-18

Publications (1)

Publication Number Publication Date
WO2022038500A1 true WO2022038500A1 (en) 2022-02-24

Family

ID=77821962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2021/057545 Ceased WO2022038500A1 (en) 2020-08-18 2021-08-17 Novel heterocyclic compounds for combating phytopathogenic fungi

Country Status (4)

Country Link
AR (1) AR123264A1 (en)
TW (1) TW202226947A (en)
UY (1) UY39385A (en)
WO (1) WO2022038500A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11578066B1 (en) 2019-12-20 2023-02-14 Tenaya Therapeutics, Inc. Fluoroalkyl-oxadiazoles and uses thereof
WO2024068519A1 (en) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hetero)aryl-5-chlorodifluoromethyl-1,2,4-oxadiazole as fungicide
WO2024068517A1 (en) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hetero)aryl-5-chlorodifluoromethyl-1,2,4-oxadiazole as fungicide
US12201617B2 (en) 2021-05-04 2025-01-21 Tenaya Therapeutics, Inc. HDAC6 inhibitors for treatment of metabolic disease and HFpEF

Citations (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296272A (en) 1965-04-01 1967-01-03 Dow Chemical Co Sulfinyl- and sulfonylpyridines
US3325503A (en) 1965-02-18 1967-06-13 Diamond Alkali Co Polychloro derivatives of mono- and dicyano pyridines and a method for their preparation
EP0141317A2 (en) 1983-10-21 1985-05-15 BASF Aktiengesellschaft 7-Amino-azolo[1,5-a]pyrimidines and fungicides containing them
EP0152031A2 (en) 1984-02-03 1985-08-21 Shionogi & Co., Ltd. Azolyl cycloalkanol derivatives and agricultural fungicides
EP0226917A1 (en) 1985-12-20 1987-07-01 BASF Aktiengesellschaft Acrylic acid esters and fungicides containing these compounds
EP0243970A1 (en) 1986-05-02 1987-11-04 Stauffer Chemical Company Fungicidal pyridyl imidates
EP0256503A2 (en) 1986-08-12 1988-02-24 Mitsubishi Kasei Corporation Pyridinecarboxamide derivatives and their use as fungicide
EP0276432A2 (en) 1986-12-12 1988-08-03 Ciba-Geigy Ag Pesticides
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0428941A1 (en) 1989-11-10 1991-05-29 Agro-Kanesho Co., Ltd. Hexahydrotriazine compounds and insecticides
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
WO1992006962A1 (en) * 1990-10-18 1992-04-30 Monsanto Company Herbicidal substituted aryl-haloalkylpyrazoles
EP0532022A1 (en) 1991-09-13 1993-03-17 Ube Industries, Ltd. Acrylate compound, preparation process thereof and fungicide using the same
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1997030060A1 (en) * 1996-02-16 1997-08-21 Basf Aktiengesellschaft Substituted aromatic phosphonic acid derivatives
DE19650197A1 (en) 1996-12-04 1998-06-10 Bayer Ag 3-thiocarbamoylpyrazole derivatives
WO1998046608A1 (en) 1997-04-14 1998-10-22 American Cyanamid Company Fungicidal trifluoromethylalkylamino-triazolopyrimidines
WO1999014187A1 (en) 1997-09-18 1999-03-25 Basf Aktiengesellschaft Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
WO1999024413A2 (en) 1997-11-12 1999-05-20 Bayer Aktiengesellschaft Isothiazole carboxylic acid amides and the application thereof in order to protect plants
WO1999027783A1 (en) 1997-12-04 1999-06-10 Dow Agrosciences Llc Fungicidal compositions and methods, and compounds and methods for the preparation thereof
WO2000029404A1 (en) 1998-11-17 2000-05-25 Kumiai Chemical Industry Co., Ltd. Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultura/horticultural bactericides
WO2000046148A1 (en) 1999-02-02 2000-08-10 Sintokogio, Ltd. Silica gel carrying titanium oxide photocatalyst in high concentration and method for preparation thereof
EP1028125A1 (en) 1998-11-30 2000-08-16 Isagro Ricerca S.r.l. Dipeptide compounds having fungicidal activity and their agronomic use
EP1035122A1 (en) 1999-03-11 2000-09-13 Rohm And Haas Company Heterocyclic subsituted isoxazolidines and their use as fungicides
WO2000065913A1 (en) 1999-04-28 2000-11-09 Takeda Chemical Industries, Ltd. Sulfonamide derivatives
DE10021412A1 (en) 1999-12-13 2001-06-21 Bayer Ag Fungicidal active ingredient combinations
WO2001054501A2 (en) 2000-01-25 2001-08-02 Syngenta Participations Ag Herbicidal composition
EP1122244A1 (en) 2000-02-04 2001-08-08 Sumitomo Chemical Company, Limited Uracil compounds and their use
WO2001056358A2 (en) 2000-01-28 2001-08-09 Rohm And Haas Company Enhanced propertied pesticides
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2002022583A2 (en) 2000-09-18 2002-03-21 E. I. Du Pont De Nemours And Company Pyridinyl amides and imides for use as fungicides
EP1201648A1 (en) 1999-08-05 2002-05-02 Kumiai Chemical Industry Co., Ltd. Carbamate derivatives and agricultural/horticultural bactericides
WO2002040431A2 (en) 2000-11-17 2002-05-23 Dow Agrosciences Llc Compounds having fungicidal activity and processes to make and use same
JP2002316902A (en) 2001-04-20 2002-10-31 Sumitomo Chem Co Ltd Plant disease control agent composition
WO2003010149A1 (en) 2001-07-25 2003-02-06 Bayer Cropscience Ag Pyrazolylcarboxanilides as fungicides
WO2003011853A1 (en) 2001-07-30 2003-02-13 Dow Agrosciences Llc 6-aryl-4-aminopicolinates and their use as herbicides
WO2003014103A1 (en) 2001-08-03 2003-02-20 Bayer Cropscience S.A. Iodobenzopyran-4-one derivatives having fungicidal activity
WO2003016303A1 (en) 2001-08-20 2003-02-27 Dainippon Ink And Chemicals, Inc. Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient
WO2003016286A1 (en) 2001-08-17 2003-02-27 Sankyo Agro Company, Limited 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2003053145A1 (en) 2001-12-21 2003-07-03 Nissan Chemical Industries, Ltd. Bactericidal composition
WO2003061388A1 (en) 2002-01-18 2003-07-31 Sumitomo Chemical Takeda Agro Company, Limited Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
WO2003066609A1 (en) 2002-02-04 2003-08-14 Bayer Cropscience Aktiengesellschaft Disubstituted thiazolyl carboxanilides and their use as microbicides
WO2003074491A1 (en) 2002-03-05 2003-09-12 Syngenta Participations Ag O-cyclopropyl-carboxanilides and their use as fungicides
WO2004049804A2 (en) 2002-11-29 2004-06-17 Syngenta Participations Ag Fungicidal combinations for crop potection
WO2004083193A1 (en) 2003-03-17 2004-09-30 Sumitomo Chemical Company, Limited Amide compound and bactericide composition containing the same
WO2005063721A1 (en) 2003-12-19 2005-07-14 E.I. Dupont De Nemours And Company Herbicidal pyrimidines
WO2005087773A1 (en) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
WO2005087772A1 (en) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
WO2005120234A2 (en) 2004-06-03 2005-12-22 E.I. Dupont De Nemours And Company Fungicidal mixtures of amidinylphenyl compounds
WO2005123690A1 (en) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-difluoromethyl-pyrazol-4-carbonic acid-(ortho-phenyl)-anilides, and use thereof as a fungicide
WO2005123689A1 (en) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and to use thereof as fungicide
WO2006015866A1 (en) 2004-08-12 2006-02-16 Syngenta Participations Ag Method for protecting useful plants or plant propagation material
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
WO2006087325A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances
DE102005009458A1 (en) 2005-03-02 2006-09-07 Bayer Cropscience Ag pyrazolylcarboxanilides
WO2007006670A1 (en) 2005-07-07 2007-01-18 Basf Aktiengesellschaft N-thio-anthranilamid compounds and their use as pesticides
WO2007082098A2 (en) 2006-01-13 2007-07-19 Dow Agrosciences Llc 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
WO2007090624A2 (en) 2006-02-09 2007-08-16 Syngenta Participations Ag A method of protecting a plant propagation material, a plant, and/or plant organs
WO2009090181A2 (en) 2008-01-15 2009-07-23 Bayer Cropscience Sa Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
WO2010069882A1 (en) 2008-12-17 2010-06-24 Syngenta Participations Ag Isoxazole derivatives for use as fungicides
WO2011028657A1 (en) 2009-09-01 2011-03-10 Dow Agrosciences Llc Synergistic fungicidal compositions containing a 5-fluoropyrimidine derivative for fungal control in cereals
WO2011077514A1 (en) 2009-12-22 2011-06-30 三井化学アグロ株式会社 Plant disease control composition and method for controlling plant diseases by applying the composition
WO2011135833A1 (en) 2010-04-28 2011-11-03 Sumitomo Chemical Company, Limited Plant disease control composition and its use
WO2012168188A1 (en) 2011-06-07 2012-12-13 Bayer Intellectual Property Gmbh Active compound combinations
WO2013007767A1 (en) 2011-07-13 2013-01-17 Basf Se Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
WO2013010862A1 (en) 2011-07-15 2013-01-24 Basf Se Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
WO2013024010A1 (en) 2011-08-12 2013-02-21 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2013024009A1 (en) 2011-08-12 2013-02-21 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2013047749A1 (en) 2011-09-29 2013-04-04 三井化学アグロ株式会社 Production method for 4, 4-difluoro-3,4-dihydroisoquinoline derivative
WO2013047441A1 (en) 2011-09-26 2013-04-04 日本曹達株式会社 Agricultural and horticultural bactericide composition
WO2013066835A2 (en) 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
WO2013092224A1 (en) 2011-12-21 2013-06-27 Basf Se Use of strobilurin type compounds for combating phytopathogenic fungi resistant to qo inhibitors
WO2013127704A1 (en) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Active compound combinations containing a thiazoylisoxazoline and a fungicide
WO2013162072A1 (en) 2012-04-27 2013-10-31 Sumitomo Chemical Company, Limited Tetrazolinone compounds and its use as pesticides
WO2015185485A1 (en) 2014-06-06 2015-12-10 Basf Se Use of substituted oxadiazoles for combating phytopathogenic fungi
WO2017072247A1 (en) 2015-10-28 2017-05-04 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
EP3165093A1 (en) 2015-11-05 2017-05-10 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017076742A1 (en) 2015-11-05 2017-05-11 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
EP3167716A1 (en) 2015-11-10 2017-05-17 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017093019A1 (en) 2015-12-03 2017-06-08 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017110862A1 (en) 2015-12-25 2017-06-29 住友化学株式会社 Oxadiazole compound and use thereof
WO2017110864A1 (en) 2015-12-25 2017-06-29 住友化学株式会社 Plant disease control composition and application for same
WO2017110861A1 (en) 2015-12-25 2017-06-29 住友化学株式会社 Plant disease control agent containing oxadiazole compound
WO2017211652A1 (en) 2016-06-09 2017-12-14 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018118781A1 (en) 2016-12-20 2018-06-28 Fmc Corporation Fungicidal oxadiazoles
WO2018202491A1 (en) 2017-05-04 2018-11-08 Basf Se Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi

Patent Citations (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325503A (en) 1965-02-18 1967-06-13 Diamond Alkali Co Polychloro derivatives of mono- and dicyano pyridines and a method for their preparation
US3296272A (en) 1965-04-01 1967-01-03 Dow Chemical Co Sulfinyl- and sulfonylpyridines
EP0141317A2 (en) 1983-10-21 1985-05-15 BASF Aktiengesellschaft 7-Amino-azolo[1,5-a]pyrimidines and fungicides containing them
EP0152031A2 (en) 1984-02-03 1985-08-21 Shionogi & Co., Ltd. Azolyl cycloalkanol derivatives and agricultural fungicides
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0226917A1 (en) 1985-12-20 1987-07-01 BASF Aktiengesellschaft Acrylic acid esters and fungicides containing these compounds
EP0243970A1 (en) 1986-05-02 1987-11-04 Stauffer Chemical Company Fungicidal pyridyl imidates
EP0256503A2 (en) 1986-08-12 1988-02-24 Mitsubishi Kasei Corporation Pyridinecarboxamide derivatives and their use as fungicide
EP0276432A2 (en) 1986-12-12 1988-08-03 Ciba-Geigy Ag Pesticides
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0428941A1 (en) 1989-11-10 1991-05-29 Agro-Kanesho Co., Ltd. Hexahydrotriazine compounds and insecticides
WO1992006962A1 (en) * 1990-10-18 1992-04-30 Monsanto Company Herbicidal substituted aryl-haloalkylpyrazoles
EP0532022A1 (en) 1991-09-13 1993-03-17 Ube Industries, Ltd. Acrylate compound, preparation process thereof and fungicide using the same
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1997030060A1 (en) * 1996-02-16 1997-08-21 Basf Aktiengesellschaft Substituted aromatic phosphonic acid derivatives
US6175007B1 (en) * 1996-02-16 2001-01-16 Basf Aktiengesellschaft Substituted aromatic phoshonic acid derivatives
DE19650197A1 (en) 1996-12-04 1998-06-10 Bayer Ag 3-thiocarbamoylpyrazole derivatives
WO1998046608A1 (en) 1997-04-14 1998-10-22 American Cyanamid Company Fungicidal trifluoromethylalkylamino-triazolopyrimidines
WO1999014187A1 (en) 1997-09-18 1999-03-25 Basf Aktiengesellschaft Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
WO1999024413A2 (en) 1997-11-12 1999-05-20 Bayer Aktiengesellschaft Isothiazole carboxylic acid amides and the application thereof in order to protect plants
WO1999027783A1 (en) 1997-12-04 1999-06-10 Dow Agrosciences Llc Fungicidal compositions and methods, and compounds and methods for the preparation thereof
WO2000029404A1 (en) 1998-11-17 2000-05-25 Kumiai Chemical Industry Co., Ltd. Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultura/horticultural bactericides
EP1028125A1 (en) 1998-11-30 2000-08-16 Isagro Ricerca S.r.l. Dipeptide compounds having fungicidal activity and their agronomic use
WO2000046148A1 (en) 1999-02-02 2000-08-10 Sintokogio, Ltd. Silica gel carrying titanium oxide photocatalyst in high concentration and method for preparation thereof
EP1035122A1 (en) 1999-03-11 2000-09-13 Rohm And Haas Company Heterocyclic subsituted isoxazolidines and their use as fungicides
WO2000065913A1 (en) 1999-04-28 2000-11-09 Takeda Chemical Industries, Ltd. Sulfonamide derivatives
EP1201648A1 (en) 1999-08-05 2002-05-02 Kumiai Chemical Industry Co., Ltd. Carbamate derivatives and agricultural/horticultural bactericides
DE10021412A1 (en) 1999-12-13 2001-06-21 Bayer Ag Fungicidal active ingredient combinations
WO2001054501A2 (en) 2000-01-25 2001-08-02 Syngenta Participations Ag Herbicidal composition
WO2001056358A2 (en) 2000-01-28 2001-08-09 Rohm And Haas Company Enhanced propertied pesticides
EP1122244A1 (en) 2000-02-04 2001-08-08 Sumitomo Chemical Company, Limited Uracil compounds and their use
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2002022583A2 (en) 2000-09-18 2002-03-21 E. I. Du Pont De Nemours And Company Pyridinyl amides and imides for use as fungicides
WO2002040431A2 (en) 2000-11-17 2002-05-23 Dow Agrosciences Llc Compounds having fungicidal activity and processes to make and use same
JP2002316902A (en) 2001-04-20 2002-10-31 Sumitomo Chem Co Ltd Plant disease control agent composition
WO2003010149A1 (en) 2001-07-25 2003-02-06 Bayer Cropscience Ag Pyrazolylcarboxanilides as fungicides
WO2003011853A1 (en) 2001-07-30 2003-02-13 Dow Agrosciences Llc 6-aryl-4-aminopicolinates and their use as herbicides
WO2003014103A1 (en) 2001-08-03 2003-02-20 Bayer Cropscience S.A. Iodobenzopyran-4-one derivatives having fungicidal activity
WO2003016286A1 (en) 2001-08-17 2003-02-27 Sankyo Agro Company, Limited 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
WO2003016303A1 (en) 2001-08-20 2003-02-27 Dainippon Ink And Chemicals, Inc. Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2003053145A1 (en) 2001-12-21 2003-07-03 Nissan Chemical Industries, Ltd. Bactericidal composition
WO2003061388A1 (en) 2002-01-18 2003-07-31 Sumitomo Chemical Takeda Agro Company, Limited Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
WO2003066609A1 (en) 2002-02-04 2003-08-14 Bayer Cropscience Aktiengesellschaft Disubstituted thiazolyl carboxanilides and their use as microbicides
WO2003074491A1 (en) 2002-03-05 2003-09-12 Syngenta Participations Ag O-cyclopropyl-carboxanilides and their use as fungicides
WO2004049804A2 (en) 2002-11-29 2004-06-17 Syngenta Participations Ag Fungicidal combinations for crop potection
WO2004083193A1 (en) 2003-03-17 2004-09-30 Sumitomo Chemical Company, Limited Amide compound and bactericide composition containing the same
WO2005063721A1 (en) 2003-12-19 2005-07-14 E.I. Dupont De Nemours And Company Herbicidal pyrimidines
WO2005087773A1 (en) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
WO2005087772A1 (en) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
WO2005120234A2 (en) 2004-06-03 2005-12-22 E.I. Dupont De Nemours And Company Fungicidal mixtures of amidinylphenyl compounds
WO2005123690A1 (en) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-difluoromethyl-pyrazol-4-carbonic acid-(ortho-phenyl)-anilides, and use thereof as a fungicide
WO2005123689A1 (en) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and to use thereof as fungicide
WO2006015866A1 (en) 2004-08-12 2006-02-16 Syngenta Participations Ag Method for protecting useful plants or plant propagation material
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
WO2006087325A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances
DE102005009458A1 (en) 2005-03-02 2006-09-07 Bayer Cropscience Ag pyrazolylcarboxanilides
WO2007006670A1 (en) 2005-07-07 2007-01-18 Basf Aktiengesellschaft N-thio-anthranilamid compounds and their use as pesticides
WO2007082098A2 (en) 2006-01-13 2007-07-19 Dow Agrosciences Llc 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
WO2007090624A2 (en) 2006-02-09 2007-08-16 Syngenta Participations Ag A method of protecting a plant propagation material, a plant, and/or plant organs
WO2009090181A2 (en) 2008-01-15 2009-07-23 Bayer Cropscience Sa Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
WO2010069882A1 (en) 2008-12-17 2010-06-24 Syngenta Participations Ag Isoxazole derivatives for use as fungicides
WO2011028657A1 (en) 2009-09-01 2011-03-10 Dow Agrosciences Llc Synergistic fungicidal compositions containing a 5-fluoropyrimidine derivative for fungal control in cereals
WO2011077514A1 (en) 2009-12-22 2011-06-30 三井化学アグロ株式会社 Plant disease control composition and method for controlling plant diseases by applying the composition
WO2011135833A1 (en) 2010-04-28 2011-11-03 Sumitomo Chemical Company, Limited Plant disease control composition and its use
WO2012168188A1 (en) 2011-06-07 2012-12-13 Bayer Intellectual Property Gmbh Active compound combinations
WO2013007767A1 (en) 2011-07-13 2013-01-17 Basf Se Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
WO2013010862A1 (en) 2011-07-15 2013-01-24 Basf Se Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
WO2013024010A1 (en) 2011-08-12 2013-02-21 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2013024009A1 (en) 2011-08-12 2013-02-21 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2013047441A1 (en) 2011-09-26 2013-04-04 日本曹達株式会社 Agricultural and horticultural bactericide composition
WO2013047749A1 (en) 2011-09-29 2013-04-04 三井化学アグロ株式会社 Production method for 4, 4-difluoro-3,4-dihydroisoquinoline derivative
WO2013066835A2 (en) 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
WO2013092224A1 (en) 2011-12-21 2013-06-27 Basf Se Use of strobilurin type compounds for combating phytopathogenic fungi resistant to qo inhibitors
WO2013127704A1 (en) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Active compound combinations containing a thiazoylisoxazoline and a fungicide
WO2013162072A1 (en) 2012-04-27 2013-10-31 Sumitomo Chemical Company, Limited Tetrazolinone compounds and its use as pesticides
WO2015185485A1 (en) 2014-06-06 2015-12-10 Basf Se Use of substituted oxadiazoles for combating phytopathogenic fungi
WO2017072247A1 (en) 2015-10-28 2017-05-04 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
EP3165093A1 (en) 2015-11-05 2017-05-10 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017076742A1 (en) 2015-11-05 2017-05-11 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
EP3167716A1 (en) 2015-11-10 2017-05-17 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017093019A1 (en) 2015-12-03 2017-06-08 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017110862A1 (en) 2015-12-25 2017-06-29 住友化学株式会社 Oxadiazole compound and use thereof
WO2017110864A1 (en) 2015-12-25 2017-06-29 住友化学株式会社 Plant disease control composition and application for same
WO2017110861A1 (en) 2015-12-25 2017-06-29 住友化学株式会社 Plant disease control agent containing oxadiazole compound
WO2017211652A1 (en) 2016-06-09 2017-12-14 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018118781A1 (en) 2016-12-20 2018-06-28 Fmc Corporation Fungicidal oxadiazoles
WO2018202491A1 (en) 2017-05-04 2018-11-08 Basf Se Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi

Non-Patent Citations (19)

* Cited by examiner, † Cited by third party
Title
"Technical Monograph", May 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide Formulation types and international coding system"
AUSTRAL. J. AGRICULT. RES., vol. 58, 2007, pages 708
AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 36, no. 12, 1983, pages 2517 - 2536
CAN. J. PLANT SCI., vol. 48, no. 6, 1968, pages 587 - 94
DETERT S: "Synthesis and electronic spectra of substituted oligo(phenylenevinylene)s", JOURNAL OF PHYSICAL ORGANIC CHEMISTRY, vol. 13, no. 10, 1 January 2000 (2000-01-01), pages 587 - 590, XP055865642 *
DUTRA GERARD: "Preparation of herbicidal (aryl)haloalkylpyrazoles", WO9206962 A1, 1 January 1992 (1992-01-01), pages 1 - 2, XP055865644 *
JOURNAL OF MEDICINAL CHEMISTRY, vol. 41, no. 5, pages 752 - 759
KNOWLES: "Agrow Reports DS243", 2005, T&F INFORMA, article "New developments in crop protection product Formulation"
KNOWLES: "Agrow Reports DS256", 2006, T&F INFORMA, article "Adjuvants and additives"
MCCUTCHEON: "Emulsifiers & Detergents, McCutcheon's Directories", vol. 1, 2008
MOLLETGRUBEMANN: "Formulation technology", 2001, WILEY VCH
PEST MANAGEM. SCI., vol. 61, 2005, pages 246
SCIENCE, vol. 316, no. 1, 2007, pages 185
SYNTHESIS, vol. 2, 2006, pages 325 - 331
TETRAHEDRON LETTERS, vol. 46, 2005, pages 3359 - 3362
TETRAHEDRON LETTERS, vol. 53, no. 37, 2012, pages 5000 - 5003
TETRAHEDRON, vol. 40, 1984, pages 2731
WEED SCI., vol. 57, 2009, pages 108
ZAGAR C: "Substituted aromatic phoshonic acid derivatives", US6175007 B1, 1 January 2001 (2001-01-01), pages 1 - 3, XP055865635 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11578066B1 (en) 2019-12-20 2023-02-14 Tenaya Therapeutics, Inc. Fluoroalkyl-oxadiazoles and uses thereof
US11926622B2 (en) 2019-12-20 2024-03-12 Tenaya Therapeutics, Inc. Fluoroalkyl-oxadiazoles and uses thereof
US12312345B2 (en) 2019-12-20 2025-05-27 Tenaya Therapeutics, Inc. Fluoroalkyl-oxadiazoles and uses thereof
US12201617B2 (en) 2021-05-04 2025-01-21 Tenaya Therapeutics, Inc. HDAC6 inhibitors for treatment of metabolic disease and HFpEF
WO2024068519A1 (en) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hetero)aryl-5-chlorodifluoromethyl-1,2,4-oxadiazole as fungicide
WO2024068517A1 (en) 2022-09-28 2024-04-04 Bayer Aktiengesellschaft 3-(hetero)aryl-5-chlorodifluoromethyl-1,2,4-oxadiazole as fungicide

Also Published As

Publication number Publication date
TW202226947A (en) 2022-07-16
AR123264A1 (en) 2022-11-16
UY39385A (en) 2022-02-25

Similar Documents

Publication Publication Date Title
US11286242B2 (en) Oxadiazoles for use in controlling phytopathogenic fungi
US12486240B2 (en) Oxadiazole compounds for controlling or preventing phytopathogenic fungi
EP3953341B1 (en) Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi
WO2019171234A1 (en) Heterocyclic compounds as fungicides
WO2022038500A1 (en) Novel heterocyclic compounds for combating phytopathogenic fungi
WO2022058877A1 (en) Novel picolinamide compounds for combating phytopathogenic fungi
US20210392895A1 (en) Novel oxadiazoles
US20210387954A1 (en) Oxadiazoles as fungicides
EP4214203A1 (en) Novel picolinamide compounds for combating phytopathogenic fungi
WO2021090282A1 (en) Novel oxadiazole compounds containing fused heterocyclyl rings for controlling or preventing phytopathogenic fungi
WO2022234470A1 (en) Novel fused heterocyclic compounds for combating phytopathogenic fungi
US20220151236A1 (en) Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi
US20250049036A1 (en) Substituted fused bicyclic pyridine carboxamide compounds for combating phytopathogenic fungi
WO2021033133A1 (en) Novel oxadiazole compounds containing 5- membered heteroaromatic ring for controlling or preventing phytopathogenic fungi

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21773147

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21773147

Country of ref document: EP

Kind code of ref document: A1